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Preface 
This thesis is based on the Ph.D project carried out from 2007-2010 at Faculty of Life Science 
(LIFE), University of Copenhagen (KU), Denmark, where the experimental work was mainly 
performed. A part of the project was also performed in collaboration with Institute of Molecu-
lar Animal Breeding and Biotechnology, Ludwig Maximilian University (LMU), Munich, 
where I have spent eight months. The main supervisors are Professor Poul Hyttel and Postdoc 
Vanessa Hall at LIFE, KU with the co-supervisors Associate Professor Bolette Bjerregaard 
from LIFE, KU and Associate Professor Morten Meyer from University of Southern Denmark. 
Finally, Postdoc Nikolai Klymiuk was unofficial supervisor at LMU. 
 
The work presented in this thesis includes an introduction including the objectives of the 
study, followed by a general background describing the relevant topics and techniques. Meth-
ods and materials as well as results are presented in three different manuscripts (see below), 
which are all related to the culture of porcine embryonic stem cells. Finally, in a discussion, 
conclusion and perspective, a parallel between the results and the literature is drawn. A review 
article on porcine embryonic stem cells is included at the end. 
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NANOG promoter regions and expression in pluripotent cells and transgenic embryos. 
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3. Summary 
Recent advances in human embryonic stem cell (ESC) research brings hope for a potential cure of 
severe diseases which are incurable with todays medical treatments. The pig is frequently used as a 
medical model for surgery and organ transplantation due to its similar anatomi and physiology to 
human. Yet, in spite of the obvious advantage of this species as a model organism of human stem 
cell therapy, little is known about porcine ESCs and their differentiation potential. In this PhD 
study, a method for derivation and evaluation of porcine ESC-like cultures was established. Out-
growth colonies (OCs) from the inner cell mass (ICM) or epiblast presented nuclear localized OCT4 
staining, which correlated with an ESC-like morphology and reverse transcriptase PCR with OCT4, 
NANOG and SOX2 showed that these markers were expressed as well. However, when subjected to 
passage, the ESC-like cells quickly lost expression of OCT4 and other pluripotency markers. In 
contrast to previous reports, OCT4 was found to be localized exclusively in the epiblast of hatched 
in-vivo blastocysts, which underlines its importance as a pluripotency marker in the pig. Further-
more, promoter regions of OCT4 and NANOG were isolated and aligned with other mammals and 
putative transcription factor binding sites were identified, including OCT4, SOX2, KLF4 and 
SMADs, which showed highest sequence identity with corresponding binding sites in other ungu-
lates and primates. Furthermore, fluorescent reporter constructs of OCT4 and NANOG were gener-
ated and analysed in pluripotent cells and porcine pre-implantation embryos by use of sperm medi-
ated gene transfer (SMGT) and somatic cell nuclear transfer. Both reporter constructs showed fluo-
rescence in 2-cell to early morula stage embryos and fluorescence of the NANOG reporter was lo-
calized exclusively in the ICM of SGMT produced blastocysts. Directed differentiation of epiblast 
cells into neural cells was accomplished using a coculture protocol and a neural progenitor cell 
(NPC) line was isolated and maintained in culture for more than two months without losing expres-
sion of common NPC markers. When subjected to differentiation, mature neurons as well as astro-
cytes and oligodendrocytes were generated. Overall, these findings have brought the pig one step 
closer as a model of human stem cell therapy. 
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4. Sammendrag (Danish summary) 
Fremskridt i menneskelig embryonal stamcelleforskning har bragt håb om en mulig helbredelse af 
sygdomme, som er uhelbredelige med nutidens medicinske behandlinger. Grisen bliver ofte brugt 
som medicinsk model for kirurgi og organtransplantation på grund af dens lignende anatomi og 
fysiologi til mennesket. Men på trods af grisens åbenlyse fordel som modelorganisme for 
menneskelig stamcelleterapi, har man kun en begrænset viden om embryonale stamceller fra svin 
samt deres differentierings potentiale. I dette PhD studie blev en metode til derivering og evaluering 
af ES-lignende kolonier etableret. ES-lignende kolonier, etableret fra den indre cellemasse eller 
epiblasten, viste kernelokaliseret OCT4 farvning, som korrelerede med en embryonal stamcelle-
lignende morfologi og revers-transkriptase PCR med OCT4, NANOG og SOX2 viste, at disse 
markører også var udtrykt i kolonierne. Cellerne mistede dog hurtigt udtrykket af OCT4 samt andre 
pluripotensmarkører når de blev udsat for passage. I modsætning til tidligere observationer, blev 
OCT4 udelukkende lokaliseret i epiblasten af hatchede in-vivo blastocyster, hvilket understreger 
dens betydning som pluripotensmarkør hos svin. Promotorregioner fra OCT4 og NANOG blev 
isoleret og sammenlignet med andre pattedyr og potentielle transskriptionsfaktor bindingssteder 
blev identificeret, såsom OCT4, SOX2, KLF4 og SMAD, som mest lignede tilsvarende 
bindingssteder i andre store husdyr og primater. Fluorescerende rapporterkonstrukter for OCT4 og 
NANOG blev endvidere genereret og analyseret i præ-implanterede embryoner ved hjælp af sæd-
medieret genoverførsel (SMGT) og somatisk kernecelletransplantation. Begge rapporterkonstrukter 
viste fluorescens fra 2-celle til tidlig morula-stadie embryoner med NANOG rapporterkonstruktet 
lokaliseret udelukkende i den indre cellemasse af SGMT producerede blastocyster. Differentiering 
af epiblast celler til neurale celler blev opnået ved dyrkning i co-kultur og en neural stamcellelinje 
blev isoleret og dyrket in-vitro i mere end to måneder uden at miste udtrykket af neurale 
stamcellemarkører. Når cellerne blev differentieret blev der endvidere dannet neuroner samt 
astrocyter og oligodendrocyter. Tilsammen har disse resultater bragt grisen et skridt nærmere som 
modelorganisme for menneskelig stamcelleterapi. 
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5. Introduction and objectives 
The isolation of embryonic stem cells (ESCs) from the mouse almost 30 years ago is considered a 
hallmark of modern biotechnology and the scientific as well as the public interest in these cells has 
increased ever since. The reason for this is apparent: ESCs possess a unique ability to differentiate 
into all the 230 specialized cell types of the body in addition to a capacity of indefinate self-
renewal. These fascinating characteristics render ESCs highly interesting as a means to study cellu-
lar development in-vitro and as a biomedical candidate to replace senescent and diseased cells of 
the body.  
 
12 years ago, ESCs from human blastocysts were furthermore derived, bringing hope for thousands 
of people suffering from incurable diseases such as Parkinson’s and Alzheimer’s Disease. However, 
this brought along an ethical aspect as well, as destruction of human blastocysts was considered 
unethical by many people. Human ESCs possess the same characteristics as their murine counter-
parts, however, the germline potential, which is considered the ultimate proof of pluripotency has, 
due to ethical reasons, never been shown. In the recent years, there has been a paradigm shift in the 
public opinion, as more and more people are realizing the therapeutic potential of hESC and the 
necessity to promote research within this field. Furthermore, the recent discovery of induced pluri-
potent stem cells could obviate the need for embryo derived stem cells in the future. 
 
With the stage set for human cell replacement therapy, the need for an animal model of stem cell 
therapy, which is phylogenetically close to humans, has never been greater. The pig has a compara-
ble anatomy and physiology and similar size and complexity of organs to humans and with the re-
cent sequencing of the genome as well as improvements in transgenic methods such as somatic cell 
nuclear transfer (SCNT), this species could constitute an important large animal model of human 
stem cell therapy. However, a major impediment is the lack of stable ESC lines in this species. Al-
though several attempts has been made over the last 20 years no porcine ESC lines have so far 
proved capable of maintaining pluripotency in long-term cultures. 
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5.1. Main objectives of the PhD study: 
 
The main objectives of the PhD study was: 
• To derive ESC-like cultures from porcine pre-implantation embryos and characterize these 
with respect to pluripotency marker expression. 
• To establish porcine reporter constructs specific for OCT4 and NANOG and test these in 
pluripotent cells and transgenic embryos. 
• To evaluate the potential of in-vitro cultured epiblast cells to differentiate into neural stem 
cells and mature neurons. 
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6. Background 
6.1. Embryonic development of the pig 
Embryonic development, which is defined as the time between fertilization and birth, is divided into 
different phases including cleavage, gastrulation, organogenesis and gametogenesis (Gilbert SF 
1949). It is evident that the pig is fundamentally different from both humans and mice with respect 
to significant aspects of their embryonic development (Oestrup et al. 2009). A thorough understand-
ing of the embryonic phases from fertilization to neurulation is important for identifying the optimal 
stage for derivation of ESCs and for identification of factors involved in neural differentiation in the 
pig. 
6.1.1. Fertilization 
Conception is the foundation of all mammalian organisms and can be defined as the formation of a 
new organism by fusion of the male and female gamete (Patten BM 1948). Fertilization occurs in 
the ampullary region of the oviduct and the embryos reach the uterus about 2 days after ovulation 
(Szollosi & Hunter 1973; Norberg 1973b; Hyttel et al. 1989). In the pig and cow, loss of cumulus 
investment allow the spermatozoon to contact the zona pellucida (ZP), after which the acrosome 
reaction occurs. Upon penetration of the ZP, syngami, which is defined as fusion of the two gam-
etes, occurs. The result is formation of the zygote, i.e. the one-cell fertilized egg, which possesses 
the unique embryonic genome. Upon gamete fusion, the content of the spermatozoon including the 
nucleus, is expelled into the ooplasm along with the sperm plasma membrane being incorporated 
into the mosaic plasma membrane of the zygote (Laurincik et al. 1995). Along with this process, the 
content of the cortical granules are released into the perivitelline space by exocytosis, establishing a 
block against polyspermic fertilization. Furthermore, meiosis is resumed and maternal chromatin is 
advancing through ana- and telophase II. The maternal and paternal chromatin are surrounded by 
nuclear envelopes establishing two small pronuclei, which upon swelling to their large spherical 
shape, migrate to a close apposition slightly off centre in the zygote. Breakdown of the envelopes 
which is observed at about 24 h after ovulation results in synkaryosis, although an actual fusion of 
pronuclei does not occur in the pig (Hyttel et al. 1988). The zygote is said to be totipotent, which 
means “entire power” and is defined as the ability to give rise to all the cells of the body (Sheridan 
& Harris 2009). Totipotency is maintained until the 4-cell stage. 
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Figure 1. Schematic illustration of the 
development of the pre-hatching por-
cine embryo through embryonic ge-
nome activation and initial blastula-
tion. Note that nucleolar precursor 
bodies (NPB) develop into nucleoli 
with fibrillar centres (FC), dense fibril-
lar component (DFC) and granular 
component at the four-cell stage, and 
that nuclear OCT4 expression is seen 
in both trophectoderm and inner cell 
mass (ICM) of the day 5 blastocyst. 
6.1.2. Cleavage 
After fertilization, a series of mitotic cell divisions called cleavages occur, which results in progres-
sively smaller cells without any change in the overall embryo size (Norberg 1973a).  During the 
next 2-3 days this progressive increase in cell number, now called blastomeres, generates first a 2-
cell, then a 4-cell and finally an 8-cell embryo (Figure 1). In the pig, the major genome activation 
occurs during the third cell cycle in the 4-cell embryo (Tomanek et al. 1989; Hyttel et al. 2000), in 
which formation of a fibrillogranular nucleolus signals the activation of the ribosomal RNA, re-
quired for protein synthesis and viability (Hyttel et al. 2000). In contrast, in the mouse and human, 
the major genome activation occurs after the second and fourth cell cycle, respectively (Oestrup et 
al. 2009). At the 8-16 cell stage, formation of tight junctions and desmosomes between the blas-
tomeres initiates a process known as compaction in which the blastomeres begin to cluster together 
in a tight group, defined as a morula (Norberg 1973a). 
6.1.3. Blastulation 
The subsequent stage, which includes the first polarization of the embryo, is known as blastulation. 
Following compaction, an outer cell layer, called the trophectoderm develops, which actively trans-
ports fluid into the embryo, thereby creating a blastocyst cavity. In addition, a group of inner blas-
tomeres gather at one pole to form the inner cell mass (ICM). The ICM cells are said to be pluripo-
tent, which means “many potent” and can be defined as the ability to form all the cells of the body, 
but not the extra-embryonic tissues (Sheridan & Harris 2009). At this stage, the embryo is defined 
as a blastocyst, which is apparent from approximately Day 5 in the pig (Figure 1) (Hyttel & Nie-
mann 1990) and at Day 3.5 and 5 in the mouse and human, respectively (Hall 2008). In the mouse, 
the ICM cells are most often used for derivation of ESCs (Ginis et al. 2004). Ultrastructural analysis 
of porcine Day 5 embryos showed that the cells of the ICM contain 1-2 nucleoli per nucleus, and 
are poor in cytoplasmic organelles (Norberg 1973a).  
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Figure 2. Schematic 
illustration of the post-
hatching porcine embryo 
through late blastulation. 
Note that the hypoblast 
develops inside the em-
bryo, that nuclear OCT4 
expression becomes re-
stricted to the epiblast, 
and that the Rauber’ layer 
is lost. (Modified from 
Oestrup et al. 2009). 
6.1.4. Hatching 
Hatching of the embryo, occurs after blastulation. At this point, major differences between porcine, 
murine and human embryonic development becomes apparent. The porcine blastocyst develops 
inside the ZP  until approximately Day 7, at which stage the pressure on the ZP becomes too strong, 
resulting in rupture and hatching from it (Hyttel P et al. 2010). Around the same time, the ICM is in 
the process of separating into two distinct cell populations (Oestrup et al. 2009). The most ventral 
part flattens to form the hypoblast, which will finally line the inside of the embryo, whereas, the 
remaining ICM cells form the epiblast (Figure 2). This differs in mouse and human embryos, where 
the epiblast is formed prior to hatching around day 3.5 – 4.5 and day 6, respectively (Hall 2008). In 
the pig, the epiblast is defined as a proliferative epithelium containing tight junctions and desmo-
somes, which form a seal with the trophectoderm to separate the internal embryonic environment 
from the external uterine environment (Flechon et al. 2004). In humans, the epiblast stage is most 
often used for derivation of ESCs (Chen et al. 2009). Around day 9 of gestation, another major dif-
ference between porcine, murine and human embryonic development becomes apparent. In the pig, 
the epiblast becomes exposed to the uterine environment, which is caused by degradation of the 
polar trophectoderm called the Rauber’s layer, after which it is referred to as the embryonic disc 
(Oestrup et al. 2009). The embryo is then defined as being in the pre-streak stage (Vejlsted et al. 
2006a). The amniotic cavity is formed later by fusion of the extra-embryonic tissues. In contrast, in 
mice and humans, the embryonic disc is formed inside the embryo by a process which involves 
cavitation of the epiblast in which the amniotic cavity is formed and the innermost cells sealing this 
cavity make up the embryonic disc (Oestrup et al. 2009). Around Day 11-12, the porcine embryonic 
disc develops into an oval shape containing a crescent-shaped thickening in the posterior end due to 
accumulation of cells (Vejlsted et al. 2006a). This marks the pre-streak stage II and is the first sign 
of anterior – posterior polarity of the embryo proper (Maddox-Hyttel et al. 2003). Pluripotency is 
maintained in the epiblast until gastrulation occurs. 
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Figure 3. Schematic illus-
tration of gastrulation in 
the porcine embryo. Note 
that the embryo elongates, 
that a posterior crescent 
including mesoderm in-
gression forms, that the 
nuclear OCT4 expression 
becomes posteriorly re-
stricted, that OCT4 positive 
primordial germ cells allo-
cate to the dorsal hindgut 
and a posterior cluster, and 
that amniotic folds form 
anteriorly and posteriorly. 
(Modified from Oestrup et 
al. 2009). 
6.1.5. Gastrulation 
At Day 12-13, the crescent-shaped thickening gathers at the posterior end of the disc and from this 
structure, the primitive streak extends anteriorly in the midline of the disc, marking the onset of 
gastrulation (Figure 3) (Vejlsted et al. 2006a). In the mouse it has been shown that members of the 
transforming growth factor β (Tgfβ) family such as Nodal have a profound role in initiating and 
maintaining primitive streak formation (Brennan et al. 2001), whereas bone morphogenic protein 4 
(Bmp4) was found to be required for the generation of primordial germ cells (PGCs) (Lawson et al. 
1999). The primitive streak elongates in an anterior direction to around two thirds of the embryo, 
forming a primitive groove in the midline, through which cell movement from the posterior part of 
the epiblast occurs (Vejlsted et al. 2006b). The result is an epithelial-mesenchymal transition of 
epiblast cells to either meso- or endodermal origin in response to different concentrations of signal-
ing factors, depending on the spatial movement through the primitive streak (Oestrup et al. 2009). 
In the anterior part of the streak, a region called the Spemann’s organizer is formed by synergistic 
input from Activin and Wnt signaling pathways (Watabe et al. 1995). The structure was named after 
the german embryologist Hans Spemann who showed that transplantion from one Xenopus embryo 
to another induced a secondary embryonic primordia (Spemann H & Mangold H 1924). When the 
primitive streak starts to regress, the primitive node gives rise to a mesodermal structure called the 
notochord, which plays important parts in the subsequent neural induction and patterning. Concur-
rently, the trophectoderm begins to elongate dramatically from a 1 cm oovoid structure to around a 
1 m thin filamentous structure (Figure 3). This striking feature may be the cause of a prolonged pre-
implantation period which is followed by non-invasive placentation in the pig compared to the 
mouse and human implantation (Flechon et al. 2004). 
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6.1.6. Neurulation 
The notochord has been shown to play a crucial role in neural induction, which is defined as the 
step when epiblast cells become ‘specified’ as neural cells (Wilson & Hemmati-Brivanlou 1995; 
Wilson & Edlund 2001). Studies on neural induction in Xenopus have shown that secretion of nog-
gin (Smith & Harland 1992), chordin (Sasai et al. 1995) and follistatin (Hemmati-Brivanlou et al. 
1994) from the notochord inhibit the action of members of the tgfβ pathway such as bmp’s, which 
would otherwise instruct the ectoderm into an epidermal fate (Colas & Schoenwolf 2001). In the 
chicken it was furthermore shown that cells receiving fibroblast growth factor (FGF) (Wilson et al. 
2000), in addition to the inhibitory signals, will form a neural plate in the anterior part of the epib-
last with the formation progressing in a anterior-posterior direction. The neural plate is a keyhole-
shaped structure with a broad anterior and a narrow posterior region (Hyttel P et al. 2010). During 
the third week of development, two lateral folds start to form on each side of the midline, thereby 
creating a neural groove. At the 5-7 somite developmental stage, the neural folds fuse to form a 
neural tube (Van Straaten et al. 2000) which is the site of initial specification of neurons as well as 
the origin of the major components of the nervous system (Colas & Schoenwolf 2001). The closure 
of the neural tube occurs anteriorly and posteriorly in a zipper-like fashion (Sadler 2005) and is me-
diated by glycoproteins which hold the folds in place until more permanent cell to cell contacts can 
be established (Sadler 2005). In contrast to the mouse, which have two anterior neuropore closing 
sites, the pig has only a single, which closes at the 22th somite stage, whereas, the posterior neuro-
pore closes at the 28th somite stage (Van Straaten et al. 2000). The notochord, furthermore plays an 
important part in the patterning of neurons in the neural tube (Vejlsted et al. 2006a). Neural pattern-
ing occurs in response to a gradient of sonic hedgehog (SHH) secreted from the notochord and 
BMPs and wingless (WNT) secreted from the neuroectoderm, which have opponent and antagonis-
tic functions along the dorso-ventral axis of the neural tube (Liem, Jr. et al. 2000). The formation of 
the neural tube, which will later give rise to the central nervous system, is known as primary neuru-
lation. The embryonic development of the pig ends at Day 35, with the formation of the major or-
gans, after which the fetal stage begins (Hyttel P et al. 2010). 
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6.2. Embryonic stem cells 
6.2.1. Pluripotency and self-renewal 
In general, three essential characteristics define ESCs (Thomson & Marshall 1998): Firstly, ESCs 
are derived from the pre-implantation or peri-implantation embryos, more precisely from the ICM 
or the epiblast. Secondly, ESCs are capable of prolonged undifferentiated proliferation, which is 
defined as self-renewal, and finally, ESCs are able to form derivatives of the three embryonic germ 
layers, ectoderm, mesoderm and endoderm as well as the germ line. These characteristics, which are 
particularly unique to ESCs, makes them highly attractive for studying developmental processes in-
vitro, as well as an interesting cell type for use in regenerative medicine (Thomson et al. 1998). 
6.2.1.1. Derivation of mouse ESC 
ESCs were first derived in the mouse (mESCs) in 1981 by two separate research groups (Evans & 
Kaufman 1981; Martin 1981). Morphologically, they are described as small, round cells with a 
large nucleus surrounded by a narrow band of non-granular cytoplasm (Robertson EJ 1987). Ultra-
structural analysis showed that mESCs contain some tight- and gap-junctions, especially close to 
the surface of colonies (Ginis et al. 2004). mESCs typically grow in tight, rounded, multilayered 
colonies on feeder cells such as inactivated mouse embryonic fibroblasts (MEF) (Robertson EJ 
1987). However, mESCs can also be cultured in feeder free conditions in the presence of leukemia 
inhibitory factor (LIF) and serum (Smith 2001), or in more defined conditions with LIF and bone 
morphogenic protein 4 (BMP4) (Ying et al. 2003). When mESCs are left without passage for ap-
proximately a week, they begin to differentiate in the periphery of the colony (Robertson EJ 1987). 
 
mESCs are typically derived from a few inbred strains of mice, such as 129 and C57BL/6 (Nagy & 
Vintersten 2006). However, mESCs have also been derived from non-permissive strains by means 
of transgenic methods such as selective ablation (McWhir et al. 1996; Gallagher et al. 2003) and by 
overexpression of kruppel-like finger 4 (KLF4), C-MYC or small molecules (Hanna et al. 2009). 
When cultured in suspension, mESC have been shown to form embryoid bodies (EBs) consisting of 
tissue from the three germ lineages, ectoderm, mesoderm and endoderm (Martin 1981). Moreover, 
when mESCs are injected into nude mice in-vivo, they form teratomas, which is a type of tumor 
consisting of tissues from the three germ lineages (Evans & Kaufman 1981).  Mouse ESCs also 
possess the capacity to generate chimeric animals when injected into early embryos in-vivo and it is 
possible to breed these chimeric mice and produce offspring derived from the mESCs (Bradley et 
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al. 1984). In addition, germ line transmission was demonstrated by Nagy and co-workers, who 
showed that completely mESC derived chimeric mice could be obtained by aggregation with 
tetraploid embryos (Nagy et al. 1993). As tetraploid embryos were developmentally compromised 
at this stage and only formed placentas, mESCs cultured up to passage 14 was forced to form the 
entire embryo proper (Nagy & Vintersten 2006). In contrast, mESCs from non-permissive strains 
typically lack the ability to contribute to chimeras (Chen et al. 2005). Studies have shown that in-
vitro cultured mESCs are capable of more than 250 population doublings without signs of reduced 
growth rate or abnormal karyotypes, while maintaining their pluripotency (Suda et al. 1987).  
6.2.1.2. Derivation of human ESC 
ESCs were derived from humans (hESCs) in 1998 by Thomson and colleagues (Thomson et al. 
1998). The morphology of hESCs was described as being similar to mESCs, and ultrastuctural 
analysis also showed formation of tight- and gap junctions between the cells, particularly at the 
edge of the colony (Park et al. 2004). However, hESCs tend to grow in more flat, loose colonies 
with a clear colony border when cultured on MEF feeder cells in medium containing basic fibro-
blast growth factor (bFGF) (Thomson et al. 1998). hESCs can also be maintained on STO feeder 
cells, which is a SIM mouse embryo-derived Thioguanine and Ouabain resistant cell line with the 
capability of dividing indefinitely (Park et al. 2003), on extracellular matrix (Klimanskaya et al. 
2005) or even in chemically defined conditions (Yao et al. 2006). However, exogenous supplemen-
tation with ACTIVIN was required to maintain hESCs in the undifferentiated state, except when 
cultured on MEF feeder cells, which are known to produce this growth factor (Beattie et al. 2005). 
When hESCs are left without passage for one to two weeks, they start to differentiate from the in-
side of the colony in contrast to mESCs (Thomson & Marshall 1998). 
 
Human ESC lines are most often derived from blastocysts which are obtained from excess in-vitro 
fertilized eggs, and thus, the quality of such embryos varies considerably (Rolletschek & Wobus 
2009). Furthermore, derivation of hESCs from morula stage embryos (Strelchenko et al. 2004) and 
single blastomeres (Klimanskaya et al. 2006) have been reported. Recently, Chen and colleagues 
studied the optimal timing of hESC-derivation using laser assisted isolation of ICM from 584 fro-
zen human embryos (Chen et al. 2009). hESC lines could be derived from embryos at days 5–9 
after fertilization, with isolation on day 6 resulting in the most efficient derivation, corresponding to 
the time of hatching (Hall 2008). This was found to be consistent with a restricted localization of 
the pluripotency marker octamer binding protein 4 (OCT4; also known as POU5F1) to the early 
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epiblast and the trophectodermal marker, caudal-related homeobox 2 (CDX2), to the trophectoderm. 
Furthermore, hESC conditioned medium was reported to improve the derivation of hESC lines from 
low quality embryos (Chen et al. 2009). 
 
The pluripotency of hESCs has been studied in-vitro by EB formation and in-vivo by teratoma for-
mation in severe combined immunodeficient (SCID) mice (Thomson et al. 1998). In both cases, 
cells from the three germ layers were identified. In contrast, chimera contribution and germ line 
potential of hESCs has, due to ethical reasons, not been tested. Human ESCs can be maintained for 
several years in culture and undergo hundreds of population doublings (Hoffman & Carpenter 
2005). 
6.2.1.3. Attempts of porcine ESC derivation 
Since the initial attempts of porcine ESC (pESC) derivation (Piedrahita et al. 1990; Notarianni et al. 
1990), a range of attempts have been made to establish porcine ESCs (pESC) (for reviews see 
(Vackova et al. 2007; Keefer et al. 2007; Brevini et al. 2007a; Hall 2008; Talbot & Blomberg 2008; 
Blomberg et al. 2008)). However, none of the attempts have resulted in the derivation of stem cell 
lines which display the same pluripotency characteristics as human and mouse ESCs (Telugu et al. 
2009). Instead, many cell lines appear to have some stem cell characteristics, and are thus termed 
stem cell-like. 
 
In general, the morphology of pESC-like cells were reported to be similar to mESCs and hESCs 
with a high nuclear-cytoplasmic ratio, containing one or two nucleoli (Piedrahita et al. 1990). Ultra-
structural analysis showed that isolated pig epiblasts from Day 8 embryos, cultured for 36 hours on 
STO feeder layers formed a monolayer of cells connected by tight junctions and desmosomes (Tal-
bot & Garrett 2001). In addition, structures such as Golgi, mitochondria and microfilaments were 
more developed compared to uncultured epiblast cells. Interestingly, a solitary cilium was observed 
projecting from the apical surface of an epiblast cell (Talbot & Garrett 2001). In hESC, primary 
cilia has recently been shown to be involved in SHH signaling and is shown to play a critical role in 
hESC differentiation parallel to that in early embryogenesis. (Kiprilov et al. 2008). 
 
At least 12 different groups have reported that pESC-like cells can generate cells representative of 
the three germ layers, when they are cultured as EBs (Vackova et al. 2007). However, the passage 
numbers, from which these cells are used, are not stated in these studies. In-vivo transplantation of 
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whole porcine blastocysts in mice gave rise to teratomas, but only in older stage embryos around 
Day 11-12 (Anderson et al. 1994). In accordance, pESC-like lines derived from Day 10-11 epiblasts 
also developed teratomas, whereas, cell lines from Day 5-6 blastocysts failed to do so (Piedrahita et 
al. 1990; Hochereau-De Reviers & Perreau 1993). It is possible that the late stages were already 
undergoing differentiation, as gastrulation initiates around Day 12 in the pig. In contrast, fetal (No-
tarianni et al. 1997) and live born chimeras (Anderson et al. 1994; Onishi et al. 1994; Nagashima et 
al. 2004) with germ line potential were produced by injection of freshly isolated ICM or early epib-
last from Day 6-7 embryos into blastocysts, which substantiates that this stage is pluripotent. When 
subjected to in-vitro culture, ICM-derived cells cultured for less than 15 passages with passage 
every fourth days proved capable of integrating into chimeric embryos (Shiue et al. 2006). How-
ever, only a single report has described the production of a live born chimeric pig derived from 
pESC-like cells, but germ line potential was not reported (Chen et al. 1999). In our laboratory, we 
have obtained and cultured cells from the same pESC line, but were unable to detect essential 
markers of pluripotency such as OCT4, NANOG and SOX2 (Personal communication, Petkov S and 
Hall V). The longest reported maintenance of a pESC-like cell line is around one year (Notarianni 
et al. 1990) or 90 passages (Talbot et al. 1993), however, these lines have not been characterized in-
vivo. 
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Figure 4. Key signaling pathway required for 
maintaining pluripotency of mouse embryonic 
stem cells . LIF signaling activates JAK–STAT3 to 
induce target genes essential for pluripotency, such 
as c-myc. c-myc is also regulated negatively by 
glycogen synthase kinase-3 (GSK3)b via inhibitory 
phosphorylation. Leukemia inhibitory factor also 
induces MAP kinase activation, which antagonizes 
self-renewal. Bone morphogenetic protein signals 
potentially function in two ways: (i) activation of 
Smad1/5/8-Id gene and (ii) suppression of p38 
MAP kinase. (Modified after Ohtsuka et al. 2008). 
 
6.2.2. Signaling pathways 
6.2.2.1. Signaling pathways in mouse ESC 
Pluripotency is maintained through different signaling pathways in the mouse and human, respec-
tively (Valdimarsdottir & Mummery 2005). In mESCs, the janus-associated tyrosine kinase and 
signal transducer and activator of transcription 3 (JAK-STAT3), BMP4, WNT and mitogen-
activated protein kinase and extracellular regulated kinases (MEK-ERK) are the major pathways 
maintaining self-renewal and pluripotency (Figure 4.) (Okita & Yamanaka 2006). LIF is known to 
support the undifferentiated state of mESCs by activating the transcription factor STAT3 through 
the JAK/STAT pathway (Smith et al. 1988) and BMP4 can enhance self-renewal and pluripotency 
of mESC by activating members of the inhibition of differentiation (id) gene family through the 
SMAD1/5/8 pathway (Ying et al. 2003). In addition, the WNT pathway has been shown to delay 
the onset of differentiation (Sato et al. 2004). Recently, a defined protocol in which a combination 
of three inhibitors targeting the FGF, MEK, and the glycogen synthase kinase 3 (GSK3) receptors 
resulted in efficient derivation and propagation of germline competent mESCs from a range of non-
permissive mouse strains (Ying et al. 2008). Surprisingly, the same strategy proved to be successful 
in derivation of rat ESCs, which were capable of germ line transmission (Buehr et al. 2008). It was 
proposed that the key to ESC derivation could lie in the use of inhibitors to shield the native state 
from differentiation, rather than growth factor stimulation. 
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Figure 5. Key signaling pathway required 
for maintaining pluripotency of human 
embryonic stem cells. Fibroblast growth 
factor is an essential factor for hESCs self-
renewal and functions in part by inducing 
Activin secretion from mouse embryonic 
fibroblasts. Activin/Nodal signaling is 
essential to support hESCs self-renewal via 
activation of Smad2/3. In contrast to 
mESCs, bone morphogenetic protein pro-
motes hESCs differentiation toward tro-
phectoderm. (Modified after Ohtsuka et al. 
2008). 
6.2.2.2. Signaling pathways in human ESC 
In contrast to mESCs, pluripotency in hESCs is maintained through the FGF, the AC-
TIVIN/NODAL and the MEK/ERK pathways (Figure 5) (Ohtsuka & Dalton 2008). bFGF signaling 
(Mummery et al. 1993; Levenstein et al. 2006) has been shown to occur through a paracrine net-
work, in which bFGF binds to MEF cells and hESC derived fibroblast-like cells, which in turn pro-
duce factors such as insulin-like growth factor necessary for the survival of hESCs (Greber et al. 
2007; Bendall et al. 2007). Furthermore, bFGF has been shown to repress BMP4 and its down-
stream effectors, SMAD1/5/8 (Xu et al. 2005). ACTIVIN/NODAL signaling through SMAD2/3 
(Vallier et al. 2005; James et al. 2005), as well as the MEK/ERK pathway (Li et al. 2007) are both 
necessary to maintain the pluripotent state of hESCs. In addition, the WNT pathway has been 
shown to delay the onset of differentiation in hESCs (Sato et al. 2004).  
 
 
6.2.2.3. Signaling pathways in porcine ESC 
In contrast to the mouse and human, not much is known about the regulation of pluripotency in the 
pig. It has been reported that NOGGIN (an antagonist of BMP4 acting to inhibit differentiation in 
human ES cell) was expressed exclusively in the epiblast of Day 8 embryos (Blomberg et al. 2008). 
Furthermore, low levels of LIF, glycoprotein 130 (GP130), and BMP4 were detected In Day 6 em-
bryos, whereas bFGF and FGF receptor (FGFR) 1 and 2 were detected in Day 11 embryos (Hall et 
al. 2009). Since FGFR1 was located exclusively in the epiblast and bFGF was produced by the sur-
rounding trophectoderm it was speculated that, as in hESCs, a paracrine FGF signaling pathway 
could play a role in maintaining pluripotency at this developmental stage. It is, however, possible 
that other unknown pathways are involved in maintaining the pluripotent state in the pig.  
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6.2.3. Pluripotency markers   
In ESCs, external signaling with growth factors leads to regulation of a number of genes ultimately 
resulting in the pluripotent state (Pan & Thomson 2007). These downstream targets have been the 
focus of much research and to date, a range of pluripotency markers have been identified in the 
mouse and human, of which some seem to be species-specific (Ginis et al. 2004). Three key tran-
scription factors, OCT4, NANOG and SOX2, seem to be highly conserved and are commonly used 
to define pluripotent cells in rodents and primates (Thomson et al. 1998). In hESCs it has been re-
ported that OCT4, NANOG and SOX2 bind simultaneously to more than 352 genes, thereby regu-
lating their expression (Boyer et al. 2005). In addition, they bind to their own promoters, thereby 
forming an interconnected auto-regulation loop which maintain the ESC identity. In the pig, how-
ever, an atypical expression pattern of these pluripotency markers have been reported (Keefer et al. 
2007; Hall et al. 2009), which casts doubt upon their role in maintaining the pluripotency network 
in this species. Hence, a comparison of the expression of core pluripotency markers in the pig and 
the mouse and human, is essential. 
6.2.3.1. Oct4 
Oct4 was first discovered in the mouse in 1990 (Okamoto et al. 1990; Scholer et al. 1990b) and was 
mapped to chromosome 17, close to the major histocompatability complex (MHC) (Scholer et al. 
1990a). OCT4 is considered the most valid marker of epigenetic reprogramming and pluripotency 
(Pesce & Scholer 2000; Pesce & Scholer 2001) and belongs to a group of proteins containing a 
POU-domain (Pit-Oct-Unc), which enables it to bind to the octamer consensus sequence 
ATGCAAAT. In conjunction with SOX2, OCT4 is known to upregulate the expression of Nanog 
(Rodda et al. 2005) and Sox2 (Catena et al. 2004), in addition to its own expression (Figure 6) 
(Okumura-Nakanishi et al. 2005). Furthermore, it upregulates Fgf4 which is essential to survival of 
post-implantaion embryos (Yuan et al. 1995; Niwa et al. 2000). Multiple other downstream targets 
of OCT4 have been identified (Loh et al. 2006; Wang et al. 2006; Babaie et al. 2007; Kim et al. 
2008a).  
 
Oct4 is expressed in a tissue-specific manner in mouse pre-implantation embryos (Schoorlemmer et 
al. 1994). The expression starts from the 4-cell stage immediately after the genome activation and 
remains present in all cells until the morula stage (Ovitt & Scholer 1998). At the blastocyst stage, 
Oct4 becomes restricted to the ICM (Dietrich & Hiiragi 2007). Following implantation, it is limited 
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to primitive ectodermal cells (Ovitt & Scholer 1998) and finally around gastrulation it becomes re-
stricted to the PGC (Pesce & Scholer 2000). Studies have shown, that mice containing a homozy-
gotic deletion of Oct4 do not develop further than the blastocyst stage and do not contain an ICM 
but consists instead entirely of trophectoderm (Nichols et al. 1998). Hence, it was proposed that 
Oct4 maintains totipotency (Yeom et al. 1996; Nordhoff et al. 2001). When Niwa and colleagues 
examined the regulation of Oct4 in mESCs they found that it was regulated in a dose dependent 
manner in which downregulation of 150% induced trophectoderm differentiation, whereas, an 
upregulation of 50% induced hypoblast or mesoderm differentiation (Niwa et al. 2000). The authors 
proposed that Oct4 functions as a “gatekeeper” of pluripotency, by preventing differentiation of 
cells into the trophoblast lineage, which is mediated through a downregulation of trophoblast-
specific genes such as Cdx2 (Figure 6) (Niwa et al. 2000).  
 
Human OCT4 was also identified close to the MHC on chromosome 6 (Takeda et al. 1992). In con-
trast to the mouse Oct4, at least two isoforms have been identified due to differential splicing, 
termed OCT4A and OCT4B (Cauffman et al. 2006). Whereas OCT4A seems to be specific for 
hESCs and hEGCs, OCT4B is also expressed in mature cells. However, the latter can be identified 
by its cytoplasmic localization (Atlasi et al. 2008). In addition, several OCT4 pseudogenes have 
been identified, but these are not functionally active. The expression profile of OCT4 in human pre-
implantation embryos was first believed to correspond to the mouse, as a difference in OCT4 ex-
pression was found between the ICM and the TE on the mRNA level (Hansis et al. 2000; Hansis et 
al. 2001). However, analysis of mRNA expression and protein staining later revealed OCT4 expres-
sion in both of these cell types, from the morula to the blastocyst stage, indicating a different ex-
pression pattern than the mouse (Cauffman et al. 2005). Using immunocytochemistry, it was re-
centy shown that OCT4 becomes confined to the ICM of the blastocyst from approximately Day 6, 
when the epiblast and hypoblast begin to form (Chen et al. 2009). In hESC, OCT4 is often used as a 
pluripotency marker, and is considered a master regulator of self-renewal (Atlasi et al. 2008). 
 
In the pig, OCT4 is located close to the MHC on chromosome 7 (Chardon et al. 2000). It does not 
seem to be specific for totipotent cells as immunocytochemical analysis revealed the presence of 
OCT4 protein in all the cells of the blastocyst, including the ICM and trophectoderm (Figure 1) 
(Kirchhof et al. 2000; Spencer et al. 2006; Keefer et al. 2007; Kuijk et al. 2008; Hall et al. 2009). 
After hatching, OCT4 was reported to be present in both the ICM and trophectoderm until Day 10-
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13, after which it is downregulated (Kirchhof et al. 2000; Kuijk et al. 2008). However, other studies 
have shown that OCT4 becomes confined to the epiblast after hatching (Figure 2) (Flechon et al. 
2004; Vejlsted et al. 2006a; Vejlsted et al. 2006b). Furthermore, Blomberg and colleagues found 
that OCT4 displayed a restricted expression pattern to the epiblast of Day 8 blastocysts (Blomberg 
et al. 2008). An upregulation of OCT4 after 24-48 hours of in-vitro culture was furthermore re-
ported, which could preclude the onset of differentiation. At day 13, OCT4 is only found in PGCs, 
which allocate to the dorsal hindgut and a posterior cluster (Figure 3) (Vejlsted et al. 2006b). Stud-
ies on different types of porcine embryos have shown that nuclear transfer blastocysts had signifi-
cantly lower expression of OCT4 compared to in-vivo and in-vitro fertilized blastocysts (Kumar et 
al. 2007; Xing et al. 2009). The low level of OCT4 expression in nuclear transfer blastocysts could 
reflect an incomplete reprogramming, or the presence of fewer cells within the embryo. 
6.2.3.2. Nanog 
Nanog was first identified in the mouse in 2003 (Wang et al. 2003; Chambers et al. 2003; Mitsui et 
al. 2003) and was named after a mythological Celtic land of eternal youth, Tir Nan Og. Nanog be-
longs to a family of proteins containing homeobox domains, and binds to the consensus sequence 
(C/G)(G/A)(C/G)C(G/C)ATTAN(G/C), where ATTA is a common homeobox DNA binding se-
quence (Mitsui et al. 2003). Nanog is believed to direct the ICM to an epiblast fate by downregulat-
ing of primitive endoderm specific genes such as Gata6 (Figure 6) (Mitsui et al. 2003). Hence, 
Nanog acts one step later in development compared to Oct4.  
 
Nanog is expressed in a tissue-specific manner in the mouse (Wang et al. 2003). The earliest ex-
pression has been detected in late morula and was confined to the ICM of blastocysts (Mitsui et al. 
2003; Hart et al. 2004; Hatano et al. 2005). After implantation, Nanog is only expressed in the epib-
last (Hatano et al. 2005). Nanog is downregulated during gastrulation when the epiblast cells enter 
the primitive streak, after which it is not detected again until formation of the genital ridge of the 
early gonads (Hart et al. 2004). Transcripts for Nanog are not detected in several adult tissues by 
Northern Blot, however, low levels of Nanog were reproducibly detected in many adult tissues by 
RT-PCR (Hart et al. 2004). Despite a delayed expression in pre-implantation embryos, the expres-
sion profile of Nanog seems to be quite similar to that of Oct4. When Mitsui and colleagues bred 
mice heterologous for Nanog, no homozygotic -/- Nanog mice were found, which was attributed to 
a lack of epiblast formation (Mitsui et al. 2003). However, it was later shown that mutant Nanog -/- 
mice were in fact able to survive to adulthood although contribution to the germ line was not ob-
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Figure 6. Transcription factor 
networks for pluripotent stem cells 
(green), trophectoderm (yellow) 
and primitive (extraembryonic) 
endoderm (blue). Positive-feedback 
loops between Oct4, Sox2 and 
Nanog maintain their expression to 
promote continuous ES cell self-
renewal. Cdx2 is autoregulated and 
forms a reciprocal inhibitory loop 
with Oct4, which acts to establish 
their mutually exclusive expression 
patterns. A similar regulatory loop 
exist for Nanog and Gata6. Coup-
tfs and Gcnf act as a negative-
feedback system to repress Oct4 
completely. (From Niwa et al. 
2007). 
 
served (Chambers et al. 2007). The authors concluded that Nanog is dispensible for expression of 
somatic pluripotency but is specifically required for formation of EGCs. Interestingly, overexpres-
sion of Nanog in mESCs has been shown to be sufficient to maintain pluripotency without the re-
quirement of feeder cells or growth factors (Chambers et al. 2003). However, Hatano and col-
leagues noticed that mESCs positive for Oct4, were not always positive for Nanog (Hatano et al. 
2005). This fluctuation was later confirmed by Chambers and colleagues, whom showed that Nanog 
is not strictly required for self-renewal of murine ESC but rather acts as a safeguard against differ-
entiation (Chambers et al. 2007). 
 
In human, NANOG protein was identified in the ICM of expanded blastocysts, but not in earlier 
developmental stages (Hyslop et al. 2005). This is in accordance with its function later in develop-
ment compared to OCT4 (Mitsui et al. 2003). Like OCT4, two isoforms of NANOG have been de-
tected in humans (Hart et al. 2004). Low levels of NANOG expression detected in many adult tis-
sues by RT-PCR was attributed to the spliced variant. Furthermore, NANOG was found to be ex-
pressed in hESCs and embryonic carcinoma cells and downregulation with small interfering RNA 
resulted in upregulation of extraembryonic endoderm and trophoblast-specific genes, indicating that 
NANOG also function as a “gatekeeper” of pluripotency in humans (Hyslop et al. 2005). 
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In the pig, NANOG mRNA expression as well as protein staining was not observed in Day 6-8 blas-
tocysts (Blomberg et al. 2008; Kuijk et al. 2008; Hall et al. 2009). Instead, NANOG was detected in 
several adult cells and tissues including porcine umbilical cord cells and porcine fetal fibroblasts 
(Carlin et al. 2006) as well as porcine brain, lung and liver (Blomberg et al. 2008). Together, these 
results points to a non-pluripotent role of NANOG in the pig. On the other hand, using immunocy-
tochemistry, NANOG has been observed exclusively in the epiblast of Day 9 and 11 blastocysts 
(Hall et al. 2009) and studies have shown that NANOG transcripts were significantly upregulated in 
in-vivo blastocysts compared to in-vitro produced blastocysts (Kumar et al. 2007; Magnani & 
Cabot 2008; Xing et al. 2009). 
6.2.3.3. Other pluripotency markers 
Several other pluripotency markers have been described in the mouse and human, of which the most 
important are the transcription factors Sox2 and Rex1 as well as stage specific embryonic antigens 
(SSEA) -1, -2, -3 and -4 and the tumor rejection antigens (TRA) -1-60 and -1-81 (Ginis et al. 2004). 
 
Sox2 is a member of the SRY-related HMG box gene family that encode transcription factors with a 
single DNA-binding domain. (Avilion et al. 2003). In the mouse, Sox2 is expressed in the cells of 
the ICM and its descendant, the epiblast, whereas, in the trophectoderm it is localized in cytoplasm. 
SOX2 has been found to regulate a range of genes associated with pluripotency, often in collabora-
tion with OCT4 (Catena et al. 2004). However, in contrast to Oct4 and Nanog, Sox2 is not an exclu-
sive marker of pluripotency as it is also expressed in early neuroectodermal cells. In-vitro, Sox2 is 
expressed in both mESCs and hESCs (Ginis et al. 2004). Studies of SOX2 expression in the pig are 
limited, however, it was reported to be exclusively expressed in the epiblast of Day 9-11 embryos 
(Hall et al. 2009). 
 
The zinc finger protein, Rex1 is a transcription factor present in the mouse and human ICM and 
ESCs (Rogers et al. 1991). However, Rex1 does not appear to be a specific marker in these species 
as it is also detected in the trophectoderm. In the pig, REX1 seems to be specific for the epiblast of 
Day 8 blastocysts and could be a useful marker of pluripotency (Blomberg et al. 2008). 
 
The cell surface markers are glycoproteins specifically expressed in early embryonic development 
(Mandal et al. 2006). Mouse ESCs express SSEA1 and -3, whereas, hESCs express SSEA3 and -4 
(Ginis et al. 2004). In addition, SSEA-1 has been shown to be expressed in the Day 7 porcine epib-
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last but not in the trophectoderm (Wianny et al. 1997) and in some cells of the Day 12 embryonic 
disc (Flechon et al. 2004). Unpublished results from our research group indicate that SSEA-1 is 
exclusively expressed in the porcine ICM at Day 6, remains restricted in the early epiblast at D8 and 
is downregulated in the late epiblast at Day 10, where expression is observed in the trophectoderm. 
Hence, it could be a potential marker of pESCs. Finally, SSEA1 has been detected in porcine PGCs 
(Takagi et al. 1997).  
 
Finally, the tumor rejection antigens, TRA-1-60 and TRA-1-81, normally synthesized in undifferen-
tiated cells, are used as markers for hESCs (Xu et al. 2001). However, in the pig, no reports on ex-
pression of TRA in ESC-like cells are available and they were not detected in PGCs (Takagi et al. 
1997). 
 
  
24 
 
6.2.4. Other types of pluripotent stem cells 
6.2.4.1. Epiblast stem cells 
Recently, a new type of pluripotent stem cell termed epiblast stem cells (EpiSCs) was identified,  
which were derived from the epiblast of Day 6.5 and Day 7.5 mice and rats, respectively (Brons et 
al. 2007). EpiSCs are developmentally and functionally different from mESCs and can be main-
tained in chemically defined culture conditions including ACTIVIN and bFGF. They share many 
characteristics with hESCs such as expression of pluripotency markers and sensitivity to single-cell 
dissociation (Brons et al. 2007; Tesar et al. 2007). Although EpiSCs do exhibit capacity for multi-
lineage differentiation and teratoma formation, they do not contribute significantly to chimeras (Te-
sar et al. 2007). Yet, reprogramming of EpiSCs to a mESC-like state has been achieved by overex-
pression of Klf4 and the resulting cells were capable of producing germline chimeras (Guo et al. 
2009). The findings outlined above demonstrate that the Activin/Nodal pathway plays a central role 
in pluripotency specifically representing the late epiblast cells just before gastrulation (Guo et al. 
2009) and have lead to the theory that hESCs could in fact be EpiSCs rather than true ESCs capable 
of germline transmission (Rossant 2008). 
6.2.4.2. Induced pluripotent stem cells 
A significant breakthrough was made in the stem cell field when Takahashi and Yamanaka in 2006 
reported the generation of induced pluripotent stem cells (iPSCs) from fetal and adult mouse fibro-
blast cells (miPSCs) by defined factors (Takahashi & Yamanaka 2006). The findings were based on 
the hypothesis that the oocyte and ESCs both contain factors required for the reprogramming and 
maintenance of pluripotency and the experimental setup comprised retroviral transduction of 24 
candidate factors in different combinations into fibroblast cells. Finally, the factors were narrowed 
down to four candidates: Oct4, Sox2, Klf4 and C-myc (Figure 7). The obtained miPSCs could be 
maintained on STO feeder cells in the presence of LIF and showed the same morphology as 
mESCs. In addition, miPSCs expressed the same pluripotency markers and were able to differenti-
ate into cells of the three germlayers, which was demonstrated both in-vitro by EB formation and 
in-vivo by teratoma and chimera formation. Later, germline competent miPSCs were obtained 
(Wernig et al. 2007; Meissner et al. 2007) by eg. selection for reprogrammed cells expressing 
Nanog (Okita et al. 2007). 
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Another significant breakthrough was the generation of iPSCs from fetal and adult human fibroblast 
cells (hiPSCs), which could potentially overcome the need for destruction of a living human em-
bryo (Takahashi et al. 2007; Yu et al. 2007; Park et al. 2008b). This was achieved using the same 
human factors OCT4, SOX2, KLF4 and C-MYC, indicating that the essential reprogramming factors 
are conserved between these species. However, in one case, the C-MYC gene was successfully sub-
stituted with the transcription factor LIN28 (Yu et al. 2007). Whereas miPSCs could be used as to 
study reprogramming or as a tool for studying disease mechanisms, hiPSCs hold great potential for 
use in cellular therapy of human diseases (Rolletschek & Wobus 2009). Firstly, these cells can be 
derived from a skin biopsy taken from a patient carrying a particular disease. These patient-specific 
hiPSCs could then be differentiated into mature cells and transplanted back into the same patient, 
thereby eliminating the risk of immunogenic rejection. Finally, hiPSCs could be used to study the 
mechanism of a particular disease or to test the effect of various drugs in-vitro. Recently, hiPSCs 
have been generated from a range of patients, including Parkinson’s Disease (PD) and Huntington’s 
Disease (HD) patients (Park et al. 2008a), which could be very useful in the future for in-vitro dis-
ease and transplantation studies. However, before hiPSCs can be used in cellular therapy, a number 
of safety issues has to be addressed. One of the most critical issues is that some of the reprogram-
ming factors may be oncogenic (Takahashi et al. 2007) as reactivation of C-myc carried by a retro-
virus resulted in tumor formation in ~20% of chimeric mice generated from miPSCs (Okita et al. 
2007). However, it was later shown that C-myc could be excluded, which is an important step to-
ward a safer application (Wernig et al. 2008a) and it was found that six of 37 chimeras derived from 
miPSCs died of tumors within 100 days after birth whereas all 26 chimeras generated without C-
myc survived this period (Nakagawa et al. 2008). In addition, treatment with a histone deacetylase 
inhibitor called valproic acid enabled reprogramming of primary human fibroblasts with only the 
two factors OCT4 and SOX2 (Huangfu et al. 2008). Furthermore, it was found that human neural 
stem cells, which already express SOX2, KLF4 and C-MYC endogenously, could more easily be 
reprogrammed by OCT4 and KLF4 (Kim et al. 2008b), or even by OCT4 alone (Kim et al. 2009). 
Another important issue is the viral integration of factors, which may lead to continued expression 
of transgenes. However, reprogramming without integration in the genome has been accomplished 
by use of adenovirus (Stadtfeld et al. 2008), plasmids (Okita et al. 2008), transposons (Kaji et al. 
2009; Woltjen et al. 2009), small molecules (Silva et al. 2008) and even proteins (Zhou et al. 2009). 
Hence, during the last 3 to 4 years, this exciting technology has taken a giant step towards a clinical 
application. 
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Figure 7. Establishment of pluripotency in 
somatic cell nuclei. The four transcription 
factors, OCT4, Sox2, Klf4 and C-myc, were 
found to be sufficient to establish pluripo-
tency in the nuclei of fibroblasts. Oct4, 
Sox2 and Klf4 might function together to 
activate target genes to establish the stable 
pluripotent transcription factor network, as 
well as the pluripotent epigenome, whereas 
C-myc might enhance the accessibility of 
target genes by stimulating DNA replica-
tion. (From Niwa et al. 2007). 
 
Recently, porcine iPSCs (piPSCs) have also been generated, which may be very important for 
safety and efficacy testing prior to transplantation of hiPSCs to human patients (Roberts et al. 
2009). This was achieved almost simultaneously by three different groups, which all relied on viral 
transduction of porcine fetal fibroblasts (PFFs) with the human factors OCT4, SOX2, KLF4 and C-
MYC (Ezashi et al. 2009; Wu et al. 2009), in addition to the corresponding mouse factors (Esteban 
et al. 2009). The morphology was reported to be similar to hESCs and primary porcine epiblast 
cells, with a high nucleus to cytoplasm ratio and prominent nucleoli (Wu et al. 2009). Like their 
human counterparts, piPSCs could be maintained on MEF feeder cells supplemented with bFGF for 
more than 220 population doublings (Ezashi et al. 2009), although one study did not use bFGF (Wu 
et al. 2009). Although they expressed the basic pluripotency markers, OCT4, NANOG and SOX2, a 
difference in the expression of surface markers was reported, as one group found expression of 
SSEA1, as in mESCs (Ezashi et al. 2009), whereas another group found expression of SSEA3 and 4 
as well as TRA-1-60 and 1-81, as in hESCs (Wu et al. 2009). The pluripotency of piPSCs was, in 
all cases, confirmed using EB formation as well as teratoma formation. However, germ line chime-
ras, which is considered the final proof of pluripotency, was not shown. Given the recent reports on 
differences between ICM derived ESCs and epiblast-derived EpiSCs, generation of piPSCs in the 
presence of LIF is currently being pursued, which could turn out to hold germ line potential (Telugu 
et al. 2009). Studying the signaling network maintaining pluripotency in piPSCs could hold the key 
to establishment of pESCs in the future. 
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6.3. Reporters in stem cell research 
Three different types of reporters have been used in stem cell research to monitor the expression of 
a particular gene in response to certain stimuli. These include promoter constructs under the control 
of regulatory DNA, fusion constructs for localization and tracking of a protein in living cells and 
bicistronic gene constructs which allow for transcription of two functional proteins from the same 
promoter (Habermann et al. 2007). Initially, β-galactosidase and luciferase were the genes most 
frequently used to monitor transcription. The staining of β-galactosidase confers a strong signal 
intensity and this method has been used for the initial characterization of the expression pattern of 
Oct4 (Yeom et al. 1996) and Nanog (Mitsui et al. 2003) in murine embryos. In contrast, luciferase 
was most often used to monitor quantitative transcription and has played an important role in de-
termining the regulatory elements in both the Oct4 (Okumura-Nakanishi et al. 2005) and Nanog 
(Wu & Yao 2005; Hattori et al. 2007) upstream promoters. However, these reporters are not suit-
able for measuring promoter activity at different time-points due to the need for enzymatic sub-
strates and fixation (Soboleski et al. 2005). 
6.3.1. Green fluorescent protein as a reporter 
To date, Green Flurorescent Protein (GFP) is the most utilized reporter protein, due to its independ-
ence from enzymatic substrates, which makes it particularly promising in transgenic embryos and 
animals (Tsien 1998). GFP was first discovered in 1962 in the jellyfish Aequorea victoria (SHI-
MOMURA et al. 1962), however, it was not until the protein was cloned and sequenced (Prasher et 
al. 1992) and inserted in other species (Chalfie et al. 1994; Inouye & Tsuji 1994), that its potential 
as a reporter was realized. Reportedly, the protein consists of 11 β-strands forming a hollow cylin-
der in which an α-helix bearing the chromophore is located (Tsien 1998). The barrel structure pro-
tects the chromophore from degradation, and the chromophore, which consists of the three amino 
acids Serine, Tyrosine and Glycine, can undergo spontaneous oxidation, thereby emitting fluores-
cence (Tsien 1998).   
 
Reportedly, three separate elements can determine if a fluorescent protein is suited as a reporter. 
Firstly, it must have a strong signal intensity. Secondly, it should not interfere with the cellular 
physiology and finally, it should have a short biological half-life (Habermann et al. 2007). In 1995, 
a red shifted variant of GFP, called enhanced GFP (EGFP), was identified and isolated by site di-
rected mutagenesis (Heim et al. 1995; Cormack et al. 1996). This protein exhibited a 100 fold in-
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creased fluorescence intensity, as well as improved folding compared to wild type GFP. Later, a 
“humanized” EGFP was generated by codon optimization (Yang et al. 1996) and by inclusion of a 
ribosome binding site (Kozak 1989), which allowed the protein to be expressed in eukaryotic cells. 
To improve the half-life of EGFP, a destabilized version, termed dEGFP, has also been generated. 
The gene mouse ornithine decarboxylase (Modc) was found to contain a PEST sequence (rich in 
proline, glutamine, serine and threonine) in its C-terminus, which targets it for rapid degradation by 
the proteasome (Li et al. 1998). This PEST sequence has been added to the EGFP variants, thereby 
lowering the half-life of EGFP from around 24 hours to two hours. Short half-lives are reported to 
be especially suited for the study of promoter activity and the protein exhibits lower cytotoxicity 
due to reduced accumulation (Habermann et al. 2007). 
6.3.1.1. GFP reporters in embryos and stem cells 
There are numerous reports on the use of EGFP as a reporter during early embryonic development 
as well as in embryonic- and adult stem cells. In 1995, it was demonstrated that EGFP could func-
tion as a reporter in transgenic mouse pre-implantation embryos (Ikawa et al. 1995). Later, it was 
found that porcine SCNT embryos containing EGFP also expressed the protein in all cells and were 
able to develop to the blastocyst stage (Uhm et al. 2000). EGFP can be used to measure quantitative 
gene expression, as the intensity of GFP fluorescence is directly proportional to mRNA abundance 
(Soboleski et al. 2005). This feature was exploited in a study by Wuensch and co-workers in which 
EGFP was used to quantitatively monitor expression of OCT4 in bovine SCNT embryos (Wuensch 
et al. 2007). Hadjantonakis and co-workers have also shown that EGFP is functional in mESCs, and 
that these cells can be used to generate transgenic mice containing EGFP (Hadjantonakis et al. 
1998). In the human, a EGFP reporter of the pluripotency gene, REX1 was shown to be an efficient 
tool to monitor the undifferentiated state of hESCs (Eiges et al. 2001). Furthermore, recent ad-
vances in generation of iPSCs (Takahashi & Yamanaka 2006) has relied on the use of pluripotency 
reporters, such as the Oct4 and Nanog promoters linked to EGFP, for selection of reprogrammed 
colonies (Okita et al. 2007). EGFP has also been used in different types of adult stem cells. Wang 
and colleagues fused the tubulin promoter to EGFP and used it to isolate neural precursor cells from 
murine and avian brains (Wang et al. 1998). Ohtsuka and colleagues have furthermore shown, that a 
destabilized EGFP coupled to the promoter of the proliferation promoting genes HES1 and HES5, 
could be used to accurately detect and localize neural stem cells in the murine brain (Ohtsuka et al. 
2006). 
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Figure 8. Crystal struc-
ture of TurboGFP. Like 
other green fluorescent 
proteins, the structure 
of TurboGFP is a β-
barrel. It consists of 
four identical mono-
mers (green, violet, red 
and blue) which forms 
a tetramer structure. 
The chromophore is 
shown as green van der 
Waals spheres. (From 
Evdokimov et al. 2006). 
6.3.1.2. Other types of fluorescent proteins 
Since the discovery of GFP, a range of different fluorescent proteins have been isolated and opti-
mized for different purposes. Many of these, such as yellow and blue fluorescent proteins, are de-
rived directly from GFP by amino acid substitutions (Tsien 1998). However, others have been iso-
lated from different types of marine animals. The first red fluorescent protein called DsRed was 
isolated from the coral Discosoma (Matz et al. 1999) and was later optimized for expression in 
mammalian cells (DsRed2 and DsRed express). Recently, several fluorescent proteins were isolated 
from the evolutionary distinct Copepoda species, which is a type of zooplankton. One of these pro-
teins, called TurboGFP showed a faster maturation than EGFP and brighter fluorescence in Xenopus 
embryos (Evdokimov et al. 2006). Like EGFP, this protein consists of β-barrels, although is formed 
of tetramers instead of a dimers (Figure 8). A red fluorescent protein (RFP) called TurboRFP was 
furthermore isolated from a sea anemone which possesses fast maturation and superior intensity 
compared to DsRed2 (Merzlyak et al. 2007). In addition, both of these proteins have been fused to a 
PEST sequence to obtain destabilized versions, which should be particularly suitable for promoter 
studies and the generation of transgenic animals. When Bell and colleagues compared TurboRFP to 
other fluorescent proteins, they found that in contrast to DsRed, it showed strong fluorescence 
which was maintained after fixation (Bell et al. 2007). However, the fluorescence was reported to 
differ from tissue to tissue. 
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6.3.2. Transgenic methods in the pig. 
There are several different ways of creating transgenic individuals in livestock species. One way is 
by injection of exogenous DNA directly into the pro-nuclei of oocytes or zygotes, which has been 
used to analyze the function of a murine Oct4 reporter in porcine and bovine embryos (Kirchhof et 
al. 2000), however, in this method the expression is reported to be mosaic and integration is often 
less than 1% (Habermann et al. 2007). Viral integration of DNA has also been attempted, however, 
the risk of silencing of the transgene should be considered when using this technique. 
 
Another method is sperm mediated gene transfer (SMGT) (Lavitrano et al. 1989), in which exoge-
nous DNA is incubated with a sperm cell and taken up by passive osmosis, thereby entering the 
nuclei. When the sperm cell is injected into a matured oocyte, it develops as an in-vitro fertilized 
embryo carrying a stably integrated transgene. The versatility of this method has been demonstrated 
by generation of transgenic pigs containing three different fluorescent proteins (Webster et al. 
2005). However, a downside of this method is that the integration sites are unknown and the amount 
of gene inserts may fluctuate between individual embryos and experiments (Habermann et al. 
2007). 
 
The final method is somatic cell nuclear transfer (SCNT) (Niemann & Kues 2000; Wolf et al. 
2000), in which a transgene is introduced into a mature cell, such as a fibroblast cell, by transfec-
tion, electroporation, nucleofection or viral integration. After selection of colonies carrying the 
transgene by use of antibiotics, single cells are injected into enucleated oocytes (devoid of maternal 
DNA), fused by an electric current, activated chemically or by electric current and allowed to re-
program in medium that prevents cell cycle progression and cultured in-vitro (Niemann et al. 2003). 
Compared to SMGT, this method is more reproducible, as a single cell can be expanded and used 
for SCNT (Habermann et al. 2007). The downside is that only a small number of cloned embryos 
develop normally as they are unpredictably affected by epigenetic reprogramming. However, an 
increased need for transgenic pigs for biomedical research has resulted in extensive focus on the 
optimization of SCNT (Vajta 2007). A particular method of SCNT called hand-made cloning, 
which does not require the need for micromanipulation (Vajta et al. 2001), has been used to produce 
transgenic blastocysts expressing EGFP (Kragh et al. 2004).  
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Several groups have generated transgenic pigs by means of SCNT, hand-made cloning or SMGT 
containing fluorescent cell markers, which are of particular interest for xeno-transplantation and 
disease modelling (Matsunari & Nagashima 2009). However, only 2 out of 17 studies, have used 
other fluorescent proteins than EGFP to produce transgenic pigs and all relied on the use of consti-
tutive promoters whereas inclusion of regulatory promoter regions has not been described (Matsu-
nari & Nagashima 2009). 
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6.4. Neural progenitor cells 
Replacement of damaged neurons by cell transplantation is actively being explored as a potential 
treatment for many neurodegenerative diseases such as Alzheimer’s Disease (AD) and Parkinson’s 
Disease (PD). Since the first isolation of neural stem cells (NSCs) 20 years ago (Temple 1989), 
these cells have provided new hopes in this field. However, an understanding of the signaling path-
ways controlling neural specification is crucial in order to exploit their therapeutic potential. In the 
literature, neural progenitor cells (NPCs) are often used as a synonym of NSCs, although the former 
is more restricted in its proliferation potential. In the following section, the cells will be referred to 
as NPCs. 
6.4.1. Multipotency and self-renewal 
In general, NPCs are defined by two functional traits: Their ability to self-renew as well as their 
multipotency, which means the ability to generate cells capable of producing neurons, astrocytes, 
and oligodendrocytes (Gage 2000). However, NPCs can also be unipotent, giving rise to only a sin-
gle type of neural cell. Additionally, the proliferation and differentiation of NPCs is controlled by 
specialized microenvironments (Basak & Taylor 2009). Hence, NPCs are not just one type of cell, 
but are constantly subject to positional and temporal changes in the brain (Temple 2001). This is 
illustrated by NPCs from the ventral midbrain, which are the only type of NPCs capable of generat-
ing functional mature dopaminergic neurons in-vivo (Conti et al. 2006). 
6.4.1.1. NPC niches and function 
In general, all cells in the adult brain originate from dividing NPCs (Fish et al. 2008). The earliest 
NPCs found in the embryo are the neuroepithelial cells of the neural plate, as they later give rise to 
all the neurons of the mammalian central nervous system (Hyttel P et al. 2010). In the fetal brain, 
NPCs are located in the ventricular zone (VZ) of the telencephalon (Conti et al. 2006) and later in 
the adult brain, NPCs are found in the subventricular zone (SVZ) of the lateral ventricle (Lewis 
1968; Doetsch et al. 1999). From this region, neuroblasts migrate along the rostral migratory stream 
into the olfactory bulb (OB), where they finally differentiate into mature neurons (Corotto et al. 
1993). In addition, NPCs can be found in the subgranular zone (SGZ) of the hippocampal dentate 
gyrus, where they primarily differentiate into granule cells (Kaplan & Bell 1983; Palmer et al. 
1997), which has been shown to be crucial for spatial learning and memory (Imayoshi et al. 2008).  
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NPCs can undergo symmetrical division, resulting in the generation of two new daughter cells (Fig-
ure 9A). This occurs when the mitotic spindle is organized parallelly to the apical (inner) surface of 
the neural plate or the SVZ and SGZ (Fish et al. 2008). In contrast, asymmetrical division of NPCs 
occurs when the spindle is located perpendicularly to the apical surface (Figure 9B). The result is 
the formation of an inner NPC which remains mitotic, as well as an outer post-mitotic neuron. Al-
ternatively, asymmetrical division can generate a migrating neuroblast precursor cell which later 
gives rise to two post-mitotic neurons (Figure 9C). In general, it is believed that neurogenesis pre-
cedes gliogenesis in mammals (Temple 2001). 
 
 
 
 
 
 
 
  
Figure 9. The mode of neural progenitor cell (NPC) division and its effect on the direction of cortical expan-
sion and growth (lateral expansion versus radial growth). (A) Lateral expansion (horizontal arrow), in which 
one NPC generates two NPC daughter cells, occurs as a result of the symmetric, proliferative division (blue). 
(B,C) Radial growth (vertical arrow) occurs as a result of either (B) asymmetric, neurogenic divisions of NPC 
(blue), in which one NPC generates one NPC as well as one neuron (red), or (C) asymmetric, differentiative 
divisions of NPCs (blue), in which one NPC generates one NPC and one neuroblast (orange), which in turn 
generates two neurons (red) and is thereby consumed (dimmed orange) (From Fish et al. 2008). 
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6.4.1.2. Derivation of NPCs 
20 years ago, NPCs were first isolated from the fetal forebrain of rats and mice (mNPCs) and cul-
tured in-vitro (Temple 1989; Cattaneo & McKay 1990; Reynolds et al. 1992). These cells were able 
to differentiate into mature neurons in-vitro. Neural progenitor cells have also been derived from 
the adult rat and mice SVZ and SGZ (Palmer et al. 1995), as well as from other areas of the brain, 
such as the retina (Tropepe et al. 2000), the OB (Pagano et al. 2000) and the spinal cord (Shihabud-
din et al. 2000). Initailly, NPCs were cultured as neurospheres, which consists of a mixture of NPCs 
and adult neural cells (Conti et al. 2006). However, transplantation of neurospheres was reported to 
be problematic due to their heterogenous nature. Later, it was found that NPCs could be cultured in 
homogeneous populations in adherent monolayer culture (Ying & Smith 2003; Conti et al. 2005). 
Furthermore, NPCs have been derived from mESC in-vitro (Okabe et al. 1996), which is commonly 
achieved by treatment of EBs with retinoic acid (RA) (Gajovic et al. 1997).  
 
In human, NPCs (hNPCs) have been derived from fetal brains (Carpenter et al. 1999) as well as 
post-mortem adult brains (Svendsen et al. 1999). These cells show a capacity to proliferate for more 
than one year in-vitro. Furthermore, hESCs have been used as a source of NPCs. In general, three 
different methods have been used to promote neural induction from hESCs. The most common 
method is based on spontaneous differentiation, by maintaining hESC cultures without passage or 
by use of EB formation (Reubinoff et al. 2001). This method commonly results in generation of 
rosette structures, resembling neuroepithelial cells of the embryonic neural tube. (Denham & Dot-
tori 2009). The second most common approach is co-culture of hESCs with murine stromal cells, 
such as PA6 or MS5 cells, which also results in rosette structures (Perrier et al. 2004). Finally, 
Chambers and colleagues have recently shown neural differentiation of hESCs and hiPSCs in a de-
fined manner by directly inhibiting the BMP and SMAD signaling pathways with the two inhibitors, 
NOGGIN and SB431542 in adherent monolayer culture (Chambers et al. 2009). The hNPCs were 
capable of generating both dopamine- and motoneurons in-vitro. 
 
In the pig, only a few studies have reported the generation of NPCs (pNPCs). Porcine NPCs have 
been derived from fetal brains (Armstrong et al. 2001; Armstrong et al. 2002; Harrower et al. 
2006), which, when cultured in-vitro, showed a capacity to differentiate into both neurons and glia. 
Recently, isolation of pNPCs from the SVZ of adult pigs has been reported, which were able to 
maintain multipotency and proliferation for up to 6 passages (Liard et al. 2009). In contrast to 
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mouse and human, pNPCs have not been derived from ESCs due to the lack of validated pESC 
lines. However, Puy and co-workers recently derived pNPCs from ICM cells of porcine blastocysts, 
which could differentiate into glial cell types in-vitro (Du et al. 2009). 
6.4.2. Signaling pathways of NPCs 
In the telencephalon, where most NPCs reside, the patterning mechanisms from the early neural 
tube, including FGF, SHH, WNT, and BMPs appear to be conserved (Corbin et al. 2008). In ro-
dents, it has been shown that proliferation of NPCs in the SVZ increased after bFGF and epidermal 
growth factor (EGF) administration in-vivo, with EGF having a more dramatic effect (Kuhn et al. 
1997). EGF (Morrison et al. 1987) and bFGF (Nurcombe et al. 1993) have also been shown to 
maintain long-term in-vitro proliferation of NPCs isolated from the SVZ. In contrast, NPCs residing 
in the SGZ were unaffected by in-vivo supplementation of either EGF or bFGF (Kuhn et al. 1997) 
but seem to proliferate in response to bFGF in-vitro (Ray et al. 1993). It has been shown that the 
competence of NPCs to generate neurons, astrocytes, and oligodendrocytes reflects a deregulation 
of dorso-ventral patterning, which is caused by exposure to bFGF during in-vitro culture (Gabay et 
al. 2003). Hence, bFGF seems to play a role in resetting NPCs to an undifferentiated state (Pollard 
et al. 2008). Furthermore, LIF has been shown to stimulate proliferation of NPCs in-vivo (Bauer & 
Patterson 2006) and promotes long propagation in-vitro (Andersen et al. 2008). In addition to these 
mitogens, several other signaling pathways have been shown to be involved in maintaining the un-
differentiated stage of NPCs, including Shh (Ahn & Joyner 2005), Notch (ndroutsellis-Theotokis et 
al. 2006) and Wnt signaling (Lie et al. 2005).  
 
Due to ethical concerns, studies on the regulation of hNPCs has mostly been carried out in-vitro. In 
general, many of the signals and mechanisms involved in neural induction seems to be highly con-
served across species (Denham & Dottori 2009). Human NPC media are also commonly supple-
mented with bFGF and EGF (Dottori & Pera 2008) and hNPCs have also been shown to be regu-
lated by WNT (Davidson et al. 2007), SHH and NOTCH signaling (Elkabetz et al. 2008). However, 
there are also fundamental differences between hNPCs and mNPCs. One example is RA treatment, 
which appears to be involved in directing hNPCs towards spinal cord progenitors (Li et al. 2005). 
Furthermore, studies have shown differences between key neural pathways controlling fetal and 
hESC derived hNPCs (Shin et al. 2007), as well as fetal and adult brain-derived hNPCs (Maisel et 
al. 2007). 
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The regulation of pNPCs has not been subject to detailed studies, although they have been shown to 
respond to the same mitogens such as bFGF and EGF (Armstrong et al. 2002). 
6.4.3. NPC markers 
To date, no unique markers of NPCs have been identified. Instead, researchers rely on a multitude 
of markers, such as the intermediate filament Nestin, the transcription factors Sox2, Pax6, the RNA 
binding protein Musashi and the neural cell adhesion molecule (Ncam) (Schwartz et al. 2005). In 
general, these markers seem to be quite conserved between species. 
 
Neuroepithelial stem cell protein (Nestin) is a class six intermediate filament protein expressed by 
NPCs located in the VZ and the SVZ (Lendahl et al. 1990; Doetsch et al. 1997). Nestin is consid-
ered a useful, although imperfect, marker of NPCs as it can be expressed by early neurons as well 
(Schwartz et al. 2005). In the pig, NESTIN expression has been reported in NPC populations cul-
tured from the adult porcine brain (Armstrong et al. 2002; Uchida et al. 2003) and in ICM-derived 
NPCs (Du et al. 2009). 
 
Sox2 is a transcription factor of pluripotent cells (see: pluripotency markers) as well as NPCs. At 
the beginning of neurogenesis, Sox2 expression becomes restricted to the neural plate (Papanayotou 
et al. 2008) and through embryogenesis it is expressed in NPCs residing in the VZ of the develop-
ing neural tube and in the SVZ and SGZ of the adult brain (Catena et al. 2004). Moreover, constitu-
tive expression of Sox2 is reported to inhibit neuronal differentiation and results in the maintenance 
of progenitor characteristics (Graham et al. 2003). Sox2 is expressed in brain-derived mNPCs and 
hNPCs (Graham et al. 2003) as well as in fetal brain derived pNPCs (Schwartz et al. 2005). 
 
Paired box 6 (Pax6) is a transcription factor used as an early marker of neuroectodermal differentia-
tion (Callaerts et al. 1997). In the fetal brain it is expressed in the VZ, the developing eye, the OB 
epithelium and in the spinal cord (Walther & Gruss 1991) and has been reported to be expressed by 
mNPC and hNPC (Suter et al. 2009). Pax6 is also known to directly modulate Sox2, thereby con-
trolling the expression of NPCs in the SVZ (Wen et al. 2008). In the pig, PAX6 has been shown to 
be expressed in retinal progenitor cells (Klassen et al. 2007) but not in fetal- and ICM-derived 
pNPCs (Schwartz et al. 2005; Du et al. 2009). 
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Other important markers of hNPCs and mNPCs, including the RNA binding protein Musashi1 (Ka-
neko et al. 2000) and the neural cell adhesion molecule (Ncam) (Maisel et al. 2007), have also been 
reported to be expressed by fetal- and ICM-derived pNPCs (Schwartz et al. 2005; Du et al. 2009). 
In contrast, the marker p75 Neurotrophin R (p75), which is expressed by human, mouse and bovine 
neural crest progenitor cells (Lazzari et al. 2006; Lee et al. 2007), has not been reported to be ex-
pressed in the pig. 
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6.5. Neural stem cell therapy 
A range of severe neurodegenerative diseases are currently affecting millions of people worldwide. 
Due to the remarkable complexity of the brain, many of these diseases are incurable with existing 
medical treatments. Instead, therapies rely on prolonging life, by administration of various drugs 
which may inhibit cell death and/or promote survival of remaining healthy cells. However, in the 
case of PD, cell based therapy has been shown to constitute a realistic alternative and trials using 
primary fetal tissue for transplantation has been completed in more than 300 patients (Lindvall & 
Bjorklund 2004). In contrast to fetal tissue, ESCs could provide an inexhaustible and more ethically 
acceptable source of cells for cell based treatment (Conti et al. 2006). Yet, as ESCs are known to 
cause teratomas in-vivo, in-vitro differentiation into NPCs or mature neurons is necessary prior to 
transplantation. In this respect, large animals, such as the pig, may prove to be essential for evaluat-
ing the risks and causes.  
6.5.1. Neurodegenerative diseases 
Parkinson’s Disease is a progressive neurodegenerative disease, affecting 1 in a 100 people over 65 
years, with as many as 50,000 new cases each year (Dauer & Przedborski 2003). The primary 
pathological feature is the death of dopamine producing neurons located in the substantia nigra in 
the brain (Freed 2002). The outcome is a lack of inhibition of motor neurons in the striatum, result-
ing in excessive muscle contraction, which gives rise to symptoms such as tremor and rigidity.  
 
Alzheimer’s Disease is the most common form of degenerative dementia affecting mainly elderly 
people and leading to progressive symptoms of memory loss (Selkoe 1999). The pathology includes 
degeneration of cholinergic cells in the cerebral cortex due to extracellular deposition of amyloid-β 
protein, plaques and neurofibrillary tangles  (Auld et al. 2002). 
 
Other severe neurodegenerative diseases includes HD, which is an inherent disease affecting mainly 
the striatum of the brain (Walker 2007), Multiple Sclerosis (MS) which affects the formation of 
myelin sheaths and leads to progressive deterioration of neurological function (Lublin & Reingold 
1996) and Amyotrophic Lateral Sclerosis (ALS) which is a disease with the pathology of degenera-
tion of motoneurons leading to muscle weakness and atrophy (Al-Chalabi & Leigh 2000). 
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6.5.2. Animal models of neurodegenerative disesases 
Within the field of neurodegenerative diseases, the rodent has traditionally been the model of choice 
(Poncelet et al. 2009). However, large animal models often provide an essential bridge between 
insights into fundamental biology and the realities of treating a human disease (Wakeman et al. 
2006). This is illustrated by several studies in which PD patients transplanted with human fetal de-
rived tissues developed dyskinesia, whereas in the rat, these cells showed functional integration 
(Hagell et al. 2002). Hence, the rodent may not be the most optimal animal model of human neuro-
logical diseases. While monkeys are considered an adequate model in neurotransplantation, eco-
nomical issues as well as ethical concerns limit the use of this animal in practice (Wakeman et al. 
2006). In contrast, the pig has been suggested as an excellent candidate of neurodegenerative dis-
eases by several authors (Vodicka et al. 2005; Wakeman et al. 2006; Lind et al. 2007; Poncelet et 
al. 2009). This is due to their gyrencephalic brain, which in contrast to the lissencephalic brain of 
rodents, more closely resembles the human brain (Hofman 1985). In addition, pigs are easily bred, 
have a long life span (12–15 years), produce large litter size and have a short gestation period (113–
115 days) compared to monkeys (Lind et al. 2007). The minipig constitutes a particularly interest-
ing model due to its relatively large brain and similar physiological and pathophysiological re-
sponses compared to humans (Wakeman et al. 2006) and while the use of inbred animals in ex-
periments generally causes diminished variability (Lind et al. 2007). Important models of PD, HD 
and MS have already been generated in the minipig, and recently, an AD minipig was generated by 
means of SCNT (Kragh et al. 2009).  
6.5.3. Stem cell transplantation in neurodegenerative disease models 
To date, most transplantation studies have been carried out with rodents in which a PD-like condi-
tion is induced by injection of the chemical 6-Hydroxydopamine (Conti et al. 2006) into the sub-
stantia nigra of one hemisphere. However, transplantation of cells into a complex organ like the 
brain is not a trivial task and depends on several issues such as the affected area, as well as the type 
of disease and its pathology. In PD, in which a paracrine network of dopamine producing cells is 
involved, the most common strategy is transplantation directly to the affected site, the striatum 
(Conti et al. 2006). Identifying the correct type of cells for transplantation is another major task, 
which often includes a tradeoff between the use of NPCs, maintaining high plasticity but with the 
risk of incorrect incorporation, and more specialized neurons with lower plasticity. 
40 
 
6.5.3.1. Stem cell transplantation in Parkinson’s Disease models 
Transplantation of undifferentiated mESC into parkinsonian rats has been attempted, however, de-
spite generation of functional dopaminergic neurons, some of these animals developed fatal terato-
mas (Bjorklund et al. 2002). This study made it clear that neural induction in addition to elimination 
of undifferentiated cells prior to transplantation is required. Kim and colleagues applied a genetic 
approach in which the nuclear receptor related 1 (Nurr1) promoter was used to select tyrosine hy-
droxylase (TH) expressing cells derived from mESCs prior to transplantation into parkinsonian rats 
(Kim et al. 2002). Interestingly, behavioral studies showed a significant reduction in motor asym-
metry in the treated rats without evident teratoma formation. The therapeutic potential of iPSCs has 
also been demonstrated in-vivo as miPSC derived NPCs were able to functionally integrate into the 
murine brain (Wernig et al. 2008b). Additionally, dopaminergic neurons generated from miPSCs 
were able to improve behaviour in a rat model of PD.  
 
Recently, the focus has turned to the use of hESCs for transplantation in animal models of PD. Roy 
and co-workers, Geeta and co-workers, and Yang and co-workers all showed long-term functional 
recovery of rodent models of PD using dopaminergic neurons derived from hESC by coculture, EB 
formation, or adherent culture, respectively (Roy et al. 2006; Geeta et al. 2008; Yang et al. 2008). 
Such studies show that hESC derived dopaminergic cells retain the same therapeutic capacity as 
shown in the mouse. 
 
To date, most studies on transplantation of pNPCs have relied on the rodent PD models mentioned 
above. Armstrong and co-workers have transplanted pNPCs derived from fetal pigs in a rat model 
of PD (Armstrong et al. 2001; Armstrong et al. 2002), however, very few TH positive neurons were 
generated, and no functional recovery was observed. Later it was found that fetal derived pNPCs 
could form long distance axons and synapses with rat neurons (Uchida et al. 2003) and Harrower 
and co-workers found that fetal derived pNPC maintained long term survival in a rat model of PD 
when subjected to extended in-vitro culture prior to transplantation (Harrower et al. 2006). 
6.5.3.2. Stem cell transplantation in other types of disease models 
In contrast to PD, which involves paracrine signaling in which even a partial pattern repair may lead 
to a significant functional recovery (Conti et al. 2006), studies on NPC transplantation in other 
types of animal disease models such as AD, HD and ALS are more complicated due to the wide-
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spread pathology of these diseases. However, NPC transplantation may be beneficial via the release 
of molecules that may either stimulate the regenerative potential or increase the survival of neurons 
(Conti et al. 2006). This is illustrated by a recent study, in which transplantation of mNPCs derived 
from newborn mice were able to improve cognition in a transgenic mouse model of AD through 
stimulation of brain-derived neurotrophic factor (BDNF) (Blurton-Jones et al. 2009). A superior 
target of cell replacement with limited requirements of pattern repair is represented by diseases 
characterized by glial degeneration, such as MS (Conti et al. 2006). It was shown that mESC-
derived oligodendrocytes migrated into the host tissue, produced myelin and myelinated host axons 
in a rat model of MS, established by chemical demyelination of the spinal cord (Liu et al. 2000). In 
the pig, transplantation of oligodendrocytes to a rat model of MS has also been attempted (Smith & 
Blakemore 2000). In this study, it was found that pNPCs required commitment to the oligodendro-
cyte lineage prior to transplantation in order to achieve significant remyelination.  
 
With the establishment of pNPCs and the emergence of important porcine disease models of PD, 
HD and AD (Lind et al. 2007), the pig could constitute an excellent large animal model of alloge-
neic stem cell therapy of human neurodegenerative diseases. 
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7. Materials, methods and results 
A detailed description of the materials and methods and results are presented in manuscripts I to III. 
 
 
7.1. Manuscript I. OCT4 expression in outgrowth colonies derived from porcine 
inner cell masses and epiblasts 
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Abstract 
 
The present study was conducted to test different methods for porcine inner cell mass (ICM) and 
epiblast isolation and to evaluate the morphology and expression of pluripotency genes in ICM- and 
epiblast-derived outgrowth colonies (OCs) and passages thereof with particular attention on the 
relationship between OCT4 expression and embryonic stem cell (ESC)-like morphology. A total of 
104 zona pellucida-enclosed and 101 hatched blastocysts were subjected to four different methods 
of ICM and epiblast isolation, respectively: Manual isolation, immunosurgery, immunosurgery with 
manual cleaning, or whole blastocyst culture. OCs were established on mouse embryonic fibroblast 
(MEF) cells and categorized according to morphology and OCT4 staining. Though all isolation 
methods resulted in ESC-like OCs, immunosurgery with manual cleaning yielded significantly 
higher rates of ICM/epiblast attachment and subsequent ESC-like morphology, whereas, no signifi-
cant difference was found between ICM and epiblasts with respect to these characteristics. All ESC-
like OCs showed nuclear OCT4 staining and expression of OCT4, NANOG and SOX2 as evaluated 
by RT-PCR. Upon initial passages, the expression of pluripotency markers was, however, gradually 
lost in spite of maintained ESC-like morphology. In conclusion, we have established a robust sys-
tem for derivation of ESC-like OCs from porcine ICM and epiblasts and we have shown that local-
ization of OCT4 is associated with an ESC-like morphology although this relationship is lost during 
early passages.   
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Introduction 
 
Embryonic stem cells (ESCs) are usually derived from the inner cell mass (ICM) of preimplantation 
embryos. ESCs have the capacity of infinite self-renewal and can, under the proper conditions, dif-
ferentiate into all cell types of the body. The successful isolation and culture of ESCs has been re-
ported first in mouse (Evans and Kaufman 1981; Martin 1981) and later in human (Thomson et al. 
1998). In the mouse, it has later been demonstrated that the ICM and epiblast give rise to two dif-
ferent stem cell populations, ESCs and epiblast stem cells (EpiSCs), respectively, (Vallier et al. 
2009). Interestingly, mouse EpiSCs share more similarities with human ESCs than mouse ESCs do. 
Attempts to establish ESCs or EpiSCs from other mammals, including the large domestic species, 
have been reported repetitively, but ultimate pluripotency has only been demonstrated by differen-
tiation into both somatic and germ cell lineages in mouse and rat (Pease and Williams 1990; Kon-
doh et al. 1999; Buehr et al. 2008; Li et al. 2008).  
 
To realise the use of ESCs or EpiSCs as a therapeutic tool in man it is of great importance to de-
velop an animal model more closely related to humans than mice and rats. The pig offer great ad-
vantages in this respect due to anatomical and physiological similarities as well as phylogenetic 
proximity to human. In the pig, the ICM differentiates into epiblast and hypoblast around the time 
of hatching on Day 6-7 of gestation, and until around Day 10, the epiblast is covered by trophecto-
derm, i.e. Rauber’s layer (Oestrup et al. 2009). Hence, stem cell isolation from pre-hatching em-
bryos is considered to give rise to ESC-like OCs while isolation from post-hatching embryos is con-
sidered to give rise to EpiSC-like OCs. 
 
Over the past two decades many attempts to establish porcine ESC or EpiSC lines have been 
reported (Evans et al. 1990; Notarianni et al. 1990; Piedrahita et al. 1990; Strojek et al. 1990; 
Hochereau-de Reviers and Perreau 1993; Talbot et al. 1993; Anderson et al. 1994; Moore and 
Piedrahita 1997; Wianny et al. 1997; Chen et al. 1999; Miyoshi et al. 2000; Li et al. 2003; Li et al. 
2004; Li et al. 2004; Brevini et al. 2007). However, no germ line transmission has yet been de-
scribed, characterization with respect to pluripotency markers has been sparse, and the ESC-like 
cell lines have not proven to renew indefinitely. Hence, the basic conditions for establishment of 
porcine ESCs or EpiSCs are still to be defined.  
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An issue of great importance when culturing ESCs and EpiSCs is a proper characterization. In addi-
tion to morphology, characterization must be based on the expression of certain markers such as the 
transcription factors OCT4, SOX2, and NANOG, surface molecules as the stage specific embryonic 
antigens (SSEA1, 3 and 4) and the tumour rejection antigens (TRA1-60 and TRA 1-81). However, 
species differences exist with respect to expression patterns: For example, murine ESC express 
SSEA1 and -3 while human express SSEA3 and -4 (Ginis et al. 2004). It still needs to be clearly 
defined which of these markers porcine ESC-like cells express. 
  
The transcription factor OCT4 is considered the gatekeeper of pluripotency in mouse and man 
(Niwa et al. 2000) and is exclusively expressed in the ICM at the blastocyst stage in these species. 
In the pig, on the other hand, OCT4 is expressed in both the ICM and the trophectoderm of the blas-
tocyst before hatching (Kirchhof et al. 2000). Later, in the hatched blastocyst, controversy exists 
with respect to the distribution of OCT4 expression: In one investigation the presence of the protein 
was exclusively demonstrated in the epiblast (Vejlsted et al. 2006), whereas, another indicates the 
presence of OCT4 in the trophectoderm as late as Day 11 (Keefer et al. 2007). These controversial 
findings call for a further investigation of tropectodermal OCT4 expression after hatching of the 
porcine embryo. In addition, a previous report indicated inconsistent expression of OCT4 in porcine 
ESC-like cells (Brevini et al. 2007). Hence, a closer investigation of the relationship between ESC-
like morphology and OCT4 localization in porcine ESC-like cells is also required. 
 
Along these lines, the present study set out (1) to clarify the expression pattern of OCT4 in porcine 
blastocysts after hatching, (2) to optimize the methodology for isolation of porcine ICMs and epib-
lasts and establishment of OCs thereof,  and (3) to investigate the morphology of porcine ESC-like 
cells in relation to the expression of pluripotency markers with special emphasis on OCT4.  
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Materials and Methods 
Unless otherwise stated, materials were purchased from Sigma-Aldrich, Broendby, Denmark. 
 
Feeder cells 
Mouse embryonic fibroblast cells (MEF; kindly donated from Hagedorn Research Institute, Gen-
tofte, Denmark) were prepared from whole mouse embryos collected at 13-14 days gestation, ex-
panded, Mitomycin C treated and frozen at -80 °C. One day prior to an ESC experiment, MEF cells 
were thawed in a 37°C warm water bath, re-suspended in medium containing Dulbecco’s modified 
Eagle’s medium (DMEM), 10% fetal bovine serum (FBS, Invitrogen, Taastrup, Denmark), 1% 
glutamine  and 1% penicillin/streptomycin and cultured in 3.5 cm petri dishes (Nunc, Roskilde, 
Denmark) at 37°C in a density of 1x104/cm2.  
 
Flushing of embryos 
Female genital organs from sows (Danish landrace x Yorkshire crosses) collected at a local abattoir 
5-8 days post insemination were transported to the laboratory in a 37 °C warm water bath for a 
maximum period of one hour. Each uterine horn was flushed with 150 ml embryo flushing medium 
(LIFE Pharmacy, KU, Frederiksberg, Denmark) with 1% FBS, and embryos were isolated by ste-
reo-microscopy. Selected embryos at the blastocyst stage were transferred to DMEM containing 
10% FBS for further processing. Overall, 27 sows were slaughtered yielding a total of 393 embryos 
of which 205 of the highest graded embryos were used for in-vitro culture, whereas the rest were 
fixed for stainings. 
 
Isolation of inner cell masses (ICM) and epiblasts 
The zona pelucida was removed from non-hatched blastocysts by submission to 5mg/ml pronase in 
DMEM low glucose (Invitrogen, Taastrup, Denmark) with 0.1% polyvinyl alchohol (PVA). The 
blastocysts were subsequently divided into four groups assigned for different methods of 
ICM/epiblast isolation: (1) manual isolation (ICM:10; epiblasts:18) where the ICM/epiblast was 
microscopically isolated from the trophectoderm using insulin needles; (2) immunosurgery 
(ICM:20; epiblasts:20) where blastocysts were incubated for 10 min in 10% guinea pig anti-pig-
serum (kindly provided by Tiziana Brevini, Center for Stem Cell Research, University of Milan, 
Italy) in DMEM low glucose with 0.1 % PVA followed by treatment with 10% guinea pig comple-
ment (kindly provided by Tiziana Brevini) in DMEM low glucose with 0.1 % PVA until the tro-
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phectoderm was visibly affected; (3) immunosurgery with manual cleaning (ICM:11; epiblasts:40) 
where the former two methods were combined in order to obtain a cleaner ICM/epiblast; or (4) 
whole blastocyst culture (ICM-embryos:63; epiblast-embryos:23) where intact blastocysts were 
directly subjected to culture. 
 
Culture of OCs and passages 
For establishment of OCs, isolated ICMs, epiblasts and whole blastocysts were cultured at 38°C on 
MEF cells in porcine ES medium consisting of DMEM low glucose supplemented with 40% Hams 
F10 (Invitrogen, Taastrup, Denmark), 10% knock-out serum replacement (KSR; Invitrogen, Taas-
trup, Denmark), 5% FBS, 1% nucleotide stock, 1% non essential amino acids (NEAA), 1% gluta-
mine, 1% penicillin/streptomycin, 1% beta-mercaptoethanol (Invitrogen, Taastrup, Denmark) and 
0.1% murine leukaemia inhibitory factor (mLIF; Chemicon, Hessen, Germany). At the initiation of 
culture, the medium was changed after 2 to 4 days and afterwards every second day. The rate of 
attached ICMs and epiblasts forming OCs was evaluated by phase contrast microscopy on Day 4 of 
culture.  
 
OCs presenting ESC-like cells, i.e. closely apposed cells with high nucleus:cytoplasmic ratio and 
one or two distinct nucleoli, were subjected to physical passages onto fresh feeder cells by cutting 
of ESC-like areas into 5-10 small clumps using insulin needles and pipetting. Subsequent passages 
were performed approximately once per week.  
  
Morphology and OCT4 staining  
All OCs and passaged colonies were evaluated morphologically by phase contrast microscopy. Se-
lected OCs (Days 7-9) and passaged colonies were processed for OCT4 immunostaining. Hatched 
Day 9 blastocysts (N=5) collected by the same procedure as described above were, in parallel, proc-
essed for staining in order to detect the specificity of OCT4 localization in the embryo.  
 
Colonies were fixed in 4% paraformaldehyde (VWR, Herlev, Denmark) in 0.1M PBS for 15-30 min 
at room temperature and stored in 1% paraformaldehyde in 0.1M PBS at 5ºC. Immunostaining of 
colonies comprised 30 min permeabilization in 1% triton X + 0.25% bovine serum albumin (BSA) 
in PBS followed by 30 min elimination of endogenous peroxidase by 3% hydrogen peroxide (H2O2; 
Merck, Glostrup, Denmark) in PBS, 3 times 5 min treatment with boiling 0.01M citrate buffer, pH 6 
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(LIFE Pharmacy, KU, Frederiksberg, Denmark) and 10 min blocking of unspecific antigen sites 
with DAKO Biotin Blocking System (Dako Denmark A/S, Glostrup, Denmark). Subsequently, the 
colonies were washed with PBS, incubated at 5°C over night with a primary antibody to OCT-3/4 
(N-19 goat polyclonal SC-8628, Santa Cruz Biotechnology Inc., Santa Cruz, US) diluted 1:250 in 
0.1% triton X + 0.25% BSA in PBS, washed 3 times 5 min in 0.1% triton X + 0.25% BSA in PBS 
and primary antibody binding was visualized by the secondary antibody kit Dako LSB®+System-
HRP (Dako cytomation, Glostrup, Denmark) and AEC substrate kit (Zymed laboratories Inc., San 
Francisco, CA, USA). Finally, the specimens were counterstained with hematoxylin and examined 
using phase contrast microscopy.  
 
Immunostaining of embryos comprised 2 hours incubation in 0.5% TNB blocking reagent (Perki-
nElmer, Hvidovre, Denmark) with 0.1% Triton X and 3% H2O2 followed by incubation over night 
at 4ºC with primary antibodies OCT-3/4 (SC-8628) diluted 1:1000 and monoclonal mouse anti-E-
cadherin (610181, BD Biosciences) diluted 1:1000 in 0.5% TNB with 0.1% Triton X. Embryos 
were washed 3 times 20 minutes in 0.1 M PBS with 0.1% Triton X and incubated for 2 hours with 
highly cross-absorbed secondary antibodies Cy2-anti-goat and Cy5-anti-mouse (Jackson Immu-
noResearch Laboratories Inc., USA) diluted 1:500 in 0.5% TNB and 0.1% triton X. Finally, em-
bryos were washed 3 times 20 minutes in 0.1 M PBS with 0.1% Triton X and stored in methanol at 
-20°C. Embryos were cleared in BABB (a 1:2 mixture of benzyl alcohol to benzyl benzoate) just 
prior to confocal microscopy. Specificity of OCT-3/4 antibody using blocking peptide was previ-
ously verified (Vejlsted et al. 2006). 
 
RT-PCR 
When passage of ESC-like colonies was performed, fragments were sampled and frozen in liquid 
nitrogen. RNA from colonies was purified using Dynabeads mRNA Direct micro kit (Dynal, Ham-
burg, Germany) following the manual supplied by the manufacturer and cDNA was synthesized 
immediately after using First strand cDNA synthesis kit (Fermentas, Copenhagen, Denmark) fol-
lowing the manual supplied by the manufacturer. RNA from porcine day 7 blastocysts served as 
positive control. PCR was performed using HotStarTaq DNA polymerase (Qiagen, Ballerup, Den-
mark) with primers for OCT4, NANOG and SOX2 (Carlin et al. 2006). GAPDH (Kuijk et al. 2007) 
served as positive control and H2O as negative control. The following PCR conditions were used: 
Hotstart at 95°C for 15 min, 35 cycles including denaturation at 94°C for 30 sec, annealing at 56°C 
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for NANOG, SOX2 and GAPDH and 68°C for OCT4 for 30 sec, and elongation at 72°C for 45 sec, 
finalized by elongation at 72°C for 10 min and incubation at 4°C. PCR products were run on a 1% 
agarose gel and visualized by staining with ethidium bromide. 
 
Statistical analysis 
The statistical analyses were performed using R (2005). The binary response variables describing 
prevalence of either attached OCs or ESC-like colonies were analyzed using binary logistic regres-
sion with embryonic developmental stage and isolation method as explanatory dependent variables. 
The polytomous response OC type was analyzed using multinomial logistic regression with embry-
onic developmental stage and isolation method as dependent variables.  
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Results 
 
OCT4 staining in hatched blastocysts 
Hatched blastocysts displayed nuclear localization of OCT4 in the epiblast, whereas, no staining 
was observed in the trophectoderm or hypoblast (Figure 1).   
 
Categorization of OCs 
On the basis of morphology and OCT4 staining, five different OC categories were defined: (1) 
Epiblast-like OCs presenting rounded, multilayered cell clusters with a compact epiblast-like struc-
ture with homogeneous nuclear OCT4 staining (Figure 2A, B). (2) Solitary ESC-like OCs, present-
ing a monolayer of ESC-like cells with homogeneous nuclear OCT4 staining surrounded by no or 
few flattened lipid-rich cells without OCT4 staining (Figure 2C, E, D). (3) Clearly delineated ESC-
like OCs presenting a monolayer of ESC-like cells with a homogeneous or, in few cases, a hetero-
geneous nuclear OCT4 staining (Figure 2G, H) with a clear demarcation to a surrounding of numer-
ous lipid-rich flattened cells without OCT4 staining (Figure 2F). (4) Poorly delineated ESC-like 
OCs presenting a monolayer of ESC-like cells with homogeneous nuclear OCT4 staining but with 
an unclear demarcation to a surrounding of numerous lipid-rich flattened cells without OCT4 stain-
ing (Figure 2I, J). (5) Differentiated OCs consisting of varying types of larger, flat cells without 
OCT4 staining in more or less well defined colonies (Figure 2K, L). OCs which succesfully con-
verted to monolayer culture and showed positive OCT4 staining including category 2 (solitary ESC-
like OCs), 3 (clearly delineated ESC-like OCs) and 4 (poorly delineated ESC-like OCs) will collec-
tively be referred to as ESC-like OCs. 
 
The four different ICM/epiblast-isolation methods resulted in OCs of all five categories except for 
manual isolation and immunosurgery, which did not give rise to epiblast-like OCs (Table 1). The 
statistical evaluation demonstrated no significant differences between manual isolation, immuno-
surgery and whole blastocyst culture with respect to proportion of attached OCs as well as propor-
tion of ESC-like OCs. However, immunosurgery with manual cleaning yielded a significantly 
higher proportion of attached OCs (69% versus 49%) as well as a significantly higher proportion of 
ESC-like OC (59% versus 32%) compared to the pooled data of the other three isolation methods. 
There was no significant difference between ICMs and epiblasts with respect to attachment rate and 
categories of OCs. However, epiblast-derived OCs tended to exhibit a more homogeneous distribu-
54 
 
tion of OCT4 positive cells in the ESC-like colonies. RT-PCR showed expression of OCT4, 
NANOG, and SOX2 in all examined ESC-like OCs as well as in epiblast-like OCs (Figure 3). 
 
Characterization of passages 
A total of 24 OCs obtained after immunosurgery with manual cleaning resulted in 18 (75%) passage 
1 (P1) colonies. In 11, 6, 3 and 2 cases, these colonies were passed on to P2, P3, P4, and P5, respec-
tively, before they went into quiescence or differentiation (Figure 4A, C). A total of 18 OCs ob-
tained by whole blastocyst culture resulted in 11 (61%) P1 colonies and 4 P2 colonies, but only one 
continued to P7 before it went into quiescence. Only a few colonies displayed nuclear localization 
of OCT4 after the first passage despite maintaining an ESC-like morphology (Figure 4B, D). In 
addition, OCT4, NANOG, and SOX2 expression, as monitored by RT-PCR, was lost at P1 or in few 
cases at P2, except for a few colonies in which NANOG and SOX2 expression was maintained up to 
P3 and P6 (Figure 2). 
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Discussion 
 
Previous conflicting data on OCT4 expression in porcine blastocysts has cast doubt upon the use of 
OCT4 as a reliable pluripotency marker in the pig. It has been shown that OCT4 is expressed both 
in ICM and trophectoderm before hatching, followed by down-regulation in the trophectoderm after 
hatching (Vejlsted et al. 2006). Yet, another study has shown OCT4 staining in both the epiblast 
and trophectoderm of hatched blastocysts (Keefer et al. 2007). Reevaluated in our hands, however, 
hatched blastocysts exhibit OCT4 staining exclusively in the epiblast. In addition, analysis of nu-
merous OCs derived from both ICMs and epiblasts clearly demonstrated that OCT4 staining corre-
lated well with ESC-like morphology, in the sense that OCT4 stained cells always exhibited ESC-
like morphology although it was possible to find colonies with ESC-like cell morphology which 
lacked OCT4 staining. The correlation between OCT4 and ESC-like morphology was, however, in 
most cases lost during passages. In human, the existence of two OCT4 isoforms, OCT4A and 
OCT4B, has been reported (Cauffman et al. 2006). Whereas OCT4A is associated with pluripotent 
cells, OCT4B is also expressed in non-pluripotent cells, and caution is required when selecting anti-
bodies meant to be specific for OCT4A (Liedtke et al. 2008). The presence of two OCT4 isoforms 
in the pig could explain the contradicting reports of OCT4 expression in hatched blastocysts since 
the antibody used for detection of OCT4 by Vejlsted et al., 2006 and in this study recognizes a hu-
man isoform of OCT4 at 43-50 KDa which corresponds with the size of isoform A, whereas, the 
antibody used by Keefer et al., 2007 recognizes a human 265 aa isoform of OCT4 which corre-
sponds to isoform B. However, further experiments are required to shed light on this issue in the 
pig. 
 
In this study, we have tested several different ICM/epiblast-isolation methods which all produced 
ESC-like cultures. We found that the most reliable method was immunosurgery with manual clean-
ing of the ICM/epiblast, as this method produced not only the highest rate of OCs but also the high-
est proportion of OCs exhibiting ESC-like morphology. When colonies were subjected to passage, 
only few survived and colonies never exceeded seven passages. Evaluation of pluripotency markers 
at the mRNA level revealed a strong down-regulation of OCT4 during the initial passages, even 
though many of the passaged colonies maintained an ESC-like morphology. In 2007, Brevini et al. 
(Brevini et al. 2007) reported, that the expression of OCT4, in contrast to that of NANOG, may vary 
from passage to passage in porcine ESC-like cells. In our hands, OCT4 expression did not fluctuate, 
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but was simply lost during early passages, wheras SOX2 and NANOG expression was found in a 
few colonies at later passages. Since SOX2 is known to be expressed in neural stem cells, the ex-
pression of this marker may also be associated with the onset of neural differentiation which is con-
sidered the default pathway in mammals (Kim et al. 2007). In mouse ESC, Nanog has been reported 
to stabilize the state of pluripotency without being a strict requirement for this condition (Chambers 
et al. 2007). Whether the same applies to porcine ESC- or EpiSC-like cultures is not yet known.  
 
In order to establish stable ESC lines, the ICM-cells need to transform and assume ESC characteris-
tics including the potential of self-renewal, setting differentiation on hold. The ability to undergo 
this transformation differed between isolation methods. For instance, culture of whole blastocysts 
and immunosurgery with manual cleaning produced some epiblast-like OCs. We believe that these 
OCs are characterized by a poor ICM/epiblast to ESC transformation as the cell clusters attached 
and expanded but retained a morphology resembling the epiblast of the embryonic disc. Conse-
quently, such OCs typically went into quiescence or gave rise to outgrowth of differentiated cells. 
Interestingly, culture of whole blastocysts, where the trophectoderm is left intact, gave rise to a high 
rate of solitary ESC-like OCs where ESC-like cells grew as a clean homogeneous cell population. 
On the other hand, when the ICM/epiblast was isolated by either manual dissection, immunosurgery 
or immunosurgery with manual cleaning the number of surrounding, flat cells expanded dramati-
cally. This was an unexpected finding, as we are confident that our immunosurgery if not elimi-
nated, then at least reduced the amount of trophectoderm. Hence, we believe that the flat surround-
ing cells in the clearly and poorly delineated ESC-like OCs represent cells derived from the 
ICM/epiblast; potentially of hypoblast nature.  
 
The choice of feeder layer for the establishment of porcine ICM- or epiblast-derived colonies has 
been examined in several studies, but with varying conclusions (Strojek et al. 1990; Catena et al. 
2004; Li et al. 2004; Kim et al. 2007). In at least two studies, STO feeder cells were found to sup-
port ICM attachment better than other feeder cell types (Piedrahita et al. 1990; Kim et al. 2007) 
while other authors found the opposite (Strojek et al. 1990; Li et al. 2004). In our hands, STO feeder 
cells resulted in very low rates of attachment (18%, n=66; data not shown) in comparison with MEF 
(50%, n=20; Table 1) when used under similar conditions. Moreover, the OCs derived on STO 
feeder cells showed a much higher tendency to differentiate (data not shown).  
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In conclusion, we have established a robust system for derivation of ESC-like OCs from porcine 
blastocysts at the ICM and epiblast stage of development and have demonstrated expression of the 
pluripotency factors OCT4, NANOG and SOX2 in the OCs. Moreover, cells with OCT4 localization 
presented a typical ESC-like morphology. During the initial passages, however, the cells lost the 
expression of first OCT4 and, later, NANOG despite retaining an ESC-like morphology.   
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Figure legends. 
 
Figure 1: Hatched Day 9 blastocyst stained for OCT4 and E-cadherin. (A) Staining for E-cadherin. 
(B) Staining for OCT4. Note that the OCT4 staining is specific for nuclei in the epiblast. (C) Merge 
of A and B. Scale bars represent 50 µm. 
 
Figure 2: Phase contrast and OCT4 immunostainings of porcine OCs. (A, B) Epiblast-like OC. The 
homogeneous nuclear OCT4 staining is obscured due to the thickness and compactness of the 
specimen (B). (C, D, E) Solitary ESC-like OC. Note the ESC-like (ESCL) morphology (C, E), the 
distinct nucleoli (arrowhead in E), the homogeneous nuclear OCT4 staining of the ESCL cells (D), 
and the lipid droplets of the surrounding flat cells (arrowhead in D). (F, G, H) Clearly delineated 
ESCL OC. Note the clear demarcation (arrowhead in F) between the ESCL area and the surround-
ing flat cells and either a homogeneous (G) or heterogeneous (H) nuclear OCT4 staining. (I, J) 
Poorly delineated ESCL OC. Note the unclear demarcation between the ESCL area and the sur-
rounding cells (I) and the homogeneous nuclear OCT4 staining in the ESCL area (J). (K, L) Differ-
entiated OC. Note the flat loosely packed cells (K) with lack of OCT4 staining (L). Scale bars rep-
resent 100 µm. 
 
Figure 3: Characterization of OC and passages by RT-PCR. The figure shows an OC and a passage 
3 colony examined for the expression of the pluripotency markers OCT4, NANOG and SOX2 with 
GAPDH as reference. D7 blastocysts served as positive control tissue and H2O as negative control. 
All samples were run on a 1% agarose gel and stained with ethidium bromide.  
 
Figure 4: Phase contrast and OCT4 immunostainings of passages from porcine ESC-like OCs. (A, 
B) Passage 1 (P1) colony with ESC-like morphology (A) and nuclear OCT4 staining (B). (C, D) P4 
colony with ESC-like morphology (C), but lack of OCT4 staining (D). Scale bars represent 100 µm. 
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Table 1: Distribution of blastocysts on ICM/epiblast-isolation methods and characterization of 
OCs. 
ICM/epiblast 
isolation method 
Number 
of em-
bryos 
Number of 
OCs (%)A 
Colony Category 
ESC-like 
(%)A Epib-last-like 
Solitary 
ESC-
like 
Clearly 
delineated 
ESC-like 
Poorly 
delineated 
ESC-like 
Dif-
feren-
tiated 
1 Manual isolation 
 
 
28 13 (46%) 0 2 3 3 5 8 (29%) 
2 Immunosurgery 
 
 
40 21 (53%) 0 5 2 8 6 15 (38%) 
3 Whole blastocyst 
culture 
 
86 41 (48%) 5 15 5 6 10 26 (30%) 
Combined (1-3) 
 
75 (49%) a 
[41-57%]      
49 (32%) a 
[25-39%] 
4 Immunosurgery 
with manual 
cleaning 
51 35 (69%)
b 
[55-80%] 2 3 15 12 3 
30 (59%)b 
[45-72%] 
A
 Percentage of embryos cultured. 
Figures with different superscripts within columns are significantly different (P<0.05) and 95% confidence intervals are presented in 
square brackets. 
 Figure 1. 
 
Figure 2. 
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Figure 4. 
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Abstract 
 
Generation of a pluripotent reporter pig, containing reporter constructs of OCT4 and NANOG, could 
constitute an important large animal model to study pluripotent populations in-vivo and for deriva-
tion of embryonic stem cell (ESC) and induced pluripotent stem cell cultures in-vitro. In this study, 
alignments of the porcine OCT4 and NANOG promoter regions with homologous regions of other 
mammals have revealed important conserved transcription factor binding sites, including SP1/SP3, 
OCT4, SOX2, KLF4 and SMADs. Two OCT4 reporter constructs were generated, each containing 
6.6 kb porcine OCT4 promoter sequence, including the distal enhancer (DE) which is shown to be 
active in ESCs and embryonic germ cells in the mouse, in front of a destabilized enhanced red fluo-
rescent protein (pO4-dERFP-IRESpuro-pA) or an enhanced green fluorescent protein (pO4-EGFP). 
Furthermore, a NANOG reporter construct containing 2.2 kb porcine NANOG promoter sequence in 
front of a destabilized enhanced green fluorescent protein (pNG-dEGFP) was generated. Whereas 
pO4-dERFP-IRESpuro-pA was tested by transfection into mouse ESCs, the pO4-EGFP and NG-
dEGFP reporter constructs were tested by attempting to produce transgenic embryos, using somatic 
cell nuclear transfer (SCNT) and sperm mediated gene transfer (SMGT). Low fluorescence was 
observed in mouse ESCs transfected with pO4-dERFP-IRESpuro-pA compared to a stably inte-
grated murine Oct4-EGFP reporter construct. In contrast, the pO4-EGFP reporter construct showed 
expression in single blastomeres of 4-cell to morula stage embryos produced by SCNT and SMGT 
and NG-dEGFP reporter construct yielded ICM specific green fluorescence in blastocysts produced 
by SMGT, which points to an important role of NANOG in maintaining the pluripotent state in the 
pig. However, fluorescence was not observed in SCNT embryos containing NG-dEGFP. The lack 
of fluorescence in most cell types and transgenic embryos is likely due to a combination of factors, 
such as variation in endogenous OCT4 expression, post-transcriptional modification as well as epi-
genetic silencing. Further studies are required to ensure correct expression of OCT4 and NANOG 
reporter constructs before a pluripotent reporter pig can be established. 
  
72 
 
Introduction 
 
Pluripotency is controlled by different signaling pathways in the mouse and human. Leukemia in-
hibitory factor (LIF) supports the undifferentiated state of mouse embryonic stem cells (mESCs) by 
activating the transcription factor STAT3 through the Jak/Stat pathway (Smith et al., 1988) and 
bone morphogenetic protein 4 (BMP4) can enhance self-renewal and pluripotency through the 
Smad1/5/8 pathway (Ying et al., 2003). In contrast, in human embryonic stem cells (hESC), basic 
fibroblast growth factor (bFGF) is required for maintenance of pluripotency and self-renewal and 
ACTIVIN/NODAL signaling through SMAD2/3 is necessary to maintain the pluripotent state (Xu 
et al., 2005;Vallier et al., 2005;James et al., 2005). Despite these signaling differences, octamer 
binding protein 4 (Oct4; also known as POU5F1), and Nanog are central downstream targets, which 
maintain the pluripotent state in both the mouse and human.  
 
Oct4 maintains the pluripotency in the inner cell mass (ICM) by inhibiting the differentiation into 
the trophectodermal lineage (Niwa et al., 2000). In accordance, homozygotic Oct4 knockout mice 
do not develop past the blastocyst stage due to the lack of a distinct ICM (Nichols et al., 1998). In 
addition, Oct4 seems to be expressed in a quantitative manner, as downregulation of Oct4 in 
mESCs has been shown to correlate with the formation of trophectoderm, whereas, upregulation 
results in formation of primitive endoderm (Niwa et al., 2000). Further evidence of a central role of 
Oct4 in pluripotency has come from reprogramming of somatic cells to induced pluripotent stem 
cells (iPSCs), in which OCT4 was identified as one of the key reprogramming factors (Takahashi 
and Yamanaka, 2006). In contrast to the mouse, OCT4 is localized in both the ICM and trophecto-
derm of the unhatched human blastocyst (Cauffman et al., 2005) but is later found exclusively in the 
epiblast of the hatched blastocyst (Chen et al., 2009). It has been reported that OCT4 splice variants 
are expressed differently in human pluripotent and non-pluripotent cells (Atlasi et al., 2008) and 
caution should be shown when using RT-PCR and immunocytochemical staining of OCT4 (Liedtke 
et al., 2008). Whereas OCT4A seem to be expressed in the nucleus, and is involved in maintaining 
pluripotency, OCT4B is only expressed in the cytoplasm of some individuals and does not seem to 
have an apparent function (Takeda et al., 1992;Cauffman et al., 2006). A retroposon called OCT4C 
has also been detected, which lacks introns and is not transcribed.  
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In the pig, OCT4 was found to be ubiquitously expressed prior to hatching (Kirchhof et al., 
2000;Spencer et al., 2006;Kuijk et al., 2008;Keefer et al., 2007;Hall et al., 2009), which was also 
reported after hatching (Kirchhof et al., 2000;Kuijk et al., 2008). Hence, it was reasoned that OCT4 
is not a reliable pluripotency marker in the pig (Keefer et al., 2007). However, other studies have 
shown OCT4 protein localization exclusively in the epiblast after hatching (Vejlsted et al., 
2006;Flechon et al., 2004;Vejlsted et al., 2006;Hall et al., 2009) and OCT4 expression was detected 
in cultured ICM and epiblast cells but not in trophoblast cells (Blomberg et al., 2008). Around gas-
trulation, OCT4 becomes restricted posteriorly in the epiblast, after which it is found exclusively in 
primordial germ cells (PGCs) (Oestrup et al., 2009). Expression of endogenous OCT4 in porcine 
iPSCs, which was downregulated upon differentiation, points to a significant role in maintaining 
pluripotency in the pig as well (Esteban et al., 2009;Ezashi et al., 2009;Wu et al., 2009). In contrast 
to the mouse and human, isoforms of OCT4 have not been reported in the pig. 
 
The promoter of Oct4 has been the subject of several studies and through alignments with promoter 
regions of different mammalian species such as mouse (Yeom et al., 1991), cow (van Eijk et al., 
1999), human (Yang et al., 2005), and recently also rabbit (Kobolak et al., 2009), several conserved 
regions have been identified (Nordhoff et al., 2001;Yang et al., 2005). A distal enhancer (DE) is 
responsible for the expression of Oct4 in the ICM and in PGCs, whereas, a proximal enhancer (PE) 
is active in the epiblast (Yeom et al., 1996). The former is of particular interest in pluripotent stem 
cell research, as it has been shown to be active in mESCs and embryonic germ cells (EGCs) as well 
(Ovitt and Scholer, 1998). The proximal promoter (PP), on the other hand, is required for general 
Oct4 expression and downregulation upon differentiation. It has been shown that pluripotency is 
maintained through an autoregulatory network in which OCT4 binds to and upregulates the promot-
ers of Nanog and Sox2 (Okumura-Nakanishi et al., 2005). In addition, OCT4 acts in a negative 
feedback mechanism by binding to its own promoter, thereby limiting its own expression (Pan et 
al., 2006). In addition to regulation by transcription factors, the Oct4 promoter region has been 
shown to be subject to epigenetic regulation. Furthermore, the DE, PE and the PP region were 
found to be hypomethylated in mESCs but hypermethylated in somatic cells, except for a binding 
site of transcription factors belonging to the SP1/SP3 family in the promoter region (Hattori et al., 
2004). In addition, histone acetylation was also found to be involved in the regulation of Oct4. 
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Nanog expression is slightly later in murine pre-implantation development. The role of Nanog is to 
maintain the pluripotent state of the epiblast by inhibiting formation of the primitive endoderm 
(Mitsui et al., 2003). In accordance, Nanog null embryos did not develop beyond implantation, and 
the ICM failed to segregate and form the epiblast. Additionally, it has been shown that overexpres-
sion of Nanog can induce cytokine-independent self-renewal of undifferentiated mESCs (Chambers 
et al., 2003), whereas, downreglation of Nanog in mESCs results in primitive endoderm and tro-
phectoderm differentiation (Hyslop et al., 2005). However, a recent study has shown that mESCs 
containing a conditional Nanog knockout could be maintained in the undifferentiated state, despite 
being prone to differentiation (Chambers et al., 2007). It was concluded that Nanog is not essential 
for pluripotency, but acts as a safeguard against differentiation and mediates germ line potential. In 
human, NANOG is not identified prior to the expanded blastocyst stage where it is located in the 
early epiblast (Hyslop et al., 2005). Different splice variants of NANOG have been identified in both 
the mouse and human (Hart et al., 2004) and NANOG transcripts were reported to be present in sev-
eral adult tissues as well. 
 
Researchers have failed to detected NANOG by immunocytochemistry in porcine blastocysts prior 
to hatching (Kuijk et al., 2008;Hall et al., 2009;Blomberg et al., 2008). Yet, NANOG was detected 
in several other types of mature tissues by RT-PCR (Carlin et al., 2006;Blomberg et al., 2008). Like 
OCT4, it has been argued that NANOG is not a reliable pluripotency marker in the pig (Carlin et al., 
2006;Kuijk et al., 2008;Blomberg et al., 2008). However, after hatching, NANOG was recently re-
ported to be localized exclusively in the epiblast of Day 9-11 embryos (Hall et al., 2009) and there-
after is maintained exclusively in EGCs (Oestrup et al., 2009). Expression of endogenous NANOG 
in porcine iPSCs, which was downregulated upon differentiation, indicates a significant role in 
pluripotency in this species too (Esteban et al., 2009;Ezashi et al., 2009;Wu et al., 2009). In contrast 
to the mouse and human, isoforms of NANOG have not been detected in the pig. However, in other 
ungulates, the existence of NANOG isoforms have been reported and in the cow, NANOG A was 
localized in the epiblast, whereas, NANOG B was observed in polar trophoblast (Degrelle et al., 
2005). 
 
The proximal promoter (PP) region of Nanog is reported to consist of several conserved regions 
(Wu and Yao, 2005;Chan et al., 2009). Recently, it was shown that SMADs can bind directly to the 
NANOG promoter in hESCs (Xu et al., 2008). Binding of TGFβ/Activin-responsive SMAD/2/3 was 
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shown to enhance the NANOG promoter activity in hESCs, whereas, binding of BMP4-responsive 
SMAD/1/5/8 reduced the NANOG expression. Furthermore, in the mouse, it was found that 
SMAD1 binds directly to the Nanog promoter, which, in concert with STAT3 and Brachyury, play 
important roles in preventing mesoderm differentiation (Suzuki et al., 2006). These studies have 
helped to shed light on how NANOG sustains ESC self-renewal and controls differentiation in vari-
ous species. However, in contrast to OCT4, NANOG is not required as a reprogramming factor of 
iPSCs but instead acts in the final step of reprogramming by instating ground state pluripotency 
(Silva et al., 2009). In the mouse, it was recently shown that OCT4 forms a complex with SOX2 
and KLF4 and binds to the Nanog promoter, which is essential for reprogramming of somatic cells 
into iPSCs (Wei et al., 2009). Repression by DNA methylation and histone modifications has also 
been shown to play a role in the regulation of Nanog (O'Neill et al., 2006;Hattori et al., 2007). Two 
areas in the PP were found to be hypomethylated in ES cells but hypermethylated in somatic cells 
and while DNA methylation was most dominant in the proximal part of the PP, it was found that 
histone modification was dominant in the distal part of the PP. 
 
Reporter constructs of Oct4 and Nanog have been used to study the expression pattern of Oct4 and 
Nanog in murine embryos (Yeom et al., 1996;Mitsui et al., 2003) as well as in mESC (Kuroda et 
al., 2005;Okumura-Nakanishi et al., 2005) and hESCs (Kuroda et al., 2005;Gerrard et al., 2005). A 
reporter construct containing the Oct4 gene including 9 kb promoter sequence in front of an en-
hanced green fluorescent protein (EGFP) was used to monitor Oct4 expression in murine pre-
implantation embryos (Yoshimizu et al., 1999;Kirchhof et al., 2000;Szabo et al., 2002). Impor-
tantly, it was found that EGFP could be used as a measure of reprogramming of cloned blastocysts, 
which correlated with the frequency of mESC derivation (Boiani et al., 2002). The same Oct4 re-
porter construct was later used to quantitatively monitor reprogramming in cloned bovine blasto-
cysts (Wuensch et al., 2007) and was found to be expressed in porcine blastocysts as well (Kirchhof 
et al., 2000). A Nanog reporter construct has furthermore been used to monitor reprogramming of 
somatic cells to iPSCs (Okita et al., 2007;Maherali et al., 2007) resulting in germline-competent 
iPSCs with increased mESC-like gene expression (Okita et al., 2007). However, a recent study has 
indicated species specific variation in the regulation of pluripotency reporter constructs, as a human 
OCT4 reporter construct was subject to epigenetic de-regulation in mouse embryonic fibroblast 
cells (Cha et al., 2008). 
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The regulatory parts of porcine OCT4 and NANOG have not been subject to any detailed analyses. 
However, alignments with the promoter sequences of OCT4 and NANOG with their homologs of 
other mammals could yield important insights into the regulation of pluripotency in the pig. Fluo-
rescent reporter proteins have furthermore opened new vistas for embryology and stem cell research 
in livestock species (Habermann et al., 2007) and generation of a pluripotent reporter pig containing 
fluorescent reporter constructs of OCT4 and NANOG could constitute an important large animal 
model to study pluripotent cell populations in-vivo as well as for derivation of ESCs and for selec-
tion of iPSCs in-vitro. However, to verify their function, fluorescent reporter constructs of OCT4 
and NANOG first need to be correlated with endogenous OCT4 and NANOG expression in-vitro. 
 
In the present study we have: 1) Isolated and analysed the promoter regions of porcine OCT4 and 
NANOG; 2) Generated different fluorescent reporter constructs containing porcine-specific se-
quences of either OCT4 or NANOG in front of red or green fluorescent proteins and; 3) Analysed 
the expression of the reporters in mESCs and porcine pre-implantation embryos generated by so-
matic cell nuclear transfer (SCNT) and sperm mediated gene transfer (SMGT).  
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Materials and methods 
Unless otherwise stated, materials were purchased from Invitrogen, Carlsbad, CA. 
 
Analysis of OCT4 and NANOG promoter sequences 
Bacterial artificial chromosomes (BACs) containing porcine OCT4 and NANOG promoter se-
quences were identified by alignment with human homologous sequences (www.ensembl.org) 
(Hubbard et al., 2009). Alignments of OCT4 and NANOG promoter sequences with other mammals, 
including macaque, human, cat, cow, mouse and rat, was carried out using Bioedit 7.0.4. Based on 
studies in the mouse and human, transcription factor binding sites were mapped according to the 
human transcriptional start site. 
 
Generation of pluripotency reporter constructs 
Generation of pO4dERFP-IRESpuro-pA 
A BAC clone CH242-102G9 (Wellcome Trust Sanger Institute, Cambridge, UK), containing the 
porcine OCT4 gene and promoter sequence, was purified using the Hispeed Plasmid Midi kit 
(Qiagen, Chatsworth, CA). Polymerase chain reaction (PCR) with the primers 5armEHf and 
5armNf as well as 3armNf and 3armBr (Table 1) produced two products, called 5’- and 3’-arms, 
corresponding to the regions -6139 to -6575 and +19 to -340 relative to the transcriptional start site 
of the mouse Oct4, respectively (Okazawa et al., 1991). The 5’- and 3’-arm PCR products were 
digested with EcoRI/NheI and NheI/BglII respectively, and ligated into the EcorI/BglII digested 
multiple cloning site (MCS) of the vector pTurboRFP-Dest1 (Evrogen, Moscow, Russia), in front 
of a destabilized enhanced red fluorescent protein (dERFP) using T4 DNA ligase (Fermentas, Bur-
lington, ON) to produce pO4aRFP. pTurboRFP-Dest1 is reported to possess a fast maturity and 
strong intensity (Merzlyak et al., 2007) and due to the destabilization signal the reporter protein has 
a short half life of approximately 2 hours which is especially suited for the study of promoter activ-
ity (Habermann et al., 2007).  
 
An internal ribosomal entry site gene linked to a puromycin selection gene (IRESpuro; Clontech, 
Ca, USA) and the poly-A tail of the bovine growth hormone (pA) were digested with NcoI/BamHI 
and SpeI/NcoI, respectively, and subcloned into XbaI/BamHI digested pBluescriptSK+ vector 
(pBSK; Agilent Technologies, CA, USA) to produce IRESpuro-pA. 
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A 1671 bp fragment of pO4aRFP containing the 5’- and 3’-arms and the dERFP was isolated by 
digestion with EcoRI/XbaI and ligated into NsiI/EcoRI digested IRESpuro-pA cassette in pBSK in 
conjunction with an XbaI/NsiI digested adapter, generated by hybridization of oligos XadN53 and 
XadN35 (Table 1), to generate pO4arep. A removable “lox2neo” cassette containing lox-P sites 
flanking the geneticin (G418) resistance gene was digested with HpaI/EcorI and introduced into 
pO4arep by digestion with HpaI/EcorI. The resulting vector was linearized with NheI and electro-
transformed into recombineering competent E. Coli SW106, which had previously been electro-
transformed with the BAC clone CH242-102G9 (Wellcome Trust Sanger Institute). Heat-induced 
recombineering occurred after 15 min incubation at 42°C, after which a final digestion with 
NotI/ClaI was carried out to isolate the 11.020 bp pO4dERFP-IRESpuro-pA from the pBSK back-
bone. The construct was digested with different combination of restriction enzymes and sequenced 
to verify correct ligation of fragments. 
 
Generation of pO4-EGFP 
High-fidelity PCR (Qiagen, Chatsworth, CA) with primers pO4RegF and pO4RegR (Table 1) was 
performed  to amplify a region -6575 bp to +19 bp upstream of the transcriptional start site of OCT4 
using the BAC clone CH242-102G9 (Wellcome Trust Sanger Institute) as a template. The resulting 
PCR product, as well as the vector pmaxFP-Green-C (Lonza, Cologne, Germany), containing an 
enhanced green fluorescent protein (EGFP) (Evdokimov et al., 2006) were digested with AseI/AgeI 
and ligated, thereby exchanging the cytomegalovirus (CMV) promoter with the OCT4 promoter 
region. Finally, the construct was linearized with AseI resulting in the 10.707 bp pO4-EGFP. 
 
Generation of pNG-dEGFP  
A BAC clone CH242-335 (Wellcome Trust Sanger Institute, Cambridge, UK) which aligned with 
the human NANOG gene and upstream sequence was used for generation of a NANOG reporter 
construct. However, no sequence information was available. Consequently, the BAC was purified 
with Hispeed Plasmid Midi kit (Qiagen, Chatsworth, CA), digested with different combinations of 
restriction enzymes and ligated into compatible ends of the pBSK vector. Following transformation 
into competent E. coli Top10 cells and incubation overnight at 37°C, plaque lifts were performed 
onto Hybond-N+ transfer membrane (GE Healthcare Bio-sciences, Little Chalfont, UK), according 
to the manufacturer’s instructions. A 195 bp DNA probe recognizing exon 1 of the porcine NANOG 
gene was generated by PCR with the primers NG6f and NG200r (Table 1). The probe was used to 
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visualize colonies containing the NANOG gene and promoter sequence using Enhanced Chemilu-
minescence Direct labelling and Detection Systems (GE Healthcare Bio-sciences, Little Chalfont, 
UK), according to the manufacturer’s instructions. Positive clones were digested with various com-
binations of restriction enzymes to determine their fragment size. In addition, terminal sequencing 
with T7 and M13 primers was performed and selected clones were fully sequenced and aligned to 
create a consensus sequence. Digestion with BamHI/PstI and BglII/PstI yielded two fragments, 
which were ligated into a BamHI digested MCS of pTurboGFP-N (Evrogen, Moscow, Russia), con-
taining a dEGFP which possess the same characteristics as dERFP (Evdokimov et al., 2006). Fi-
nally, the CMV promoter was removed by digestion with BamHI/apaLI resulting in a 6076 bp 
pNG-GFP. The construct was verified by digestion with different combination of restriction en-
zymes and sequenced to verify correct ligation of fragments. 
 
Transfection of mouse embryonic stem cells 
Mouse embryonic stem cells containing a murine Oct4-GFP reporter construct were cultured ac-
cording to Nichols and co-workers (Nichols et al., 1990). Briefly, mESCs were cultured overnight 
on gelatinized culture dishes in mESC medium consisting of GMEM medium (Sigma-aldrich, St. 
Louis, MO) supplemented with 2 mM glutamine (Invitrogen, Carlsbad, CA), 1 mM sodium pyru-
vate (Invitrogen), 1% nonessential amino acids (Invitrogen), 10% fetal bovine serum (FBS) (Invi-
trogen), 0,1% beta-mercaptoethanol (Sigma-aldrich, St. Louis, MO) and 20ng/ml leukemia inhibi-
tory factor (Chemicon, Billerica, MA) at 37°C in 20% O2, 5% CO2 in N2. Transfection of Oct4-GFP 
mESCs with pO4dERFP-IRESpuro-pA was carried out using Lipofectamine 2000, according to the 
manufacturer’s instructions. Transfection with a vector containing a CMV promoter upstream of 
dERFP, and with H2O was performed as a positive and a negative control, respectively. After four 
hours, the medium was changed to fresh mESC medium, and the cells were cultured for 24 hours at 
37°C in 20% O2, 5% CO2 in N2. The following day, the cells were fixed in 4% paraformaldehyde 
(PFA) for 20 min and transferred to 1% PFA. Fluorescence was observed using a Leica DMRB 
fluorescent microscope and Leica Application Suite version 2.81 (Leica Microsystems).  
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Somatic cell nuclear transfer 
Nucleofection of porcine fetal fibroblast cells 
Isolation and nucleofection of porcine fetal fibroblast cells (PFFs) was carried out according to 
Wuensch and colleagues (Wuensch et al., 2007). Briefly, PFFs were isolated from Day 27 embryos 
of the “Schwabisch Hällisch” landrace by use of collagenase and cultured in DMEM (Sigma-
aldrich, St. Louis, MO) containing 5% FBS. At passage 3, the linearized reporter constructs pO4-
EGFP and pNG-dEGFP were introduced into the PFFs by means of nucleofection with Amaxa ba-
sic nucleofector kit for primary fibroblasts using program U12 of the Amaxa nucleofection device 
(Lonza, Verviers, Belgium). For each construct, a total of 2.1 µg DNA was nucleofected into 
0.8x106 PFFs which were selected in 0.6 mg/ml G418 for two weeks. 
 
Somatic cell nuclear transfer 
Ovaries were collected at a local abattoir and transported to the laboratory in phosphate buffered 
formalin (PBS) containing 75 µg/ml potassium penicillin G (Sigma-aldrich, St. Louis, MO), 50 
µg/ml streptomycin sulfate (Sigma-aldrich) and 0.1% (w/v) polyvinylalcohol (PVA; Sigma-
aldrich). Cumulus-oocyte complexes (COCs) were collected by aspiration and cultured in NCSU23 
medium (Petters and Wells, 1993) supplemented with 0.6 mM cysteine, 10 ng/ml epidermal growth 
factor (EGF), 10% porcine follicular fluid, 75 µg/ml potassium penicillin G, 50 µg/ml streptomycin 
sulfate (all from Sigma-aldrich, St. Louis, MO) and 10 IU/ml equine chorionic gonadotropin (eCG) 
(Intervet, Millsboro, USA) and 10 IU/ml human chorionic gonadotropin (hCG) (Intervet). COCs 
were cultured for 22 h with eCG and hCG, and then without hormones for 20 h at 38.5°C in 20% 
O2, 5% CO2 in N2. Oocytes displaying evenly granulated ooplasm and extrusion of the first polar 
body were selected for the experiments. 
 
Somatic cell nuclear transfer was performed using in-vitro matured (IVM) oocytes as recipient cy-
toplasts, as previously described (Kurome et al., 2006). Enucleation was performed using a chemi-
cally assisted method (Yin et al., 2002). Oocytes were cultured in NCSU23 medium supplemented 
with 0.1 µg/ml demecolcine, 0.05 M sucrose and 4 mg/ml BSA (all from Sigma-aldrich, St. Louis, 
MO) for 0.5-1 h and then enucleated by aspirating the first polar body and adjacent cytoplasm in 
Hepes-TL-PVP containing 0.1 µg/ml demecolcine, 5 µg/ml cytochalasin B (CB) and 10% FBS (all 
from Sigma-aldrich, St. Louis, MO). Enucleation was confirmed by staining cytoplasts with 5µg/ml 
bisbenzimide (Hoechst 33342; Sigma-aldrich, St. Louis, MO). 
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A mixed population of PFFs containing stable integrations of either pO4-EGFP or pNG-dEGFP 
were used as nuclear donors after cell cycle synchronization by serum starvation for 48 h. A single 
donor cell was inserted into the perivitelline space of an enucleated oocyte. Donor cell-oocyte com-
plexes were placed in a 280 mM mannitol solution (pH 7.2) containing 0.15 mM MgSO4, 0.01% 
PVA, and 0.5 mM Hepes (all from Sigma-aldrich, St. Louis, MO) and held between 2 electrode 
needles. Membrane fusion was induced using an Electro cell fusion LF101 (NEPA GENE Co. Ltd., 
Chiba, Japan) by applying a single direct current (DC) pulse (200 V/mm, 20 µs ×1) and a pre- and 
post-pulse alternating current (AC) field of 5 V, 1 MHz for 5 s, respectively. Reconstructed em-
bryos were cultured in NCSU23 for 1-1.5 h, followed by electrical activation. Reconstructed em-
bryos were washed twice in an activation solution consisting of 0.3 M mannitol, 50 µM CaCl2, 100 
µM MgSO4 and 0.01% PVA, then placed between 2 wire electrodes of a fusion chamber slide and 
overlaid with activation solution. A single DC pulse of 150 V/mm was applied for 100 µ. Activated 
oocytes were treated with 5 µg/ml CB for 3 h to suppress extrusion of the pseudo-second polar body. 
In-vitro culture of embryos was performed in 20-µl droplets of Porcine zygote medium (PZM) (Yo-
shioka et al., 2002) in 5% O2, 5% CO2 in N2 at 38.5 C. 
 
Embryo transfer 
Six to seven month old prepuberal gilts were used as recipients. Estrus synchronization was con-
ducted by oral administration of altrenogest (Regumate, Serumwerk Bernburg, Germany) over a 15 
day period, followed by intramuscular injection of 750 IU pregnant mare serum gonadotropin (In-
tergonan, Intervet, Germany) 24 hours after last gestagen administration. Ovulation was induced 3 
days later by intramuscular injection of 750 IU human chorionic gonadotropin (Ovogest, Intervet, 
Germany). Two days after Intergonan treatment, recipients were anesthesized and brought into 45° 
dorsal recumbency. 1-2 cell-stage embryos containing pO4-EGFP or pNG-dEGFP were transferred 
laparoscopically into the right oviduct and embryos were cultured in-vivo for 10 days prior to flush-
ing (Day 11-12 embryos). 
 
Sperm mediated gene transfer 
Ovary collection and in-vitro maturation  
Danish Landrace x Yorkshire gilt ovaries were collected from a local abattoir (Danish Crown, 
Ringsted, Denmark) and were kept at 30 - 330C from collection until follicular aspiration. The 
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COCs were aspirated and cultured in IVM medium containing TCM-199 (Sigma-aldrich, St. Louis, 
MO) supplemented with 50 ng/ml EGF (Sigma-aldrich, St. Louis, MO), 10 IU/ml eCG, 5 IU/ml 
hCG (Suigonan Vet., Intervet Scandinavia, Skovlunde, Denmark), 100 µM 2-mercaptoethanol, 5 
µl/ml Insulin-Transferrin-Selenium, L-Glutamine-Penicillin-Streptomycin, and 4 mg/ml bovine 
serum albumin (BSA; Sigma-aldrich, St. Louis, MO) for 44 - 48 hrs at 38.50C in 20% O2, 5% CO2 in 
N2. 
 
Preparation of semen 
Semen from 10 Duroc boars was purchased from Hatting boar station (Hatting-KS, Ringsted, Den-
mark) as a mixed fresh ejaculate in extender and was kept at 16 - 180C until use. Semen was washed 
free of extender twice in a non-capacitating medium (113 mM NaCl, 5 mM KCl, 5.56 mM glucose, 
1.2 mM KH2PO4, 1.2 mM MgSO4, 22 mM Na-lactate, 5 µg/ml phenol red, 50 µg/ml gentamycine 
(all from Sigma-aldrich, St. Louis, MO)), then resuspended in capacitating IVF medium (90 mM 
NaCl, 12 mM KCl, 0.5 mM NaH2PO4, 25 mM NaHCO3, 0.5 mM MgSO4, 2 mM Na-pyruvate, 8 
mM CaCl2, 1.9 mM caffeine, L-Glutamine-Penicillin-Streptomycin, 5 ug/ml phenol red, 4 mg/ml 
BSA (all from Sigma-aldrich, St. Louis, MO) and pre-incubated for 10 - 15 min at 38.50C in 20% 
O2, 5% CO2 in N2.  
 
Sperm mediated gene transfer 
From a final sperm concentration of 1 x 106 cells/ml, 3 µl was added to a 3 µl 10% polyvinyl pyr-
rolidone droplet (PVP, Cook Medical, Bloomington, IN) with 3 µl of either pO4-EGFP or pNG-
dEGFP to a final conc. 4 ng/ml DNA and incubated at room temperature for one hour. H2O served 
as a negative control. Prior to SMGT, mature oocytes were freed from cumulus cells by 5 – 10 sec 
of vortexing and individual sperm cells were immobilized by squeezing the tail between the bottom 
of the disc and the injection pipette (El Shourbagy et al., 2006). SMGT was carried out using a 
25µm holding pipette and an 8µm injection pipette according to standard procedures. After SMGT, 
oocytes were cultured for up to 1 week in porcine zygote medium 3 (PZM-3) supplemented with 4 
mg/ml BSA at 38.50C in 5% O2, 5% CO2 in N2 (Yoshioka et al., 2002).  
 
Monitoring of fluorescence and fixation of embryos 
Cleavage and blastocyst formation of SCNT and SMGT embryos was monitored over a 7 days cul-
ture period. Fluorescence microscopy was carried out at Day 2 (4-8 cell stage), Day 5 (morula 
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stage) and Day 7 (blastocyst stage). For immunocytochemical analysis, embryos from the same 
stages were fixed in 4% PFA for 20 min and stored in 1% PFA at 4°C. For reverse transcriptase 
PCR (RT-PCR), 5 SCNT blastocysts were pooled, transferred to lysis buffer (AH diagnostics, Oslo, 
Norway) and frozen at -80°C. 
 
Flushing of somatic cell nuclear transfer embryos 
Recipients were slaughtered at a local abattoir 10 days post embryo transfer (Day 11-12 embryos) 
and the uterus was isolated and transported to the laboratory in a 38°C warm water bath for a 
maximum period of one hour. Each uterine horn was flushed with 150 ml PBS containing 1% FBS, 
and embryos were isolated by stereo-microscopy. For immunocytochemical analysis, embryos were 
fixed in 4% Paraformaldehyde (PFA) for 20 min and stored in 1% PFA at 4°C. For reverse tran-
scriptase PCR (RT-PCR), 5 embryos were pooled, transferred to lysis buffer and frozen at  
-80°C. 
 
RNA purification 
For reverse transcriptase PCR (RT-PCR), 5 SCNT blastocysts were pooled, transferred to lysis 
buffer (AH diagnostics, Oslo, Norway) and frozen at -80°C. The SCNT embryos were placed in 
lysis buffer (AH diagnostics, Oslo, Norway) and stored at -80°C. Total RNA was purified using the 
Nucleospin RNA XS kit (AH diagnostics) and reverse transcription was performed using RevertAid 
First strand cDNA synthesis kit (Fermentas, Burlington, ON) according to the manufacturer’s in-
structions. For each sample, a negative reaction was included, by omission of M-MuLV Reverse 
Transcriptase enzyme. 
 
PCR and RT-PCR  
PCR was performed with primers of OCT4 and NANOG (Table 1) with porcine chromosomal DNA 
as a positive control. RT-PCR was performed with primers of GFP (Table 1) with DNA from PFFs 
containing pO4-EGFP or pNG-dEGFP as positive controls and H2O as a negative control. In both 
conditions PCR was carried out using Hot Start PCR master mix (Fermentas, Burlington, ON) with 
the following PCR conditions: Hotstart at 95°C for 15 min, 35 cycles including denaturation at 
94°C for 30 sec, annealing at 56°C for 30 sec, and elongation at 72°C for 45 sec, and finalized by 
elongation at 72°C for 10 min and incubation at 4°C. The PCR and RT-PCR products were run on a 
1% and a 3% agarose gel, respectively, and visualized by staining with ethidium bromide. 
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Immunocytochemistry 
Immunocytochemistry of SCNT and SMGT embryos comprised 30 min permeabilization in 0,1% 
triton X + 0.25% bovine serum albumin (BSA) in PBS followed by 3 times 5 min treatment with 
boiling 0.01M citrate buffer, pH 6 (LIFE Pharmacy, KU, Frederiksberg, Denmark) and 30 min 
blocking of unspecific antigen sites with 5% normal donkey serum (Sigma-aldrich, St. Louis, MO) 
in PBS. Subsequently, the embryos were washed with PBS and incubated at 5°C overnight with 
primary antibodies anti-OCT4 goat polyclonal (SC-8628, Santa Cruz Biotechnology, Santa Cruz, 
CA) diluted 1:250 in 0.1% triton X + 0.25% BSA in PBS or anti-NANOG rabbit polyclonal (Pepro-
tech, Rocky Hill, NJ) diluted 1:500 in 0.1% triton X + 0.25% BSA in PBS or anti-TurboGFP rabbit 
polyclonal (Evrogen, Moscow, Russia) diluted 1:1000 in 0.1% triton X + 0.25% BSA in PBS. The 
following day the embryos were washed 3 times in PBS, incubated 1 hour with fluorescent-
conjugated secondary antibodies (Alexa Fluor) diluted 1:400 in 0.1% triton X + 0.25% BSA in 
PBS, washed 3 times in PBS, incubated in 0.1 µl/ml Bisbenzimide Hoechst (Sigma-aldrich, St. 
Louis, MO) and mounted in fluorescence mounting medium (Dako, Glostrup, Denmark). Specific-
ity of OCT4 and NANOG antibodies has previously been verified (Vejlsted et al., 2006;Hall et al., 
2009) and as a negative control, embryos were incubated in the absence of primary antibodies. All 
specimens were examined using a Leica DMRB fluorescent microscope and Leica Application 
Suite version 2.81 (Leica Microsystems). 
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Results 
 
Alignment of the porcine OCT4 gene and promoter region with other mammals. 
The reported 5699 bp porcine OCT4 coding sequence consists of five exons and is located on chro-
mosome 7 (NM001886435) and the resulting mRNA sequence is 1083 bp (NM001113060). Align-
ment with bovine, human and murine OCT4 showed that the 360 amino acid (aa) protein is ex-
tremely conserved between species as it shares 96,4%, 93,0% and 83,6% aa sequence identity 
among these species, respectively.  
 
Several regions in the porcine OCT4 reporter sequence showed homology with other mammals 
(Figure 1). A CCCTCCCCC sequence located -2065 to -2056 relative to the murine transcriptional 
start site was found to be 100% conserved between the other mammals. In addition, the sequence 
AGATGCATGACAAAG located -2020 to -2005 was also conserved except for a single nucleotide 
difference in the bovine and rat sequences. High sequence identity was also identified in the se-
quence TCCAGGCCCATTCAAGGGTTGAGCAC located -1047 to -1020 except for the mouse 
and rat which showed a few nucleotide differences. In addition, the sequence 
GGGGGCGGGGCCAGAGGTCAAGGCTA located -72 to -47 showed 100% similarity to the 
other mammalian sequences. Finally, several sequences with the consensus GGG(A/T)GGG or 
CCC(A/T)CCC were found to be highly conserved as well. 
 
Alignment of the porcine NANOG gene and promoter region with other mammals. 
The 6.487 kb porcine NANOG coding sequence consists of four exons and is located on chromo-
some 5 (EF522119) and the resulting mRNA sequence is 1181 bp (DQ447201). In contrast to 
OCT4, alignment with bovine, human and murine NANOG showed that the 304 aa protein is less 
conserved, as it shares 79,5%, 73,8% and 56,11% sequence identity among these species, respec-
tively.  
 
Homology was only observed in the NANOG PP region (Figure 2). The sequence 
TAAAAAGTGGAAACAAGGTGGACCTGCAA located -262 to -233 relative to the murine tran-
scriptional start site showed sequence identity with other ungulates and primates, but differed from 
the rodents. In contrast, the sequence GTCTG located -175 to -171 was 100% conserved between 
the other mammals. The sequence TTTGCATTACAATG located -150 to -136 was also completely 
86 
 
conserved, except for a single nucleotide in the canine sequence. The sequences GGGGGTGTG 
and GGGGCGGGC located -83 to -74 and -64 to -55, respectively were conserved between the 
other mammals, however, some variations between primates, ungulates and rodents was observed. 
High sequence identity was also observed in a TATAA sequence located at -33 to  
-28, except in the rodents. Finally, several AGAC sequences located in the NANOG PP region were 
relatively conserved between other mammals. 
 
Generation of a red fluorescent reporter construct of OCT4. 
Three BAC clones with high homology to the human OCT4 gene and promoter sequence were iden-
tified and PCR with primers of OCT4 spanning exons 3 to 5 confirmed that all three clones contain 
the porcine OCT4 gene as they produced a single product of the expected 898 bp (Figure 3A). In 
contrast, a reaction with chromosomal DNA produced an additional product of 268 bp, indicative of 
an intron-lacking pseudogene. The 189 kb BAC clone CH242-102G9, containing the complete 
OCT4 gene as well as 53,066 kb upstream region was used in the present study, as it shows 99,6% 
sequence identity with the porcine OCT4 coding sequence and 100% identity with the porcine 
OCT4 mRNA sequence. 
 
The OCT4 reporter construct pO4dERFP-IRESpuro-pA was generated by homologous recombina-
tion with the BAC clone 242-102G9 to ensure the highest possible sequence identity (Figure 4A). It 
includes approximately 6.6 kb of the upstream region of OCT4 inserted directly upstream of 
dERFP, The IRES sequence allows for a puromycin selection gene to be transcribed from the same 
messenger, which is useful for the selection of OCT4 positive colonies, and a poly-A tail from the 
bovine growth hormone, ensures correct translation. The reporter construct also contains a constitu-
tively expressed G418 resistance gene for selection of transfected cells, which is floxed with loxP 
sites for subsequent removal. 
 
Generation of a green fluorescent reporter construct of OCT4 
A second OCT4 reporter construct called pO4-EGFP was generated by High-fidelity PCR (Figure 
4B). It also consists of approximately 6.6 kb upstream region inserted in front of EGFP and in-
cludes a constitutive neomycin gene for selection of transfected cells. 
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Generation of a green fluorescent reporter construct of NANOG 
Two BACs with homology to the human NANOG gene and promoter sequence were identified. 
PCR with primers of NANOG spanning exon 3 and 4 showed that the BAC clone CH242-335 pro-
duced a single product of the expected 300 bp, whereas, chromosomal DNA and another BAC 
clone produced an additional product of 160 bp indicative of an intron-lacking pseudogene (Figure 
3B). A NANOG pseudogene has previously been identified on chromosome 1 (XM_001928688), 
which has a single exon of 1159 bp and lacks a poly-A-tail. It shares 99% sequence identity with 
the mRNA of the real NANOG gene. 
 
Since sequence information was not available on BAC clone 242-335, colony blotting was used to 
generate the NANOG reporter construct pNG-dEGFP (Figure 4E). Hybridization with a NANOG 
probe (Figure 4C) and restriction digestion (Figure 4D) yielded a total of 40 clones containing in-
serts of varying size. Terminal sequencing with T7 and M13 primers identified that 7 of the clones 
contained exon 1 of the NANOG gene in either the 5´ or 3´ sequenced ends. Three of the largest 
clones were fully sequenced which resulted in a 2178 bp sequence with 100% sequence identity 
among them, which was inserted in front of dEGFP. The NANOG reporter construct includes a con-
stitutive neomycin gene for selection of transfected cells. Recently, a sequence containing 3305 bp 
promoter sequence of the porcine NANOG gene was published (EF522119) (Miyamoto et al., 
2008). The 2178 bp promoter sequence identified in this study matches this promoter sequence by 
98%, indicating that the sequences are nearly identical. 
 
OCT4 reporter expression in mouse embryonic stem cells 
Transfection of mESCs with the pO4dERFP-IRESpuro-pA reporter construct resulted in weak red 
fluorescence in some of the cells in contrast to a stably integrated murine Oct4-GFP reporter con-
struct, which showed high fluorescence in most of the cells. (Figure 5A-D). However, transfection 
with H2O was negative (Figure 5E-H) and transfection with a control vector constitutively express-
ing dERFP yielded comparable low red fluorescence (data not shown). 
 
OCT4 and NANOG reporter expression in SCNT produced embryos 
Porcine fetal fibroblast cells containing the pO4-EGFP and pNG-dEGFP reporter constructs were 
used in both in-vitro and in-vivo cloning experiments. The in-vitro experiments included 5 and 4 
SCNT experiments with PFFs containing the OCT4 and NANOG reporter constructs, respectively 
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(Table 2). In addition, a single experiment using PFFs without constructs was performed (negative 
control). The experiments included reconstruction of 25-50 oocytes per construct per day and the 
rate of donor cell fusion and initial cleavage rates were ~75% and 55-95% respectively (Table 2). 
However, the blastocyst development rates were relatively low at approximately 15-18% (blastocyst 
developmental rates of 13 - 20% have previously been reported in the pig (Kurome et al., 2006)). In 
general, there were no apparent developmental differences between different groups of embryos 
containing the OCT4 and NANOG reporter constructs. The same was true for the control embryos 
without constructs, although a slightly higher cleavage rate was observed. Green fluorescence was 
only observed in the cytoplasm of two 8-cell and one morula stage embryo containing the OCT4 
reporter construct and showed equal expression in all blastomeres (Table 2; Figure 6A), whereas, no 
fluorescence was observed at the blastocyst stage (Table 2; Figure 6E). Immunocytochemistry 
showed nuclear localized OCT4 in blastomeres at the 8-cell to morula stage (Figure 6B) embryos, 
however, cytoplasmic localization of OCT4 was most evident (Figure 6D). However, at the blasto-
cyst stage, only nuclear localization of OCT4 was observed (Figure 6 F-H). In contrast, green fluo-
rescence was not observed in any of the examined embryo stages containing the NANOG reporter 
construct (Figure 6I) and staining with a NANOG antibody showed only cytoplasmic NANOG 
staining (Figure 6 J-L).  
 
The in-vivo experiment included two SCNT experiments with reconstruction of around 50 oocytes 
from each of the OCT4 and NANOG reporter constructs, which were transferred into two different 
recipient sows after 1-2 days of in-vitro culture (Table 3). Comparable fusion rates to the in-vitro 
experiment was observed with the OCT4 and NANOG reporters, although a slightly higher cleavage 
rate at around 85% was observed. No Day 11-12 embryos were obtained following transfer of the 
pO4-EGFP SCNT embryos, which was presumably due to a lack of pregnancy (Table 3). However, 
several Day 11-12 embryos containing the NANOG reporter construct were isolated and staged 
(Vejlsted et al., 2006), including five ovoid and many filamentous embryos (Table 3). Unfortu-
nately, green fluorescence was not detected in the embryos (Data not shown). 
 
In an attempt to identify the possible reasons for the lack of green fluorescence, cDNA from pools 
of 5 in-vitro produced blastocysts containing either the OCT4 or the NANOG reporter constructs as 
well as 5 Day 11-12 in-vivo produced embryos containing the NANOG reporter construct were ana-
lysed by RT-PCR. A positive control reaction with DNA purified from PFFs containing either the 
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OCT4 or the NANOG reporter constructs showed clear bands the gel (Figure 7A and B, lane 1). A 
faint band was also detected using cDNA of blastocysts containing the OCT4 reporter construct as 
template (Figure 7A, lane 2), but not with cDNA of blastocysts containing the NANOG reporter 
construct (data not shown). In contrast, a clear band was obtained with cDNA of D11-12 embryos 
containing the NANOG reporter construct (Figure 7B, lane 2). Negative control reactions lacking 
RT enzyme or with H2O as template showed no signals (Figure 7A and B, Lane 3 and 4). 
 
Finally, staining with a GFP antibody was carried out on in-vitro produced 8-cell, morula and blas-
tocyst stage embryos containing both reporter constructs and on D11-12 embryos containing the 
NANOG reporter construct, however, no specific fluorescence was observed (data not shown). 
 
OCT4 and NANOG reporter expression in SMGT produced embryos 
Green fluorescence was consistently observed in 1-cell to morula-stage embryos containing the 
OCT4 reporter construct, but was only observed in individual blastomeres and thus presented a mo-
saic expression pattern (Figure 8A). Furthermore, the fluorescence seemed to correlate with OCT4 
staining (Figure 8B-D). In contrast, green fluorescence was not observed in blastocysts containing 
the OCT4 reporter construct. With the NANOG reporter construct the embryos showed green fluo-
rescence from the 1-cell stage to the morula stage also presenting a mosaic expression pattern. 
Green fluorescence was furthermore observed in three blastocysts containing the NANOG reporter 
construct, which was localized exclusively in the ICM (Figure 8E). However, staining with a 
NANOG antibody was negative (Figure 8F-H). 
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Discussion 
 
The expression pattern of porcine OCT4 and NANOG has been subject to much attention and it has 
been argued that these transcription factors are not important for maintaining the pluripotent state in 
the pig (Keefer et al., 2007;Carlin et al., 2006;Kuijk et al., 2008;Blomberg et al., 2008). However, 
recent studies have shown a similar expression patters of OCT4 and NANOG compared to the hu-
man (Vejlsted et al., 2006;Hall et al., 2009). The aim of this study was to isolate the porcine OCT4 
and NANOG promoter regions and analyse them by alignments with the promoter regions of other 
mammals and by expression of fluorescent reporters in pluripotent cells and transgenic embryos. 
 
The picture emerging from studies on regulation of Oct4 and Nanog in the mouse and human is that 
these pluripotency markers are regulated by a combination of transcription factors as well as DNA 
methylation and chromatin remodelling. The binding sites identified in the porcine OCT4 promoter 
region were, for the most part, highly conserved. The conserved sequences CCCTCCCCC and 
AGATGCATGACAAAG identified at approximately -2 kb in the porcine OCT4 promoter corre-
spond to the sites 2A and 2B, respectively, which makes up the DE of the murine promoter. 
Whereas site 2A has been shown to bind to an unknown transcription factor, possibly SP1/SP3, site 
2B has been shown to bind a OCT4/SOX2 complex (Okumura-Nakanishi et al., 2005). 
 
The conserved sequence TCCAGGCCCATTCAAGGGTTGAGCAC located at around -1 kb corre-
sponds to the binding site 1B in the PE which has been shown to be involved in retinoic acid medi-
ated downregulation during differentiation in the mouse (Okazawa et al., 1991). The PE is reported 
to be responsible for OCT4 expression in the epiblast and in embryonal carcinoma (EC) cells (Oka-
zawa et al., 1991). Interestingly, the site 1A, which forms the second half of the PE in the mouse, is 
almost completely missing in the pig. However, it was recently shown that this region is not con-
served in other ungulates and primates and may not be important for regulation of OCT4 (Kobolak 
et al., 2009).  
 
The conserved sequence GGGGGCGGGGCCAGAGGTCAAGGCTA located around -50 bp, 
which corresponds to the SP1/SP3 transcription factor binding site in the PP, is believed to regulate 
initiation of transcription from TATA-less promoters, such as Oct4 (Ovitt and Scholer, 1998). This 
sequence partly overlaps with a hormone responsive element, which can bind molecules induced by 
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retinoic acid and has been shown to be involved in downregulation of Oct4 upon differentiation 
(Schoorlemmer et al., 1994;Minucci et al., 1996). 
 
Finally, several sequences containing the consensus GGG(A/T)GGG or CCC(A/T)CCC have been 
identified in the porcine OCT4 promoter, which are putative binding sites, however, so far their 
function remains unknown (Kobolak et al., 2009). 
 
In the porcine NANOG promoter, several areas within the PP region showing high sequence identity 
with other mammals were identified. The sequence TAAAAAGTGGAAACAAGGTGGACCTGC-
AA located at approximately -250 was quite conserved between primates and ungulates but did not 
show significant sequence identity with a reported FOXD3 binding site, which has been shown to 
upregulate Nanog expression in the mouse (Pan and Thomson, 2007). Hence, it may represent an 
unknown transcription factor binding site in ungulates and primates.  
 
The sequence GTCTG located around -175 bp was completely conserved in all the examined 
mammals and along with three AGAC sequences these sites are reported to act as SMAD binding 
sites in the human (Xu et al., 2008). In hESCs, the TGFβ/Activin pathway has been shown to en-
hance the activity of NANOG through direct binding of SMADs. Since the AGAC sequences are 
quite conserved in the porcine NANOG promoter but shows more variation in the rodents, it could 
point to an active role of TGFβ/ACTIVIN signaling in the pig as well. 
 
The sequence, TTTGCATTACAATG located around -150 bp is reported to be an OCT4/SOX2 
binding site necessary for the major promoter activity of NANOG (Kuroda et al., 2005). Further-
more, the sequences GGGGGTGTG and GGGGCGGGC located around -75 bp in the porcine pro-
moter sequence corresponds to two SP1/SP3 transcription factor binding sites (Wu and Yao, 2006). 
In the mouse and human, it was recently shown that KLF4 binds to these sites and directly interacts 
with OCT4/SOX2 in regulating the expression of NANOG (Chan et al., 2009;Wei et al., 2009). The 
observation that binding sites of OCT4, SOX2 and KLF4 are conserved in all the mammals, includ-
ing the pig is particularly interesting, as these transcription factors are reported to be crucial and 
sufficient for reprogramming of fibroblasts into iPSCs (Nakagawa et al., 2008).  
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A TATAAA site was furthermore identified at -30 bp, which is usually involved in transcription by 
RNA polymerase II. It has been reported that TATA less promoters allows for a fast transcription 
switch-off which is important in differentiating cells (Ovitt and Scholer, 1998). The reason why a 
TATA site was observed in the NANOG promoter of ungulates and primates, but not in rodents is 
unknown, however, it could be speculated that other sites are involved in downregulation of 
NANOG in rodents. 
 
In the mouse, negatively regulating cis elements are furthermore reported to bind in the -5 kb pro-
moter region (Chan et al., 2009), however, so far the corresponding area in the porcine NANOG 
promoter has not been sequenced. In this region, Smad1 has been shown to bind to the sequences 
GCCGCGCCA, GCCGCACC and GCCACGGC and STAT3 and Brachyury to the sequences 
TTCCTAGAA and GGGACACACCTAGGGTTCCC, respectively. In concert, these transcription 
factors are reported to block bone morphogenic protein (BMP) induced differentiation in mESCs 
(Suzuki et al., 2006). Furthermore, it has been suggested that leukemia inhibitory factor (LIF) sig-
naling through STAT3 can upregulate Nanog (Pan and Thomson, 2007), which may explain why 
overexpression of Nanog can maintain mESCs in their undifferentiated state without supplementa-
tion of LIF (Chambers et al., 2003).  
 
As stable ESC-lines expressing pluripotency markers such as OCT4 and NANOG currently do not 
exist in the pig, another type of pluripotent cell was used to analyse the porcine pluripotency re-
porter constructs. Since the murine Oct4 promoter has been shown to be functional in porcine em-
bryos (Kirchhof et al., 2000), it was hypothezised that the porcine OCT4 reporter construct might 
also be functional in mESCs. However, only weak fluorescence was observed in mESCs transfected 
with the OCT4-dERFP construct in contrast to a reporter construct of murine Oct4, which displayed 
more widespread green fluorescence. The observation that constitutively expressed dERFP was also 
expressed at a low level in mESCs may point to inefficiency in translation of the fluorophore as 
fluorophores are known to be expressed differently in various types of cells. In one study, dERFP 
was found to be expressed at different levels in different tissues, with eg. low level expression in 
mouse lung and liver but with high expression in mouse muscle (Bell et al., 2007). A human OCT4 
reporter construct which was found to be expressed in mouse fetal fibroblast cells has furthermore 
demonstrated, that the mouse can not always be used to study tissue-specific changes in other spe-
cies (Cha et al., 2008). In contrast, the recently generated porcine iPSCs could serve as a more reli-
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able cell type for in-vitro analysis of the pluripotency reporter constructs, since stable expression of 
OCT4 and NANOG at a comparable level to hESCs have been reported in these cells (Wu et al., 
2009).  
 
Examination of OCT4 and NANOG reporter constructs in cloned porcine preimplantation embryos 
yielded only green fluorescence in three 8-cell to morula stage embryos carrying the porcine OCT4 
reporter construct, whereas, fluorescence was not observed in embryos containing the NANOG re-
porter construct. The most obvious explanation for this may be a different expression profile of 
OCT4 and NANOG in the pig, compared to the mouse and human. Accordingly, staining with a 
NANOG antibody did not show nuclear localized NANOG in any of the stages, indicating that the 
blastocyst stage is perhaps not optimal for the study of pluripotency markers in the pig. However, as 
staining with an OCT4 antibody did show nuclear localized OCT4 at the blastocyst stage, one 
would expect fluorescence in all the cells of the blastocyst carrying the OCT4 reporter construct.  
 
A more plausible explanation is that silencing of the exogenous pluripotency reporter constructs 
occurs, as it has previously been shown that reporter constructs are subject to epigenetic silencing in 
hESCs (Liew et al., 2007). In a recent study, a human OCT4 reporter construct containing a 4 kb 
upstream sequence was completely silenced 72 hours after nucelofection and G418 selection in 
hESCs and EC cells, which was primarily attributed to in-vitro methylation (Stewart et al., 2008). In 
contrast, the CMV promoter driving G418 was not silenced possibly due to the selection pressure 
exerted on this promoter. It is possible that a similar mechanism is responsible for silencing of the 
porcine OCT4 and NANOG reporter constructs in nucleofected PFFs during selection in G418. It 
could be interesting to apply antibiotic selection to mESCs transfected with pO4dERFP-IRESpuro-
pA to examine if OCT4 was capable of driving puromycin resistance in these cells. 
 
A final possibility is that post-transcriptional modifications could be responsible for the lack of re-
porter expression. RT-PCR showed GFP expression in blastocysts containing the OCT4 reporter 
construct, as well as in Day 11-12 embryos containing the NANOG reporter construct, whereas, 
staining with a GFP antibody did not yield any specific staining. It is likely that splicing, which 
normally prevents the expression of intron-lacking pseudogenes, inhibits the conversion of reporter 
RNA to messenger RNA due to the lack of introns. This hypothesis is supported by the fact that a 
94 
 
mouse reporter construct, containing the entire Oct4 gene including introns, could be expressed in 
porcine embryos (van Eijk et al., 1999). 
 
Using SMGT, fluorescence of the OCT4 reporter construct was consistently observed from around 
the 1-cell stage to the early morula stage embryo, after which the fluorescence was lost. This obser-
vation fits with a gradual silencing of the OCT4 reporter construct during in-vitro culture. In con-
trast, with this method the NANOG reporter construct was found to be localized exclusively in the 
ICM of blastocysts, but since NANOG was not detected by immunocytochemistry it seems that 
only NANOG transcripts are present at this stage. In general, with SMGT the location and number 
of transgene integration sites are reported to fluctuate (Habermann et al., 2007). This could explain 
the observed mosaic expression profile of the OCT4 and NANOG reporter constructs in SMGT em-
bryos in contrast to SCNT embryos in which a ubiquitous green fluorescence was observed with the 
OCT4 reporter. Furthermore, a higher number of reporter construct integrations could explain why 
expression of the NANOG reporter construct was only detected by SMGT and not by SCNT. How-
ever, as the SMGT technique has not been completely optimized yet, further studies are required to 
verify correct expression of the pluripotency reporters, including fluorescent in situ hybridization to 
analyse integration of transgenes. 
 
Several steps could be taken to ensure correct expression of the reporter constructs in porcine cells 
and tissues. Inclusion of additional enhancer elements, especially in the 3’ region has been shown to 
reduce silencing in hESCs and EC cells (Stewart et al., 2008). However, in the case of OCT4, all the 
known enhancers were already included. Liew and colleagues have shown that addition of a 
polyoma virus mutant enhancer called PyF101 retains reporter driven EGFP expression in hESCs 
and EC cells (Liew et al., 2007). A similar approach may be applied to the porcine pluripotency 
reporter constructs. However, the most reliable way to overcome silencing as well as incorrect 
splicing is by use of homologous recombination, which could either be carried out by BAC recom-
bineering, or by directly inserting a reporter protein in front of OCT4 and NANOG by use of target-
ing vectors. The latter, however, could have serious implications in the maintenance of pluripo-
tency, as has previously been shown in mESCs (Niwa et al., 2000;Chambers et al., 2003). 
 
  
95 
 
Conclusion 
This study provides the first comprehensive analysis of the porcine OCT4 and NANOG promoter 
regions. Detailed sequence analysis showed that the porcine OCT4 and NANOG promoter regions 
contain most of the transcription factor binding sites reported to be involved in maintaining the 
pluripotent state in the mouse and human, which points to an important role of OCT4 and NANOG 
in the pig as well. Interestingly, most of the transcription factor binding sites showed the highest 
sequence identity with primates compared to rodents. For the generation of a pluripotent reporter 
pig, the OCT4 and NANOG reporter constructs need further verification and testing in pluripotent 
cells or transgenic embryos, expressing stable levels of porcine OCT4 and NANOG. 
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Figure legends 
 
Figure 1. Alignment of OCT4 promoter region. OCT4 promoter region in seven species were 
compared. A 7.8kb alignment containing the 1st exon and the upstream regulatory sequence was 
analysed. The distal enhancer (DE), proximal enhancer (PE) and proximal promoter (PP) are shown 
with transcription factor binding sites indicated. Nucleotides which are conserved among the seven 
species are bolded and shown in a blue background. Repetitive elements which have been identified 
by BLAST search are indicated in dark green. The 5´-untranslated region is shown in light red, 
whereas, the open reading frame is shown in dark red. The regulatory region used for the OCT4 
reporter construct in the present study is shown above the alignment scheme. 
 
Figure 2. Alignment of NANOG promoter region. NANOG promoter region in six species were 
compared. A 3.9kb alignment containing the 1st exon and the upstream regulatory sequence was 
analysed. The proximal promoter (PP) is shown with transcription factor binding sites indicated. 
Nucleotides which are conserved among the seven species are bolded and shown in a blue 
background. Repetitive elements which have been identified by BLAST search are indicated in dark 
blue. The 5´-untranslated region is shown in light orange, whereas, the open reading frame is shown 
in dark orange. The regulatory region used for the NANOG reporter construct in the present study is 
shown above the alignment scheme. 
 
Figure 3. PCR analysis of BACs. Characterization of BACs by PCR. (A) PCR with primers of 
porcine OCT4. Lane 1: Pig chromosomal DNA, lane 2: BACRP44-400E7, lane 3: BAC242-102G9, 
lane 4: BAC242-83M14. (B) PCR with primers of porcine NANOG. Lane 1: Pig chromosomal 
DNA, lane 2: BAC242-335, lane 3: BAC242-172H17. All panels show 1% agarose gel stained with 
ethidium bromide. 
 
Figure 4. Overview of the OCT4 and NANOG reporter constructs. Schematic representation of 
the reporter constructs used in the present experiment. (A) The red fluorescent OCT4 reporter con-
struct pO4dERFP-IRESpuro-pA showing a constitutively expressed G418 gene (orange), the 6.6 kb 
OCT4 promoter region (blue), a destabilized, enhanced red fluorescent protein (red) and an IRE-
SpuroPA cassette (grey). (B) The green fluorescent OCT reporter construct pO4-EGFP showing a 
6.6 kb OCT4 promoter region (blue), an enhanced green fluorescent protein (green) and a constitu-
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tively expressed neomycin resistance gene flanked by loxP sites (orange). (C) A colony blotting 
membrane hybridized with a NANOG DNA probe. (D) Restriction pattern of clones containing 
NANOG promoter region using different restriction enzymes. (E) The green fluorescent NANOG 
reporter construct pNG-dEGFP showing a 2.2 kb NANOG promoter region (purple), a destabilized, 
enhanced green fluorescent protein (green) and a constitutively expressed neomycin resistance gene 
flanked by loxP sites (orange). 
 
Figure 5: mESC containing a red fluorescent OCT4 reporter construct. mESCs containing a 
murine green fluorescent Oct4 reporter construct transfected with pO4dERFP-IRESpuro-pA. (A-D) 
mESCs transfected with a porcine red fluorescent OCT4 reporter construct. (E-H) mESCs trans-
fected with H2O (negative control). (A and E) Bright field image om mESC colonies. (B and F) 
Green fluorescence of murine Oct4 reporter construct (C and G) Red fluorescence of porcine OCT4 
reporter construct (D and H) Merge. Scale bars represent 0.05 mm.  
 
Figure 6. RT-PCR analysis of SCNT embryos containing green fluorescent OCT4 and 
NANOG reporter constructs. Characterization of SCNT embryos by RT-PCR with primers of 
GFP. (A) Lane 1: DNA from PFFs containing pO4-dEGFP, lane 2: cDNA from 5 pooled blasto-
cysts containing pO4-EGFP, lane 3: -RT enzyme, lane 4: H2O (negative control). (B) Lane 1: DNA 
from PFFs containing pNG-dEGFP, lane 2: cDNA from 5 pooled D11-12 embryos (epiblasts) con-
taining pNG-EGFP, Lane 3: -RT enzyme, Lane 4: H2O (negative control). All panels show 3% aga-
rose gel stained with ethidium bromide. 
 
Figure 7. SCNT embryos containing green fluorescent OCT4 and NANOG reporter con-
structs. Fluorescence of SCNT embryos containing pO4-EGFP or pNG-dEGFP (A-D) Morula 
stage embryo containing a green fluorescent OCT4 reporter construct stained with a red fluorescent 
OCT4 antibody. (E-H) Blastocyst stage embryo containing a green fluorescent OCT4 reporter con-
struct and stained with a OCT4 antibody. (I-L) Blastocyst stage embryo containing a green fluores-
cent NANOG reporter construct stained with a red fluorescent NANOG antibody. (A, E and I) 
Green fluorescence (reporter construct). (B, F and J) Red fluorescence (antibody staining). (C, G 
and K) DAPI staining of nuclei. (D, H and L) Merge. Scale bars represent 0.05 mm.  
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Figure 8. SMGT embryos containing green fluorescent OCT4 and NANOG reporter con-
structs. Fluorescence  of SMGT embryos containing pO4-EGFP or pNG-dEGFP (A-D) 4-cell stage 
embryo containing a green fluorescent OCT4 reporter construct stained with a red fluorescent 
OCT4 antibody. (E-H) Blastocyst stage embryo containing a green fluorescent NANOG reporter 
construct stained with a red fluorescent NANOG antibody. (A and E) Green fluorescence (reporter 
construct). (B and F) Red fluorescence (antibody staining). (C and G) DAPI staining of nuclei. (D 
and H) Merge. Scale bars represent 0.05 mm. 
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Table 1. Primers used for generation of reporter constructs, PCR and RT-PCR. 
 
 
 
Table 2. In-vitro SCNT experiment. 
 
 
 
 
 
Table 3. In-vivo SCNT experiment. 
Reporter %Fusion %Cleavage (Day 1) 
%Embryos 
transferred Pregnancy 
%Fluorescent 
embryos 
pO4-GFP 78 (108/138) 84 (36/43) 91 (98/108) -  
pNG-GFP 81 (112/139) 83 (48/58) 90 (101/112) + 0 (0/101) 
  
Primer name Sequence (5’-3’) Annealing emp. Product size 
5armEHf ctgaGAATTCagtcGTTAACtttgctgtacacctgaaac 75°C 436 bp 
5armNr acctgtGCTAGCatgcactgctcatgcca 78°C 
3armNf aggtagGCTAGCttgaggagacagtgccag 72°C 348 bp 
3armBr gtctgcAGATCTccaaggggactgctc 72°C 
XadN53 CTAGTcgaggacttccttgaGTGCA 64°C 25 bp 
XadN35 CtcaaggaagtggtcgA 48°C 
NG6f gctagattggggtggttagc 57°C 195 bp 
NG200r cactcatgttgagttgaagaag 52°C 
pO4RegF gttaaATTAATctttgctgtacacctgaaac 64°C 6594 bp 
pO4RegR gtggaACCGGTtctccaaggggactgctc 78°C 
pOct4Fw aggtgttcagccaaacgacc 60°C 898 / 268 bp 
pOct4Rv gccagaagggcaaacgatca  63°C 
pNanogF1 cgaatgaaatgtaagaggt 47°C 300 / 160 bp 
pNanogR1 gtggggtaatcagagctgg 55°C 
GFP_F2 actacagctccgtggtggac 57°C 119 bp 
GFP_R2 ggtgttgctgtgatcctcct 57°C 
Reporter %Fusion %Cleavage 
%Fluorescent 
embryos %Blastocysts 
%Fluorescent 
blastocysts 
pO4-EGFP 73 (141/192) 65 (91/141) 3 (3/91) 15 (16/141) 0 (0/16) 
pNG-dEGFP 77 (113/147) 55 (62/113) 0 (0/113) 18 (16/113) 0 (0/16) 
Neg. control 76 (22/29) 95 (21/22) 0 (0/22) 18 (4/22) 0 (0/4) 
 Figure 1. 
Figure 2.  
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Abstract 
 
Neural progenitor cells (NPCs), derived from embryonic stem cells (ESCs) are capable of self-
renewal and differentiation into neural and glial lineages, making them promising candidates for 
cell-based therapy of neurodegenerative diseases. However, safety aspects need to be determined 
through transplantation into relevant animals such as the pig. The aim of this study was to derive 
NPCs from porcine epiblast cells and evaluate their differentiation potential. Epiblasts were isolated 
from embryos 9 days post insemination and cultured on mouse embryonic feeder cells in ESC me-
dium. Outgrowth colonies were passaged to MS5 stromal cells where neural rosettes formed. When 
rosette structures were isolated and cultured in Matrigel-coated dishes in the presence of FGF and 
EGF, a homogeneous population of NPCs outgrew which has been maintained for more than 15 
passages. Comparative real-time PCR and immunocytochemistry showed expression of the makers 
KI67, SOX2, NESTIN, VIMENTIN, and PAX6 in 56%, 100%, 96%, 100% and 99% of the cells, re-
spectively. The same markers were also identified in the lateral ventricles of the fetal porcine brain, 
a location known to harbour NPCs. NPCs were subjected to differentiation using five different 
growth factor combinations including (1) no growth factors (control), (2) RA and SHH (motoneu-
rons), (3) FGF8 and SHH (dopaminergic midbrain neurons), (4) PDGF (oligodendrocytes), and (5) 
RA and LIF (astrocytes). TUJI, a marker of immature neurons, was significantly upregulated in 
protocol 2 (58% positive cells) as were markers of mature neurons such as NF and TH. In contrast, 
the oligodendrocyte marker MBP was significantly upregulated in protocol 3 (63% positive cells), 
whereas the astrocyte marker, GFAP, was significantly upregulated in protocol 1, 2, 3, and 4 (33%, 
25%, 43% and 22%, respectively). The present study provides the first evidence of a porcine epib-
last-derived NPC-line, capable of differentiating into mature neurons and glia, which brings the pig 
one step closer as a model of human NPC therapy. 
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Introduction 
 
Neural progenitor cells (NPCs) are multipotent and can form neurons, astrocytes and oligodendro-
cytes induced by either, instructive, paracrine cues, or by selective survival mechanisms (Mehler & 
Kessler 1999). NPCs can be isolated directly from the ventricular zone (VZ) from the developing 
fetus and subventricular zone (SVZ) from the adult (Mehler & Kessler 1999), but they can also be 
differentiated from embryonic stem cells (ESC). Their multipotency and ability to self-renew in-
vitro render these cells interesting candidates for cell-based therapy of neurodegenerative diseases 
such as Alzheimer’s and Parkinson’s disease. Rodents, such as the mouse and the rat, are well-
established models for neurotransplantation studies. Such research has shown that transplantation of 
NPCs can improve cognition in a mouse model of Alzheimers disease (Blurton-Jones et al. 2009), 
induce remyelination in a mouse model of multiple sclerosis (Pluchino et al. 2003), and improve 
locomotion and respiration in a rat model of Amyotrophic Lateral Sclerosis (Lepore et al. 2008). 
Furthermore, several groups have shown that ESC-derived dopaminergic neurons can induce resti-
tution of motor function in a rat model of Parkinson’s disease (Geeta et al. 2008; Roy et al. 2006; 
Yang et al. 2008). In contrast to these promising results, a recent treatment of a human Ataxia Te-
langiectasia patient with NPCs derived from human fetuses resulted in development of a malignant 
brain tumour (Amariglio et al. 2009). This unfortunate outcome pinpoints that more detailed pre-
clinical studies are required to minimize the risks. As new studies outline considerable differences 
in the brain between mice and humans, including differences in astrocyte activity (Oberheim et al. 
2009) and in the aging processes (Oh et al. 2009), safety studies of NPC-transplantations in other 
animal models than rodents is of vital importance.  
 
Large animal models may be of utmost importance in the field of translational neuroscience, as a 
tool for testing safety and potentials of NPC-treatment. The pig is an excellent candidate, as it re-
sembles man in both size, anatomy and physiology (Lind et al. 2007); all of which are important 
aspects when studying diseases affecting a complex organ, like the brain. The minipig is particu-
larly suitable as a model of Parkinsons disease due to the similar anatomy of the substantia nigra 
(Nielsen et al. 2009) and development of a stable Parkinsonian-like syndrome in response to the 
chemical MPTP (Bjarkam et al. 2008). Recent advances in somatic cell nuclear transfer has resulted 
in the generation of a transgenic minipig model of human Alzheimer’s disease (Kragh et al. 2009). 
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As an extension, transgenic in-vitro disease models could be established by derivation of porcine 
NPC (pNPC) lines from transgene embryos allowing in-vitro drug screening.  
 
In the fetal human brain, NPCs isolated from the cerebral cortical VZ are reported to express the 
transcription factors SOX1 and SOX2, the intermediate filament NESTIN, as well as the RNA bind-
ing protein MUSASHI (Shin et al. 2007). In the adult brain, NPCs are located in the subventricular 
zone (SVZ) of the lateral ventricular wall and in the subgranular zone (SGZ) of the hippocampal 
dentate gyrus (Ma et al. 2009). These cells have unique molecular profiles, which are likely due to 
the microenvironment of the varying regions of the brain where they reside. Adult, actively dividing 
NPCs isolated from the SVZ, express SOX2 and NESTIN, in addition to the homeobox transcription 
factor paired box gene 6 (PAX6) (Ma et al. 2009). In contrast, adult quiescent NPCs, corresponding 
to radial glial-like cells, express NESTIN, glial fibrillary acidic protein (GFAP) and stage specific 
embryonic antigen 1 (SSEA1) (Ma et al. 2009). Although the fundamental NPC-markers seems to 
be shared between fetal and actively dividing adult NPCs, the vast majority of genes are differen-
tially expressed, indicating a fundamental difference in the way these cells maintain their neuropro-
genitor state (Maisel et al. 2007). 
 
NPCs have also been established in-vitro from pluripotent cells, as e.g. ESC, which is an attractive 
alternative to brain-derived NPCs due to their potentially, unlimited supply. NPCs were first de-
rived from murine ESCs (mNPCs) in 1996, and these cells proved capable of differentiating into 
both neurons and glial cell types (Okabe et al. 1996). Later, NPCs were also derived from human 
ESCs (hNPCs) (Reubinoff et al. 2000) and their potential to differentiate into neurons and glial cells 
was verified (Reubinoff et al. 2001). ESC-derived hNPCs share many markers with their fetal coun-
terparts such as expression of SOX1, SOX2, NESTIN and MUSASHI. However, differences in ex-
pression are also evident, especially within key differentiation pathways such as leukemia inhibitory 
factor (LIF), basic fibroblast growth factor (bFGF) and Wnt signaling (Shin et al. 2007). 
 
To date, several methods for derivation of NPCs from hESC have been reported (Schwartz et al. 
2008). Although the neural differentiation pathway is reported to function as a default mechanism 
in hESC, most methods relies on neural induction either by formation of embryoid bodies (EBs) or 
by co-culture with different types of mouse stromal cells (Schwartz et al. 2008). Whereas EBs can 
directly give rise to hNPCs, neural rosettes, which are morphologically reminiscent of the develop-
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ing neural tube (Lazzari et al. 2006) give rise to hNPCs in the co-culture method. Human NPCs are 
furthermore capable of long term culture in an undifferentiated state when cultured in the presence 
of bFGF and epidermal growth factor (EGF) (Andersen et al. 2009).  
 
NPC carry the potential to differentiate into three different lineages: neurons, astrocytes and oli-
godendrocytes (Erceg et al. 2009). When growth factors are withdrawn from hNPCs, a mixed popu-
lation of neurons and glial cells will spontaneously form (Joannides et al. 2007). In contrast, treat-
ment of NPCs with various growth factors can promote differentiation into more specialized cell 
types. Retinoic acid (RA), which plays an important role in the development and maintenance of the 
nervous system (Maden 2007), has been shown to promote formation of motoneurons from hESC-
derived NPC (Lee et al. 2007; Li et al. 2005). Other factors such as SHH, which is crucial for pat-
terning of the ventral neural tube (Patten & Placzek 2000), and FGF8, which is involved in organiz-
ing the embryonic mid- and hindbrain (Crossley et al. 1996), have been shown to promote the for-
mation of dopaminergic neurons (Park et al. 2005; Perrier et al. 2004; Roy et al. 2006; Yan et al. 
2005). In addition, platelet derived growth factor (PDGF) has been shown to stimulate oligodendro-
cyte formation (Hu et al. 2008; Kang et al. 2007), In contrast, pathways involved in astrocyte dif-
ferentiation remains poorly understood and these cells are mostly generated spontaneously 
(Trounson 2006). However, it was recently shown that astrocyte formation can be induced from 
mNPC by addition of RA and LIF (Asano et al. 2009). 
 
At present, the possibility of establishing porcine NPCs (pNPCs) from ESCs is hampered by the 
fact that pluripotent ESC cultures cannot be maintained long-term in this species (Vackova et al. 
2007). However, research has indicated that long term culture of porcine epiblast cells results in 
spontaneous generation of immature astrocytes and neurons (Talbot et al. 2002). Thus, the neural 
pathway may function as the default mechanism in this species. Lazzari and co-workers were the 
first to derive neuroectoderm directy from the inner cell mass (ICM) of bovine preimplantation em-
bryos, and the resulting rosettes gave rise to a population of neural crest progenitor cells which 
could be maintained in-vitro for more than 112 days. When growth factors were withdrawn these 
cells were able to differentiate into mature neuronal and glial subtypes in addition to chondrocytes 
and smooth muscle cells (Lazzari et al. 2006). Recently, Du and co-workers have shown that por-
cine ICM cells can be differentiated into pNPC and maintained for up to 2 months in-vitro (Du et 
al. 2009). However, the differentiation potential of these cells was limited to glial cells, including 
118 
 
astrocytes and oligodendrocytes. Recent reports on generation of porcine induced pluripotent stem 
cells (iPSC) may open up exciting possibilities of using iPSC derived pNPCs as a model of isogenic 
NPC-therapy (Esteban et al. 2009; Ezashi et al. 2009; Wu et al. 2009). 
 
To realize the potential of using the pig as a large animal model of NPC-treatment, the need for a 
stable embryo derived pNPC-line with the capacity to differentiate into mature neurons and glial 
cells is apparent. The aim of the present study was (1) to isolate porcine pNPCs from epiblast cells 
and characterize these by means of established hNPC markers, and (2) to evaluate the potentials of 
the pNPCs for long-term culture and differentiation into mature neurons and glia. 
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Materials and Methods 
Unless otherwise stated materials were purchased from Invitrogen, Carlsbad, CA. 
 
Isolation and culture of epiblast cells 
Uteri from two Danish sows (Landrace x Yorkshire crosses) were artificially inseminated over 2 
days with semen from Duroc boars and collected at a local abattoir 9 days post insemination (Day 
9). Each uterine horn was flushed with 150 ml embryo transfer solution (LIFE Pharmacy, KU, 
Frederiksberg, Denmark) containing 0.1% FBS and collected via a flushing catheter. Embryos were 
subsequently isolated in DMEM containing HEPES (Sigma-aldrich, St. Louis, MO) and 10% FCS 
by stereo-microscopy. 
 
Epiblasts from Day 9 expanded hatched blastocysts (Vejlsted et al. 2006) were mechanically iso-
lated from the surrounding trophectoderm and hypoblast, using insulin needles. The isolated epib-
lasts were cultured as outgrowth colonies (OCs) in dishes containing 2x104/cm2 mouse embryonic 
fibroblast (MEF) feeder cells (DSMZ, Braunschweig, Germany) in ESC medium consisting of 
knockout DMEM (Sigma-aldrich), 10% knockout serum replacement (KSR), 5% FCS, 1% penicil-
lin/streptomycin (Sigma-aldrich), 1% non-essential amino acids (Sigma-aldrich), 0.2% beta-
mercaptoethanol (Sigma-aldrich), 20 ng/ml human basic fibroblast growth factor (bFGF) and 20 
ng/ml human Activin A (R&D systems, Minneapolis, MN) and cultured at 38°C in 20% O2, 5% 
CO2 in N2.  
 
Derivation and culture of pNPCs 
An overview of the derivation and differentiation of pNPCs is presented in Figure 1. Mouse stromal 
cells (MS5; DSMZ) were cultured for one day in gelatin-coated dishes in a medium consisting of 
alpha-MEM medium (Sigma-aldrich) containing 10% FBS. On Day 5 following epiblasts-isolation, 
ESC-like areas of OCs were cut into 4-12 small pieces by use of insulin needles and co-cultured 
with 2x104/cm2 MS5 cells in serum replacement medium (SR medium) containing DMEM, 15% 
KSR and 2 mM L-glutamine (Perrier et al. 2004). The cells were cultured at 38°C in 20% O2, 5% 
CO2 in N2 and medium was replaced every 2-3 days without passage. Rosettes, which typically ap-
peared after 12-17 days co-culture, were isolated by insulin needles, cut into small pieces and trans-
ferred to Matrigel-coated dishes (BD Biosciences, Franklin Lakes, NJ) in medium containing 
DMEM/F12, 1xB-27 supplement, 1xN2 supplement, 20 ng/ml EGF and 20 ng/ml bFGF and cul-
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tured at 38°C in 20% O2, 5% CO2 in N2 with medium change every 2-3 days. After 8 days, appear-
ing NPCs were disaggregated in 1% Trypsin/EDTA and split into new Matrigel-coated dishes (BD 
Biosciences) at a ratio of 1:5 with subsequent passage every 3-4 days. For analysis of cell dou-
blings, individual NPCs were counted at each passage using a haemocytometer and total doublings 
were calculated. Cells from passage 1 (primary culture of rosettes), 3 and 15 were sampled for 
comparative real-time PCR analysis and from passage 4 and 16 for immunocytochemical analysis. 
 
Differentiation of pNPCs into neurons and glia. 
To evaluate the differentiation potential of pNPCs, five alternate differentiation protocols were per-
formed. pNPCs at passage 4 were disaggregated into single cells and seeded at a density of 
1x105/cm2 in Matrigel-coated dishes (BD Biosciences) and dishes containing Matrigel-coated glass 
coverslips (ThermoFisher Scientific, Waltham, MA). The cells were cultured for a total of three 
weeks in N2 medium consisting of DMEM/F12 and 1xN2 supplement in the following conditions: 
Protocol 1 (mixed neurons and glia); N2 medium without growth factors (Joannides et al. 2007). 
Protocol 2 (motoneurons); two weeks culture in N2 medium containing 1 µM all-trans-retinoic acid 
(RA; Sigma-aldrich), 200 ng/ml recombinant murine sonic hedgehog (SHH), 20 ng/ml human re-
combinant brain-derived neurotrophic factor (BDNF, Prospec, Rehovot, Israel), 0.2mM ascorbic 
adic (AA; Sigma-aldrich) followed by one week maturation in 20 ng/ml human recombinant glial 
cell line-derived neurotrophic factor (GDNF, Prospec, Rehovot, Israel), 20 ng/ml BDNF (Prospec) 
and 0.2mM AA (Sigma-aldrich) (Lee et al. 2007). Protocol 3 (Dopaminergic midbrain neurons); 
two weeks culture in 200 ng/ml SHH, 100 ng/ml human recombinant fibroblast growth factor 8 
(FGF8), 20 ng/ml BDNF (Prospec) and 0,2mM AA (Sigma-aldrich) followed by one week matura-
tion in 20 ng/ml GDNF (Prospec) and 20 ng/ml BDNF (Prospec) and 0.2mM AA (Sigma-aldrich) 
(Perrier et al. 2004). Protocol 4 (Oligodendrocytes); 20 ng/ml human recombinant platelet-derived 
growth factor-AB (PDGF; Sigma-aldrich) (Hu et al. 2008) and Protocol 5 (Astrocytes); 1 µM RA 
and 20 ng/ml recombinant murine leukemia inhibitory factor (LIF; Chemicon, Hessen, Germany) 
(Asano et al. 2009). Differentiation was performed at 38°C in 5% O2, 5% CO2 in N2, with half of 
the media changed every third day. Only cells in protocol 3 and 4 were passaged 1:2 on Day 9 due 
to continued proliferation. At the conclusion of the experiment, three samples were obtained from 
each protocol for comparative real-time PCR and two samples were obtained for immunocytochem-
istry. 
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RNA purification and Reverse Transcription 
pNPCs and differentiated cells were trypsinized into single cells, placed in lysis buffer (Qiagen, 
Chatsworth, CA), snap-frozen in liquid nitrogen and stored at -80°C. As positive control tissue, 
porcine brains from three fetuses, isolated from the uterus of a Danish sow (Landrace x Yorkshire 
crosses) 42 days post insemination (Day 42) (Vejlsted et al. 2006), were isolated from the skull and 
minced using a razorblade. As negative control tissue, MS5 cells were cultured as described above. 
Both were placed into lysis buffer, frozen in liquid nitrogen and stored at -80°C. Total RNA was 
purified with RNeasy mini or micro kit (Qiagen) and the RNA content and purity was measured on 
a Nanodrop 1000 spectrophotometer (ThermoFisher Scientific). Reverse transcription was per-
formed using RevertAid First strand cDNA synthesis kit (Fermentas, Burlington, ON) according to 
the manufacturer’s instructions. For each sample, a negative reaction was included, by omission of 
M-MuLV Reverse Transcriptase enzyme. 
  
Comparative real-time PCR  
Comparative real-time PCR using the ∆∆CT method was performed with a Lightcycler SW480 and 
SYBR Green I Master mix (Roche, Basal, Switzerland). The method comprised 45 cycles of dena-
turation at 95°C for 10 seconds, annealing at 58°C for 10 seconds and elongation at 72°C for 20 
seconds. Each biological sample was run in triplicates with porcine specific primers designed on the 
basis on alignments with human genes, or with primers used in previous studies (Table 1). H2O and 
murine MS5 stromal cell cDNA served as negative controls and pooled brain cDNA from Day 42 
porcine fetuses served as endogenous control tissue. Three different reference genes were tested on 
all the samples; glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (Kuijk et al. 2007), Tata box 
binding protein 1 (TBP1) (Nygard et al. 2007) and phosphoglycerate kinase 1 (PGK1) (Boda et al. 
2009). GeNorm (Vandesompele et al. 2002) and NormFinder (Andersen et al. 2004) were 
subsequently used to determine the most optimal reference gene.  
 
Statistical analysis  
Samples were normalized using the ∆∆Ct method. The ∆CT value was calculated by normalizing 
the CT value of the target gene with the CT value of the house-keeping gene. The ∆∆CT value was 
calculated by normalizing the ∆CT value to the reference tissue. Finally, the fold change in gene 
expression was determined by using the equation 2-∆∆CT. In the differentiation experiment, calcula-
tion of standard deviations as well as statistical analysis was performed on the 2-∆∆CT value using 
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one way ANOVA to analyse the difference between treated and non-treated samples with a signifi-
cance level of p ≤ 0.05. 
 
Fixation of cells and tissues 
pNPCs and differentiated cells were cultured on Matrigel-coated (BD Biosciences) glass coverslips 
(ThermoFisher Scientific), fixed for 20 min in 4% PFA and stored in 1% PFA at 4°C. As a positive 
control, the head from a Day 42 fetus was fixed overnight in 4% paraformaldehyde (PFA), frozen in 
Tissue-tek (Sakura Finetek, Torrance, CA), cut into 5 µm sections using a cryostat (Leica microsys-
tems, Vetzlar, Germany) and stored at -80°C. As a negative control tissue, MS5 cells were cultured 
as described above on Matrigel coated (BD Biosciences) glass coverslips (ThermoFisher Scientific), 
fixed for 20 min in 4% PFA and stored in 1% PFA at 4°C. 
 
Immunocytochemistry 
Immunocytochemistry comprised 30 min permeabilization in 0.1% Triton-X, 1 hour blocking in 5% 
Donkey serum (Sigma-aldrich) and incubation over night with primary antibodies (Table 2) in 
0.25% BSA, 0.1% Triton X (Sigma-aldrich) in PBS. The following day, cells were washed 3 times 
in PBS, incubated 1 hour with fluorescent-conjugated secondary antibodies (Alexa Fluor; 1:400) in 
0.25% BSA, 0.1% Triton-X in PBS, washed 3 times in PBS, incubated in 0.1 µl/ml Bisbenzimide 
Hoechst (Sigma-aldrich) and mounted in fluorescence mounting medium (Dako, Glostrup, Den-
mark). The OCs were used to verify specificity of pluripotency markers and the brain of a Day 42 
porcine fetus, prepared as described above, was used to verify specificity of neuronal antibodies. 
Murine MS5 cells were included as a negative control. All specimens were examined using a Leica 
DMRB fluorescent microscope and Leica Application Suite version 2.81 (Leica Microsystems). For 
quantification of positive antibody labelling of undifferentiated and differentiated cells, a minimum 
of 200 Hoechst-stained cells from eight different, equally distributed locations on a glass coverslip 
were counted and compared to the number of cells with positive staining using the freeware quanti-
fication program, ImageJ (Collins 2007). 
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Results 
 
Derivation of pNPCs from epiblast cells 
A total of 47 epiblasts were isolated from Day 9 embryos (Figure 2A, B) and cultured on MEF cells 
and on Day 4, 23 OCs (49%) had formed. Some of the OCs grew as a central dense core, resem-
bling the embryonic epiblast, surrounded by a monolayer of presumptive hypoblast cells, whereas 
others grew in a monolayer of ESC-like cells (Figure 2C). Both outgrowth types presented typical 
ESC-like cells with a large nuclear-cytoplasmic ratio containing one or two prominent nucleoli. 
Following passage of ESC-like cells onto MS5 stromal feeder cells, the cells quickly attached and 
formed large colonies of cells with ESC-like morphology. Around Day 12-17 round rosettes with a 
central lumen started to form in the colonies (Figure 2D). When these rosettes were isolated and 
cultured in Matrigel-coated dishes in N2 medium containing bFGF and EGF, a population of cells 
rapidly grew out (Figure 2E) presenting a bipolar morphology with large nuclei containing two or 
more prominent nucleoli (Figure 2F). After the first passage, the cells attained a uniform morphol-
ogy and neurospheres formed spontaneously during the first three passages (Figure 2G), and when 
cultured in non-coated dishes (Figure 2H). At present, the cells have been cultured for more than 2 
months (16 passages) without losing their proliferation capacity or the ability to generate neuro-
spheres.  
 
Proliferation of pNPCs 
Cell doublings were monitored over time by counting individual cells at each passage. Initially, the 
proliferation rate of pNPCs was exceptionally high with around 10 doublings each passage, how-
ever, at later passages this decreased to around 2.5 doublings for each passage, which remained 
more or less stable (Figure 3A). The proliferation marker KI67, which was examined by immunocy-
tochemistry in pNPCs at passage 3, was expressed 55.8% of the cells (Figure 3B). 
 
Comparative Real-time analysis of pNPCs 
To determine the nature of pNPCs, the cells were analysed at passage 1, 3 and 15 by comparative 
real-time PCR. Reactions were performed with porcine specific primers of NPCs and mature neu-
rons, based on previous characterization of hNPCs (Table 1). All reactions yielded a single tran-
script and amplicons were confirmed by sequencing. Reference genes tested on all the samples de-
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tected consistent levels of transcripts, indicating integrity of the cDNA samples. GAPDH, which 
was determined to be the most optimal reference gene, was subsequently used for normalization. 
 
Expression of the transcription factor SOX2 was three fold higher in the primary rosette cultures 
compared to fetal brain (control tissue) (Figure 4A). At passage three, this level was around 1.5 and 
at passage 15 it was around 0.75, indicating some down-regulation, despite maintaining a relatively 
high expression. The intermediate filament NESTIN followed more or less the same expression pro-
file as SOX2 with a decrease from three fold to around 0.5 fold the level of the control tissue during 
passages (Figure 4B). In contrast, the intermediate filament VIMENTIN showed a high expression 
of transcripts at all the examined stages, which was around 5 fold higher than the control tissue 
(Figure 4C). The transcription factor, PAX6 was expressed 0.3 fold the level of the control tissue in 
the rosette cultures, but at passage 3 and 15 the expression was almost undetectable (Figure 4D). 
Finally, BETA-TUBULIN III (TUJI), and NCAM, both considered markers of immature neurons, 
showed comparable level of transcripts to the control tissue in the primary rosette cultures, but were 
only expressed 0.1 - 0.2 times the control tissue in the subsequent passages (Figure 4E-F).  
 
Immunocytochemical analysis of pNPCs 
Immunocytochemical analysis with an antibody of OCT4 (considered a markers of pluripotency in 
human and mice), showed nuclear localized OCT4 labelling in OCs, whereas this marker was com-
pletely absent in pNPCs at passage 4 (Data not shown). In contrast, quantitative immunocytochemi-
cal analyses with previously published hNPC markers (Table 2), showed nuclear localization of 
SOX2 in 99.3% of the pNPCs at the same passage (Figure 5A-C). The pNPCs also showed cyto-
plasmic localization of NESTIN (Figure 5D-F) and VIMENTIN (Figure 5G-I) in 96.0% and 99.6% 
of the examined cells, respectively. Furthermore, nuclear localization of PAX6 (Figure 5J-L) was 
observed in 99.1% of the cells, which was surprising as transcripts of PAX6 were barely detectable 
by comparative real-time PCR. In contrast, TUJI (Figure 5M-O) was localized to the cytoplasm in 
0.3% of the cells, and NCAM staining was negative (data not shown). To further analyse the 
pNPCs, stainings with GFAP and SSEA1 (considered markers of human radial glial cells) were 
carried out, however, in both cases stainings were negative (data not shown). Immunocytochemistry 
performed at passage 16 confirmed nuclear localization of KI67 and SOX2 and cytoplasmic stain-
ing of NESTIN and VIMENTIN, whereas, PAX6 was negative at this stage and a weak cytoplasmic 
TUJI staining was observed in a slightly higher percentage of the cells (Supplementary Figure 1). 
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Immunohistochemical analysis of Day 42 fetal brain 
Immunohistochemical analysis of a Day 42 porcine fetal brain identified specific areas which 
showed localization of the NPC markers including the developing nasal conchae, the neural layer of 
the retina, and the ventricular zone (VZ) of the lateral ventricle (Figure 6A). In the VZ, nuclear lo-
calization of KI67, SOX2, and PAX6 and cytoplasmic localization of NESTIN and VIMENTIN 
was observed (Figure 6B-F), whereas, the surrounding marginal zone displayed cytoplasmic local-
ization of TUJI and NCAM (Figure 6G-H). Localization of KI67, SOX2, PAX6, NESTIN, and 
TUJ1 was also observed in the developing nasal conchae and KI67, SOX2, PAX6, NESTIN, 
VIMENTIN, TUJ1, and NCAM in the neural layer of the retina (Data not shown). 
 
Differentiation of pNPCs into mature neurons and glia 
To test the differentiation potential of the pNPCs (Figure 7A), five different protocols were applied. 
All the protocols comprised removal of the growth factors bFGF and EGF from the culture media 
and addition of factors to promote the generation of different populations of mature nerve and glial 
cells.  
 
In the first protocol, without addition of growth factors, the pNPCs mainly attained a multipolar 
neuron-like appearance with several axons protruding from a single soma (Figure 7B). In the sec-
ond protocol including RA, SHH, BDNF and AA, the pNPCs again attained a multipolar neuron-
like appearance, but in contrast to the previous protocol, extensive clustering of cells was apparent, 
with long axons protruding from groups of cell soma (Figure 7C). In the third protocol containing 
FGF8, SHH, BDNF and AA clustering of cells with a multipolar neuron-like appearance was also 
observed, although to a much lesser extent, and some cells with larger nuclei were observed be-
tween the clusters (Figure 7D). At least some of the cells were still proliferating in this protocol and 
the culture was passaged at Day 9. In the fourth protocol containing PDGF, larger nuclei were ob-
served, often with wide cytoplasmic protrusions (Figure 7E). Again, continued growth required the 
cells to be passaged at Day 9. Finally, in the fifth protocol containing RA and LIF, a neuron-like 
appearance was most predominant with pronounced clustering of cells (Figure 7F). 
Comparative real-time PCR analysis of differentiated pNPCs 
Comparative real-time PCR was performed at the end point of the differentiation experiment. At 
this point, NESTIN expression had decreased to around half the level of undifferentiated cells in 
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Protocols 1 and 4, whereas, in the remaining protocols the levels were unaltered (Figure 8A). The 
expression of the early neuronal marker TUJI was 10 and 5 times higher than in undifferentiated 
cells in protocols 2 and 5, respectively, whereas this marker only showed a slight upregulation in 
protocols 1, 3 and 4. Only protocol 2, however, showed significant difference from undifferentiated 
cells (Figure 8B). The same expression profile was identified for markers of more mature neurons 
such as NEUROFILAMENT (NF) and TYROSINE HYDROXYLASE (TH), which were both signifi-
cantly up-regulated in protocol 2 (Figure 8C-D). GFAP, a marker of astrocytes, was around 100 
fold higher in protocol 1, 2, 3 and 4 which was significantly different from undifferentiated cells 
(Figure 8E). In contrast, GFAP was not statistically different from undifferentiated cells in protocol 
5. Finally, a marker of oligodendrocytes, MYELIN BASIC PROTEIN (MBP), was tested, however, 
this marker was around the detection limit in fetal brain. Nevertheless, it was significantly upregu-
lated around 12 fold compared to undifferentiated cells in protocol 3, whereas, in the other proto-
cols, MBP was only upregulated between 1 and 5 times. (Figure 8F).  
 
Immunocytochemical analysis of differentiated pNPCs 
Immunocytochemical analysis and quantification of differentiated cells showed that cytoplasmic 
localization of NESTIN was still observed in 59.0%, 67.8%, 52.2%, 11.5% and 79.5% of the cells 
in protocols 1, 2, 3, 4 and 5, respectively, indicating that complete downregulation of this marker 
did not occur (Figure 9A-C). Cytoplasmic localization of TUJI was found in 33.7%, 58.0%, 28.6%, 
21.3% and 80.0% of the cells in protocols 1-5, respectively (Figure 9D-F), which corresponded 
relatively well with the observed expression profile of TUJI. In addition, cytoplasmic localization of 
TH was observed in protocol 2, but only in few individual cells (Figure 9G-I). Cytoplasmic local-
ization of GFAP was observed in 33.8%, 24.5%, 42.6%, 21.9% and 13.3% of the cells in protocols 
1-5, respectively (Figure 9J-L), which also correspond more or less with the expression profile of 
this marker. Finally, cytoplasmic localization of O4, a marker of type I and II pro-oligodendrocytes 
but not of O-2A progenitor cells (Dhara et al. 2008), was observed in protocols 3 and 4 at 29.6% 
and 63.0% of the cells, respectively (Figure 9M-O).  
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Discussion 
 
The current study presents for the first time a pNPC line derived from epiblast cells with the ability 
to differentiate into both mature neurons and glial cells. The pNPCs have currently been cultured 
for more than 15 passages without losing their proliferative capacity. 
 
Culture of epiblast cells on murine MS5 stromal feeder cells gave rise to formation of rosettes after 
12-17 days in culture. The same has been reported for murine and human ESCs cultured under the 
same conditions (Barberi et al. 2003; Perrier et al. 2004), indicating that the factors involved in in-
duction of neural fate are conserved between mammalian species. Lazzari and colleagues have pre-
viously reported formation of rosettes after 17 days culture of bovine ICM cells on STO feeder cells 
and shown that the rosettes represent an in-vitro model of early neural specification and differentia-
tion as they respond to the same stimuli as their in-vivo counterparts (Lazzari et al. 2006). Hence, 
porcine epiblast-derived rosettes could be used to study and predict early neural development in the 
porcine embryo. 
 
In this study, pNPCs were derived and cultured in the presence of bFGF and EGF. bFGF is a well-
known mitogen of neural specification, and EGF is reported to promote self-renewal of NPCs 
(O'Keeffe et al. 2009). Interestingly, medium containing the same growth factors was also used to 
derive neural crest precursor cells from bovine ICM cells, which were able to differentiate into neu-
ral as well as smooth muscle and cartilage cells (Lazzari et al. 2006). However, in the present study, 
no morphological signs of differentiation to the mesenchymal cell lineage were observed.  
 
An important feature of stem cells is their ability to grow indefinitely in culture, however, this fea-
ture is questionable in the case of adult stem cells, such as NPCs. To shed light on this issue, cell 
doublings were monitored over time. The pNPCs were capable of more than 60 population dou-
blings without ceasing to proliferate, although a initially high proliferation rate followed by a period 
of slower, yet stable proliferation was observed. This was best described by a logarithmic growth 
curve, which has previously been reported for hNPCs (Reubinoff et al. 2001). However, with the 
symmetrical divisions of undifferentiated NPCs, one would ideally expect an exponential growth, 
which has been reported in other studies (Hong et al. 2008; Lazzari et al. 2006). KI67 staining of 
the cells at passage 3 showed that 55.8% of the pNPCs expressed this proliferation marker, which is 
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comparable to the 50% KI67 positive cells found by Du and colleagues (Du et al. 2009). In com-
parison, hNPCs have been shown to express KI67 in 53.5% of the cells, whereas mNPCs express 
KI67 in 80% of the cells (Sun et al. 2009), indicating that pNPCs have similar proliferation rate as 
hNPCs. 
 
Whereas neural rosettes were positive for most of the markers examined, which indicate a mixed 
cell population, the pNPCs were only positive for SOX2, NESTIN and VIMENTIN with low expres-
sion of PAX6 as detected by comparative real-time PCR and verified by immunocytochemistry. The 
prevalence of these markers in most of the cells corroborate their NPC identity and points to a 
nearly homogeneous population. Furthermore, pluripotent cells did not seem to be present among 
the pNPCs as staining for the pluripotency marker OCT4 was negative. In comparison, Du and col-
leagues found that ICM derived pNPCs cells were positive for NESTIN, SOX2 and VIMENTIN, 
whereas PAX6 was not observed (Du et al. 2009), which match our present findings in the pig very 
well. 
 
Analysis of Day 42 porcine fetal brain using immunohistochemistry showed expression of KI67, 
SOX2, NESTIN, VIMENTIN, and PAX6 in the VZ of the lateral ventricle, whereas, TUJI and 
NCAM were located in the marginal zone. Hence, the expression profile of the pNPCs derived in 
this study corresponds well with fetal pNPCs located in the VZ. When Schwartz and colleagues 
analysed fetal-derived pNPCs with hNPC markers they found expression of SOX2, VIMENTIN 
and NCAM, whereas NESTIN was not detected due to lack of antibodies specificity (Schwartz et 
al. 2005). However, in this study, entire forebrains were used for isolation of NPC, which could 
potentially include NCAM expressing retinal progenitor cells (RPCs). Studies on porcine RPCs  
have confirmed this expression profile (Klassen et al. 2007; Klassen et al. 2008). 
 
GFAP is a marker found in several different cell types. It has been shown to be expressed in adult- 
but not in fetal-derived mNPCs (Imura et al. 2003) and in concert with SSEA1, it is frequently used 
to characterize radial glia in the human brain (Howard et al. 2008; Mo et al. 2007). The epiblast-
derived pNPCs were negative for both GFAP and SSEA1, indicating that these cells share more 
characteristics with fetal pNPCs derived from the VZ. Du and colleagues found GFAP staining in 
13% of pNPCs (Du et al. 2009), however, as GFAP is also a marker of type 2 astrocytes (Talbot et 
al. 2002), it is possible that some of these cells had already differentiated into the astrocyte lineage.  
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For cells to be characterized as true NPCs, ie. multipotent, they must possess the ability to differen-
tiate into both mature neurons and glial cells. To determine the differentiation potential of pNPCs, 
the cells were subjected to various combinations of growth factors known to promote differentiation 
of mNPCs and hNPCs into mature neurons and glia. 
 
Generation of mature neurons from pNPCs was most efficient in protocol 2, containing RA, SHH, 
BDNF and AA. This is not surprising as RA and SHH are known to play key roles in neural pat-
terning in the early embryo (Maden 2007; Patten & Placzek 2000). Interestingly, TH, a marker of 
dopaminergic neurons, was also found to be present in protocol 2, whereas protocol 3, containing 
SHH and FGF8, frequently used to generate dopaminergic neurons from hESCs (Perrier et al. 
2004), TH positive cells were not observed. the different response to these growth factors could be 
explain by species specific differences. It has previously been shown that a sequential application of 
FGF8 and SHH promotes formation of doperminergic midbrain neurons (Hong et al. 2008; Yan et 
al. 2005). Thus, the yield of dopaminergic neurons could perhaps be optimized by inclusion of these 
factors immediately after isolation of rosettes. 
 
Oligodendrocyte progenitor cells were most abundant in protocol 4, containing PDGF as detected 
by immunocytochemistry. This observation is not in agreement with the expression of MBP tran-
scripts, which was significantly upregulated in protocol 3. However, as O4 is a marker of oligoden-
drocyte precursors rather than mature oligodendrocytes, other factors such as BDNF, GDNF and 
AA might be required for the final maturation to mature MBP-expressing oligodendrocytes. In hu-
man, it has previously been reported that low quantities of oligodendrocytes were generated from 
hESC-derived NPCs (Dhara et al. 2008; Reubinoff et al. 2001). However, a protocol for generation 
of large amounts of oligodendrocyte progenitor cells from hESC has recently been published, in-
cluding 10 days supplementation with RA and SHH followed by 20 days supplementation with 
bFGF and 2 months maturation in PDGF, insulin-like growth factor 1 and neurotrophin 3, which 
could be applied to the pNPCs (Hu et al. 2009). 
 
Mature astrocytes were efficiently generated in protocols 1 to 4, which is in agreement with the 
general dogma of spontaneous astrocyte formation (Trounson 2006). Surprisingly, the combination 
of RA and LIF in protocol 5, which has been shown to yield high number of astrocytes from mNPC 
(Asano et al. 2009) had the opposite effect in this study. It is possible that LIF is responsible for the 
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inhibitory effect on astrocyte formation as it was the only factor included exclusively in protocol 2. 
In human, LIF has been shown to stimulate long term culture of hNPCs (Andersen et al. 2009) and 
it would be interesting to see if the same holds true for pNPCs. 
 
Accumulating evidence suggests that NPCs derived from early-stage embryos posses superior plas-
ticity compared to those derived from older stages. This is illustrated in a study by Chung and col-
leagues in which ESC-derived mNPCs were able to differentiate into dopaminergic neurons in cul-
ture, whereas, fetal brain-derived mNPCs from ventral mesencephalon lacked this ability (Chung et 
al. 2006). Furthermore, transplantation of pNPCs derived from Day 22 and Day 27 embryos into a 
rat model of Parkinson’s disease showed that only the early-stage cells survived the transplantation 
(Armstrong et al. 2003). Harrower and co-workers also found a significant improved survival and 
integration of in-vitro cultured pNPCs compared to primary porcine grafts in a rat model of Parkin-
son’s disease (Harrower et al. 2006). Thus, it seems that in-vitro culture could play an important 
role in resetting the NPCs to an earlier state, perhaps through erasure of their immunological iden-
tity. Since the pNPCs in this study are derived directly from the epiblast and cultured under in-vitro 
conditions, differentiation, integration and survival in porcine brains might be favoured compared to 
their in-vivo derived counterparts. 
 
The epiblast-derived pNPCs analysed in this study share many characteristics with hESC derived 
NPCs such as expression of NPC markers, their capacity for long term proliferation and ability to 
differentiate into mature neurons and glia. As a result, they may be used in porcine brain transplan-
tation studies as a model of hNPC replacement therapy. Porcine brains share many anatomical and 
physiological characteristics with humans and pigs have already become the standard experimental 
model for human brain development (Lind et al. 2007). The increasing number of porcine disease 
models emerging through nuclear transfer (Kragh et al. 2009), combined with recent advances in 
generation of iPSCs may prove to be essential for the study of NPC-based treatment of severe neu-
rodegenerative diseases. 
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Figure legends. 
 
Figure 1. Derivation and differentiation pNPCs. The sequential steps for derivation of pNPC as 
well as the five different protocols used for generation of mature neurons and glial cells. 
 
Figure 2. Morphology of pNPCs. Morphology of pNPCs derived from porcine epiblast cells. (A) 
Expanded Day 9 in-vivo blastocyst. (B) Isolation of epiblast from the surrounding trophectoderm. 
Arrowhead points to an isolated epiblast. (C) Epiblast monolayer outgrowth colony grown for 5 
days on MEF feeder cells. (D) Neural rosette formed from epiblast cells after 17 days culture on 
MEF and MS5 feeder cells. Arrow points to a rosette structure. (E) Neural rosette isolated and cul-
tured in Matrigel-coated dishes in medium containing bFGF and EGF. Arrow points to pNPCs out-
growing from the rosette. (F) pNPCs derived from neural rosettes. (G) Neurosphere spontaneously 
formed during passage 3. (H) Neurospheres formed at passage 15, when cultured on non-coated 
dishes. Scale bars represent 0,1 mm.  
 
Figure 3. Proliferation of pNPCs. (A) Total cell doublings of pNPCs, estimated by counting of 
cells at each passage. (B) KI67 staining of pNPCs at passage 3. (C) DAPI staining of pNPCs at pas-
sage 3. (D) Merge of B and C. Scale bars represent 0.05 mm.  
 
Figure 4. Expression of NPC markers by pNPCs. Expression of NPC-markers in pNPCs at pas-
sage 1 (primary rosettes), passage 3 and passage 15. (A) SOX2 expression. (B) NESTIN expression. 
(C) VIMENTIN expression. (D) PAX6 expression. (E) TUJI expression and (F) NCAM expression. 
The expression was measured by comparative realtime PCR with Day 42 porcine brains as refer-
ence tissue. The samples were normalized to the housekeeping gene GAPDH. 
 
Figure 5. Immunocytochemistry of pNPCs. Staining of pNPCs with NPC-markers at passage 3. 
(A) SOX2. (D) NESTIN. (G) VIMENTIN. (J) PAX6. (M) TUJI. (B, E, H, K, and N) DAPI. (C, F, I, 
L and O) Merge of primary antibody staining and DAPI. Scale bars represent 0.05 mm.  
 
Figure 6. Immunohistochemistry of porcine fetal brain. Immunohistochemical staining of a por-
cine brain from a Day 42 fetus. (A) Morphology of the telencephalon, Scale bar represent 0.1 mm. 
Insert shows a close up of the lateral ventricle with arrows pointing to the ventricular zone (VZ) and 
the marignal zone (MZ), respectively. Scale bars represent 0.2 mm. (B-H) Antibody stainings of the 
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VZ and MZ of the lateral ventricle. (B) KI67. (C) SOX2. (D) NESTIN. (E) VIMENTIN. (F) PAX6. 
(G) TUJI. (H) NCAM. Scale bars represent 0.1 mm. 
 
Figure 7. Morphology of differentiated pNPCs. Morphology after three weeks culture of pNPCs 
in different growth factors combinations. (A) Undifferentiated pNPCs at passage 3 cultured in the 
presence of bFGF and EGF. (B) No growth factors. (C) RA and SHH. (D) FGF8 and SHH. (E) 
PDGF and (F) RA and LIF. Scale bars represent 0.1 mm.  
 
Figure 8. Expression of markers in differentiated pNPCs. Expression of neural and glial cell 
markers in pNPCs submitted to five different differentiation protocols (protocol 1-5). (A) NESTIN,. 
(B) TUJI. (C) NF. (D) TH. (E) GFAP and (F) MBP. The expression was measured by comparative 
realtime PCR relative to the expression in undifferentiated pNPCs. Samples were normalized to the 
housekeeping gene GAPDH. The experiments were performed in biological triplicates by differen-
tiating the cells at passage 3. Significant difference from undifferentiated pNPCs is indicated with 
different significance levels by ***= p<0.001, **=p<0.01 and *=p<0.05. Error bars represent stan-
dard error of the mean. 
 
Figure 9. Immunocytochemistry of differentiated pNPCs. Antibody stainings with markers of 
mature neural and glial cells. Differentiation protocols are shown in bracket. (A) NESTIN (protocol 
5), (D) TUJI (protocol 5). (G) TH (protocol 2). (J) GFAP (protocol 3). (M) O4 (protocol 4). (B, E, 
H, K, and N) DAPI. (C, F, I, L and O) Merge of primary antibody staining and DAPI. Scale bars 
represent 0.05 mm.  
 
Supplementary Figure 1. Immunocytochemistry of pNPCs. Staining of pNPCs with NPC mark-
ers at passage 16. (A) KI67. (D) SOX2. (G) NESTIN. (J) VIMENTIN. (M) PAX6. (P) TUJI. (B, E, 
H, K, N and Q) DAPI. (C, F, I, L, O and R) Merge of primary antibody staining and DAPI. Scale 
bars represent 0.05 mm.  
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Table 1. Primers used for comparative realtime PCR 
Primer name Sequence (5’-3’) Annealing emp. Product size Reference 
Sox2_Fw CGCACATGAATGGCTGGAGCAAC 69 182 bp. TC269881 
Sox2_Rv GGGCGAGCCGTTCATGTAGGTCTG 71 
Pax6_Fw GAGTTCTTCGCAACCTGGCTA 60 188 bp. CU463938.9 
Pax6_Rv TGGTATTCTCTCCCCCTCCTT 59 
Nestin_Fw GGCAGTGGTTCCAAGGCT 58 161 bp. XM_001925549.1 
Nestin_Rv GGCTGGCATAGGTGTGTCAA 59 
Vimentin_Fw GTGATGTCCGCCAGCAGT 57 218 bp. DQ190948.1 
Vimentin_Rv GCGTTCCAGAGACTCGTT 53 
TujI_Fw GTGGTGCGGAAGGAGTGTG 59 218 bp. FP102308.4 
TujI_Rv TGGTGGATGGACAGCGTGG 63 
NCAM_Fw CGGAGGGAAGCACACGGAG 63 168 bp. AK237885.1 
NCAM_Rv CGCTTTGCTCTCGTTCTCCTT 61 
TH_Fw GCACGCCTCCTCGCCCAT 66 181 bp. CF367294.1 
TH_Rv CTCCACCGTGAACCAGTA 51 
GFAP_Fw TTGACCTGCGACGGGAGTC 61 225 bp. Dyce et al. 2004 
GFAP_Rv AGGTGGCGATCTCGATGTCC 62 
MBP_Fw GAGGCAGAGCTCCTGACTACAAA 61 101 bp. Zeng et al. 2006 
MBP_Rv GTCCCGTCCTCCCAGCTT 59 
NF_Fw CAGAGCTGGAGGCACTGAA 57 146 bp. Zeng et al. 2006 
NF_Rv CATCTCCCACTTGGTGTTCC 57 
GAPDH_Fw TCGGAGTGAACGGATTTG 54 219 bp. Kuijk et al. 2007 
GAPDH_Rv CCTGGAAGATGGTGATGG 53 
TBP1_Fw AACAGTTCAGTAGTTATGAGCCAGA 58 153 bp. Nygard et al. 2007 
TBP1_Rv AGATGTTCTCAAACGCTTCG 55   
PGK1_Fw AGATAACGAACAACCAGAGG 52 126 bp. Kuijk et al. 2007 
PGK1_Rv TGTCAGGCATAGGGATACC 53   
 
 
Table 2. Antibodies used for immunofluorescence 
Detection of Name Host species Dilution Manufacturer 
Proliferating cells Ki67 Mouse IgG 1:100 Dako M7240 
ESC Oct3/4 Goat IgG 1:750 Santa Cruz SC-8628 
ESC / NPC Sox2 Mouse IgG 1:100 RD Systems MAB2018 
NPC Nestin Rabbit IgG 1:4000 Millipore AB5922 
NPC Pax6 Rabbit IgG 1:4000 Millipore AB2237 
NPC Vimentin Mouse IgG 1:500 Zymed18-0052 
Young neurons NCAM Mouse IgG 1:2000 Abcam ab8233 
Young neurons Beta-Tubulin III /TUJI Mouse IgG 1:4000 Sigma-aldrich T8660 
Mature neurons TH Rabbit IgG 1:500 Pel-Freez P40101-0 
Oligodendrocytes O4 Mouse IgM 1:250 Millipore MAB345 
Astrocytes / Radial glia GFAP Rabbit IgG 1:1000 Millipore PAB5804 
Radial glia SSEA1 / LEX Mouse IgM 1:1000 Biolegend 125602 
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 Supplementary figure 1. 
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8. Discussion 
Developing the pig as a model for cell replacement therapies has become increasingly relevant, 
considering the need to further investigate stem cell tumorigenesis and disease mechanisms (Oes-
trup et al. 2009). Furthermore, establishment of stable pESC lines would allow for precise genetic 
engeneering either through chimera technology or by improving the efficiency of SCNT technology 
(Keefer et al. 2007). Yet, despite two decades of effort, establishment of pESCs has remained an 
elusive goal, which may be hindered by some unique features of porcine preimplantation develop-
ment (Telugu et al. 2009). 
 
One of the most important conditions for derivation of ESC cultures is selection of the optimal 
stage embryo for isolation of the ICM or its derivative, the epiblast (Chen et al. 2009). However, 
the window of opportunity in which to derive ESCs might be different in the pig compared to 
mouse and human due to a longer preimplantation period (Keefer et al. 2007). From a ultrastruc-
tural perspective, the ICM of Day 5-6 embryos has been shown to maintain an undifferentiated 
morphology compared to the epiblast of Day 10-11 embryos, which showed significant specializa-
tion containing epithelial features such as tight junctions, interdigitating lateral membranes and mi-
crovilli (Janus Jacobsen, unpublished results). However, expression profiling of human pluripo-
tency-related genes has demonstrated that only the epiblast of Day 10-11 embryos showed active 
transcription of common pluripotency markers, except for OCT4 which was present in the Day 5-6 
embryos as well (Hall et al. 2009). Hence, it is of importance to identify the stage of development 
when the porcine embryo has activated the pluripotent signaling network, but has not yet initiated 
differentiation, as this is expected to be the best candidate for derivation of ESCs. In this study, both 
ICM and epiblast cells isolated from Day 5-8 unhatched and hatched blastocysts, respectively, were 
able to produce ESC-like OCs when subjected to in-vitro culture. Furthermore, isolation of the 
ICM/epiblast by immunosurgery and manual cleaning appeared to result in the highest attachment 
rates and ESC-like rates. Yet, despite the initial ability of the ICM and epiblast to convert to in-vitro 
culture, a general loss of pluripotency was observed after a few initial passages, presumably due to 
a lack of critical growth factors which are required to prevent differentiation while maintaining pro-
liferation.  
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Recent evidence points to different signaling factors controlling pluripotency in the ICM and the 
epiblast, respectively, as EpiSCs derived from the late epiblast stage in the mouse were comparable 
to hESCs with respect to growth factor requirement and marker expression (Tesar et al. 2007). 
However, since EpiSCs are not capable of germ line transmission (Guo et al. 2009), it may be nec-
essary to use the ICM for derivation of germ line capable ESCs in the pig. This is in good agree-
ment with studies showing that live born chimeras with germ line potential could be produced by 
injection of freshly isolated ICM cells from day 6-7 embryos into blastocysts (Anderson et al. 1994; 
Onishi et al. 1994; Nagashima et al. 2004). Further studies on the signaling pathways working to 
maintain pluripotency in different stages of the porcine pre-implantation embryo are required for 
identification of the factors controlling pluripotency in this species. 
 
The difficulties in establishment of porcine ESC lines may have been exacerbated by the lack of 
specific markers exclusive to the ICM and its derivative the epiblast (Telugu et al. 2009). In the 
mouse and human, Oct4 is a candidate regulator in pluripotent and germline cells (Niwa et al. 
2000). Although OCT4 is localized exclusively in the ICM of the unhatched murine blastocyst 
(Ovitt & Scholer 1998), this restrictive expression pattern may be the exception rather than the rule, 
as OCT4 is reported to be localized in both the ICM and trophectoderm of the unhatched blastocyst 
of other mammals, such as the rhesus monkey, human, pig and cow (van Eijk et al. 1999; Kirchhof 
et al. 2000; Mitalipov et al. 2003; Cauffman et al. 2005). In the human, it was recently reported that 
the most optimal time for isolation of ESC lines was from Day 6 blastocysts, which correlated with 
the restriction of OCT4 to the early epiblast (Chen et al. 2009). In contrast, in the pig, OCT4 has 
been reported to be present in both the epiblast and the trophectoderm of the hatched blastocyst 
(Keefer et al. 2007). However, in our study, it was shown that OCT4 was restricted exclusively to 
the epiblast of porcine Day 9 hatched blastocysts. These contradicting observation could be a result 
of different OCT4 isoforms, as the antibody used in our study recognize the human OCT4A iso-
form, whereas the antibody used by Keefer and colleagues recognize the human OCT4B isoform 
expressed in the trophectoderm (Liedtke et al. 2008). Using the former antibody, we have further-
more shown that OCT4 was localized exclusively in cells presenting ESC-like morphology in-vitro, 
which has previously been corroborated on the mRNA level (Blomberg et al. 2008). These findings 
indicate that the OCT4A isoform may constitute a reliable pluripotency marker in the pig, for iden-
tification of the optimal stage embryo for derivation of ESC-lines and for monitoring of pluripo-
tency in culture. 
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Reporters of OCT4 and NANOG could be extremely important tools for defining the optimal stage 
embryo for derivation of porcine ESCs, as well as for monitoring of pluripotency in culture. Analy-
sis on the promoter sequences of porcine OCT4 and NANOG have revealed a range of conserved 
binding sites of transcription factors involved in regulation of pluripotency in the mouse and hu-
man, indicating a conserved function in the pig as well. A higher sequence identity was observed 
between ungulates and primates than between ungulates and rodents, suggesting a closer relation-
ship with humans with respect to the regulation of these pluripotency markers. Furthermore, a re-
strictive expression pattern of NANOG to the ICM of Day 7 blastocyst was observed using a green 
fluorescent NANOG reporter, which is indicative of an important function of this transcription fac-
tor in maintaining pluripotency as well. Like OCT4, it has previously been argued that NANOG is 
not a reliable pluripotency marker in the pig, due to the detection in several mature tissues using 
RT-PCR (Carlin et al. 2006; Blomberg et al. 2008; Kuijk et al. 2008). In contrast to the mouse, hu-
man and cow (Hart et al. 2004; Degrelle et al. 2005), isoforms of NANOG have not been identified 
in the pig. However, the detection of a partial NANOG sequence (AJ877915.1) (Brevini et al. 
2007b) in porcine pre-implantation embryos and in ESC-like cells which shows 81% homology 
with the coding sequence of NANOG (DQ447201.1) (Carlin et al. 2006) could originate from dif-
ferential splicing. Until the existence of OCT4 and NANOG isoforms has been meticulously ana-
lysed, the results of pluripotency marker expression in porcine cells should be interpreted with cau-
tion and additional pluripotency markers reported to exhibit tissue-specific expression, including 
SOX2 (Hall et al. 2009),  REX1 (Blomberg et al. 2008) and SSEA1 (Wianny et al. 1997) should be 
included. 
 
Despite the inability of the epiblast to maintain pluripotency during prolonged in-vitro culture, 
spontaneous differentiation toward several different lineages including fibroblasts, endoderm-like 
cells, neuron-like cells, pigmented cells, contracting muscle cells and epithelial-like cells have been 
reported (Talbot et al. 1993; Talbot et al. 2002). In the current study, epiblasts from Day 9 embryos 
subjected to differentiation on MS5 cells, also developed into structures such as pigmented retinal 
tissue, beating cardiomyocytes and gut epithelial tissue representing the three germ layers ectoderm, 
mesoderm and endoderm, respectively (unpublished results). These observations could be consid-
ered as a proof that the epiblast derived OCs are pluripotent. Furthermore, developing rosettes gave 
rise to a pure population of NPCs, capable of long-term self-renewal while maintaining their undif-
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ferentiated state and directed differentiation of the NPCs yielded cells of the three lineages, neurons, 
astrocytes and oligodendrocytes, demonstrating their multipotency. To our knowledge, this is the 
first time a NPC line has been derived directly from epiblast cells. It was previously shown that 
rosettes derived from bovine blastocysts respond to the same signaling factors involved in neural 
specification in-vivo (Lazzari et al. 2006). In the present study, factors such as SHH and RA, which 
are considered potent mitogens of neural specification in-vivo, significantly upregulated neural 
markers in-vitro, suggesting a conserved response of the NPCs to these signaling factors in-vitro. 
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9. Conclusion 
With human stem cell research rapidly approaching a clinical application, the need for a suitable 
animal model of stem cell therapy has become increasingly apparent. In the current thesis, the initial 
conditions for adaptation of the porcine ICM and epiblast cells to in-vitro culture was established. 
Using bioinformatical analysis, a conserved regulation of the pluripotency markers OCT4 and 
NANOG between the pig and other ungulates, primates and rodents was shown, indicating a con-
served mechanism of these markers in maintaining pluripotency in the pig. OCT4 was furthermore 
found to be a reliable marker of pluripotency as it was located exclusively in the epiblast of hatched 
in-vivo blastocysts and in ESC-like cells in-vitro. Furthermore, NANOG displayed a restrictive ex-
pression in the ICM of porcine in-vitro produced blastocysts using a green fluorescent NANOG re-
porter. Finally, a epiblast derived NPC line, capable of long term self-renewal and differentiation 
into neurons, astrocytes and oligodendrocytes, was established. Collectively, these results show that 
OCs derived from porcine epiblast cells are pluripotent, but lack the ability of self-renewal, whereas 
epiblast derived NPCs are both multipotent and retain self-renewal capacity. Despite the current 
lack of stable pESC lines, the pig could constitute an important model of human neural stem cell 
therapy. 
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10. Perspectives 
There are several possible means to identify the pathways involved in pluripotency in the pig, which 
is most likely maintained by a combination of transcription factors and epigenetic reprogramming 
(Talbot & Blomberg 2008). Functional studies of OCT4/SOX2 and OCT4/SOX2/KLF4 binding to 
the promoter of OCT4 and NANOG in ICM, epiblast and trophectodermal cells may help to shed 
light on these factors. Furthermore, studies on the methylation and histone modification would be 
highly relevant. In light of the different reports of expression of core pluripotency markers in the 
pig, a reporter pig of OCT4 and NANOG would constitute a valuable tool to directly observe tran-
scripton in different tissues instead of relying on indirect methods such as RT-PCR. 
 
Recent evidence points to Klf4 and C-myc as key players in reprogramming to a pluripotent state. In 
the mouse and human, it has been shown that KLF4 interacts with OCT4/SOX2 to upregulate 
Nanog expression in ESCs and iPSCs (Chan et al. 2009; Wei et al. 2009) and NANOG has in turn 
been shown to be responsible for instating ground state pluripotency in undifferentiated cells (Silva 
et al. 2009). Furthermore, in the mouse, Klf4 overexpression has been shown to be sufficient to re-
vert EpiSCs into germ line competent ESCs (Guo et al. 2009). C-myc has, in contrast, been shown 
to be involved in epigenetic reprogramming by promoting DNA replication, thereby relaxing chro-
matin structure (Niwa 2007). In concert, upregulation of Klf4 and C-myc has enabled the derivation 
of mESCs from non-permissive mouse strains (Hanna et al. 2009). Since the ICM and epiblast cells 
of the porcine blastocyst are reported to have a low levels of endogenous C-MYC and KLF4 expres-
sion (Telugu et al. 2009), upregulation of these transcription factors in porcine ICM or epiblast cells 
may hold the key to establishment of stable pESC lines. This could either be achieved by viral 
transduction or by use of inhibitors which shield the pluripotent cells from differentiation. 
 
Recently, piPSCs have been generated by use of OCT4, SOX2, KLF4 and C-MYC (Esteban et al. 
2009; Ezashi et al. 2009; Wu et al. 2009). These cells would be ideal for studying signaling path-
ways controlling pluripotency in the pig. An approach for the establishment of pESCs could be to 
use co-culture with piPSCs or conditioned medium similarly to the approach used by Martin (1981) 
in which conditioned medium from a teratocarcinoma cell line was used for establishment of 
mESCs (Martin 1981). Like in the mouse, germline capable piPSC could potentially be isolated by 
use of the porcine green fluorescent NANOG reporter generated in this study.  
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Despite the successful derivation of pNPCs from porcine epiblast cells, the methods adapted from 
differentiation of hESCs into NPCs could be further optimized by inclusion of signaling molecules 
shown to be involved in neural induction in-vivo. Inclusion of ACTIVIN to the ESC medium, 
which is known to sustain hESC self-renewal (Beattie et al. 2005), but also to stimulate mesoderm 
and endoderm formation in the early embryo (Schier 2003), could have stimulated the formation of 
endo- and mesodermal structures as well. Instead, it would be interesting to include NOGGIN, as 
this growth factor has been shown to be involved in the early induction of neuroectoderm in-vivo 
(Smith & Harland 1992) and to stimulate neural differentiation of hESCs in-vitro (Sonntag et al. 
2007). Recently, it was shown that differentiation of hESC to NPCs could be obtained in a defined 
manner by induction with the factors NOGGIN and SB431542 (Chambers et al. 2009), which obvi-
ate the need of xenogenic cells and compounds, theraby facilitating the use of hNPCs in regenera-
tive medicine and disease modeling. A similar approach could be applied to the neural induction of 
porcine epiblast cells. 
 
Recently, hIPSCs have been generated from a range of patients, including PD and HD patients 
(Park et al. 2008a), which could be used for syngeneic treatment of patients in the future. With the 
recent reprogramming of porcine fibroblast cells into piPSCs, these cells could provide an excellent 
source for differentiation into pNPCs. Combined with the emergence of important porcine disease 
models of PD, HD and AD (Lind et al. 2007), this would constitute an excellent model of neural 
stem cell therapy of human neurodegenerative diseases. 
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